NZ556219A - Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level - Google Patents

Info

Publication number

NZ556219A

NZ556219A NZ556219A NZ55621906A NZ556219A NZ 556219 A NZ556219 A NZ 556219A NZ 556219 A NZ556219 A NZ 556219A NZ 55621906 A NZ55621906 A NZ 55621906A NZ 556219 A NZ556219 A NZ 556219A

Authority

NZ

New Zealand

Prior art keywords

pyrimidin

yloxy

phenyl

methanesulfonyl

fluoro

Prior art date

2005-01-10

Links

• Espacenet
• Global Dossier
• Discuss

• 210000004369 blood Anatomy 0.000 title claims abstract description 222
• 239000008280 blood Substances 0.000 title claims abstract description 222
• DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 title claims abstract description 200
• 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 title claims abstract 33
• 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 title abstract 4
• 206010012601 diabetes mellitus Diseases 0.000 title description 56
• 230000001668 ameliorated effect Effects 0.000 title description 52
• 238000011282 treatment Methods 0.000 title description 23
• 238000002648 combination therapy Methods 0.000 title description 11
• 150000001875 compounds Chemical class 0.000 claims abstract description 250
• 238000000034 method Methods 0.000 claims abstract description 123
• 238000012360 testing method Methods 0.000 claims abstract description 87
• 230000000580 secretagogue effect Effects 0.000 claims abstract description 47
• 210000003158 enteroendocrine cell Anatomy 0.000 claims abstract description 24
• 230000028327 secretion Effects 0.000 claims abstract description 12
• 239000000556 agonist Substances 0.000 claims description 334
• 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 claims description 266
• 239000003112 inhibitor Substances 0.000 claims description 253
• 102400000322 Glucagon-like peptide 1 Human genes 0.000 claims description 197
• 239000000203 mixture Substances 0.000 claims description 117
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 claims description 83
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 claims description 83
• 102000005962 receptors Human genes 0.000 claims description 68
• 108020003175 receptors Proteins 0.000 claims description 68
• 230000000694 effects Effects 0.000 claims description 63
• 150000001413 amino acids Chemical group 0.000 claims description 44
• 239000003446 ligand Substances 0.000 claims description 32
• 125000003729 nucleotide group Chemical group 0.000 claims description 30
• 239000002773 nucleotide Substances 0.000 claims description 29
• 108091033319 polynucleotide Proteins 0.000 claims description 28
• 239000002157 polynucleotide Substances 0.000 claims description 28
• 102000040430 polynucleotide Human genes 0.000 claims description 28
• 150000003384 small molecules Chemical class 0.000 claims description 27
• 210000004027 cell Anatomy 0.000 claims description 25
• 239000012634 fragment Substances 0.000 claims description 24
• 239000003814 drug Substances 0.000 claims description 22
• 241000124008 Mammalia Species 0.000 claims description 21
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 21
• IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical group C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 claims description 19
• IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 claims description 19
• 230000027455 binding Effects 0.000 claims description 19
• 238000009739 binding Methods 0.000 claims description 19
• 229940095074 cyclic amp Drugs 0.000 claims description 19
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 19
• 238000003752 polymerase chain reaction Methods 0.000 claims description 18
• 229920001184 polypeptide Polymers 0.000 claims description 18
• 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 claims description 14
• MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 claims description 12
• 230000008569 process Effects 0.000 claims description 12
• 239000000523 sample Substances 0.000 claims description 12
• 239000013604 expression vector Substances 0.000 claims description 11
• 239000000427 antigen Substances 0.000 claims description 10
• 108091007433 antigens Proteins 0.000 claims description 10
• 102000036639 antigens Human genes 0.000 claims description 10
• 150000002632 lipids Chemical class 0.000 claims description 10
• 238000003556 assay Methods 0.000 claims description 9
• 230000000295 complement effect Effects 0.000 claims description 8
• 239000012528 membrane Substances 0.000 claims description 8
• ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 claims description 6
• 102100020751 Dipeptidyl peptidase 2 Human genes 0.000 claims description 6
• 102100033115 Mitogen-activated protein kinase kinase kinase 1 Human genes 0.000 claims description 6
• 101710164423 Mitogen-activated protein kinase kinase kinase 1 Proteins 0.000 claims description 6
• ZOOGRGPOEVQQDX-UHFFFAOYSA-N cyclic GMP Natural products O1C2COP(O)(=O)OC2C(O)C1N1C=NC2=C1NC(N)=NC2=O ZOOGRGPOEVQQDX-UHFFFAOYSA-N 0.000 claims description 6
• 238000000338 in vitro Methods 0.000 claims description 5
• 150000001982 diacylglycerols Chemical class 0.000 claims description 4
• 239000000275 Adrenocorticotropic Hormone Substances 0.000 claims description 3
• 101800000414 Corticotropin Proteins 0.000 claims description 3
• 102000043136 MAP kinase family Human genes 0.000 claims description 3
• 108091054455 MAP kinase family Proteins 0.000 claims description 3
• 241000283973 Oryctolagus cuniculus Species 0.000 claims description 3
• IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 claims description 3
• 229960000258 corticotropin Drugs 0.000 claims description 3
• 210000003574 melanophore Anatomy 0.000 claims description 3
• 239000000049 pigment Substances 0.000 claims description 3
• 108060001084 Luciferase Proteins 0.000 claims description 2
• 239000005089 Luciferase Substances 0.000 claims description 2
• 239000006185 dispersion Substances 0.000 claims description 2
• 101710087084 Dipeptidyl peptidase 2 Proteins 0.000 claims 3
• 230000009918 complex formation Effects 0.000 claims 3
• 239000012472 biological sample Substances 0.000 claims 2
• 230000036765 blood level Effects 0.000 claims 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 106
• 239000008103 glucose Substances 0.000 abstract description 106
• 229940100607 GPR119 agonist Drugs 0.000 abstract description 2
• 102100033839 Glucose-dependent insulinotropic receptor Human genes 0.000 abstract description 2
• 101000996752 Homo sapiens Glucose-dependent insulinotropic receptor Proteins 0.000 abstract description 2
• 229940124213 Dipeptidyl peptidase 4 (DPP IV) inhibitor Drugs 0.000 abstract 1
• 239000003603 dipeptidyl peptidase IV inhibitor Substances 0.000 abstract 1
• -1 alkyl radical Chemical class 0.000 description 296
• 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 description 253
• 101800000224 Glucagon-like peptide 1 Proteins 0.000 description 169
• 125000000217 alkyl group Chemical group 0.000 description 167
• JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 85
• 229910052736 halogen Inorganic materials 0.000 description 84
• 150000002367 halogens Chemical class 0.000 description 84
• 125000003545 alkoxy group Chemical group 0.000 description 78
• 125000001188 haloalkyl group Chemical group 0.000 description 78
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 71
• 125000001072 heteroaryl group Chemical group 0.000 description 69
• 125000004093 cyano group Chemical group *C#N 0.000 description 67
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 65
• 125000002252 acyl group Chemical group 0.000 description 62
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 61
• 150000003857 carboxamides Chemical class 0.000 description 56
• 125000004438 haloalkoxy group Chemical group 0.000 description 56
• 125000005431 alkyl carboxamide group Chemical group 0.000 description 55
• 125000004390 alkyl sulfonyl group Chemical group 0.000 description 53
• 125000004422 alkyl sulphonamide group Chemical group 0.000 description 52
• 125000004414 alkyl thio group Chemical group 0.000 description 50
• 125000004423 acyloxy group Chemical group 0.000 description 48
• 125000004644 alkyl sulfinyl group Chemical group 0.000 description 48
• 125000001424 substituent group Chemical group 0.000 description 47
• 125000000623 heterocyclic group Chemical group 0.000 description 46
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 45
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 44
• 125000004441 haloalkylsulfonyl group Chemical group 0.000 description 43
• 125000003282 alkyl amino group Chemical group 0.000 description 42
• 125000005432 dialkylcarboxamide group Chemical group 0.000 description 42
• 125000004440 haloalkylsulfinyl group Chemical group 0.000 description 40
• 239000008194 pharmaceutical composition Substances 0.000 description 40
• 125000004995 haloalkylthio group Chemical group 0.000 description 39
• 101000750094 Homo sapiens Chemerin-like receptor 2 Proteins 0.000 description 38
• 125000003118 aryl group Chemical group 0.000 description 38
• 102100021198 Chemerin-like receptor 2 Human genes 0.000 description 37
• 125000000753 cycloalkyl group Chemical group 0.000 description 37
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 36
• 230000002195 synergetic effect Effects 0.000 description 34
• 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 32
• JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 30
• 230000037396 body weight Effects 0.000 description 30
• 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 29
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 29
• 125000004663 dialkyl amino group Chemical group 0.000 description 29
• 239000002253 acid Substances 0.000 description 27
• 239000002552 dosage form Substances 0.000 description 25
• 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 24
• 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 description 22
• 125000005363 dialkylsulfonamide group Chemical group 0.000 description 20
• 150000002148 esters Chemical class 0.000 description 20
• 230000003834 intracellular effect Effects 0.000 description 20
• 239000000126 substance Substances 0.000 description 20
• 229910052717 sulfur Inorganic materials 0.000 description 20
• 229910052760 oxygen Inorganic materials 0.000 description 19
• FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 19
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 19
• 108091006027 G proteins Proteins 0.000 description 18
• 102000030782 GTP binding Human genes 0.000 description 18
• 108091000058 GTP-Binding Proteins 0.000 description 18
• 229910052757 nitrogen Inorganic materials 0.000 description 18
• 125000002947 alkylene group Chemical group 0.000 description 17
• 125000000304 alkynyl group Chemical group 0.000 description 15
• 239000003937 drug carrier Substances 0.000 description 15
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
• 230000004044 response Effects 0.000 description 14
• 125000003342 alkenyl group Chemical group 0.000 description 13
• 229910052799 carbon Inorganic materials 0.000 description 13
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 12
• 235000001014 amino acid Nutrition 0.000 description 12
• 125000002933 cyclohexyloxy group Chemical group C1(CCCCC1)O* 0.000 description 12
• 229910052739 hydrogen Inorganic materials 0.000 description 12
• 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 12
• 229960004063 propylene glycol Drugs 0.000 description 12
• 108020004414 DNA Proteins 0.000 description 11
• 239000004146 Propane-1,2-diol Substances 0.000 description 11
• 229910020008 S(O) Inorganic materials 0.000 description 11
• 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 11
• 230000004913 activation Effects 0.000 description 11
• 229940079593 drug Drugs 0.000 description 11
• 230000002265 prevention Effects 0.000 description 11
• 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 11
• 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 10
• IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 10
• 125000004453 alkoxycarbonyl group Chemical group 0.000 description 10
• 125000004391 aryl sulfonyl group Chemical group 0.000 description 10
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 10
• 238000009472 formulation Methods 0.000 description 9
• 230000005764 inhibitory process Effects 0.000 description 9
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
• 201000001320 Atherosclerosis Diseases 0.000 description 8
• LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 8
• 241000699670 Mus sp. Species 0.000 description 8
• 208000008589 Obesity Diseases 0.000 description 8
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
• 201000001421 hyperglycemia Diseases 0.000 description 8
• 239000000463 material Substances 0.000 description 8
• 235000020824 obesity Nutrition 0.000 description 8
• 238000007410 oral glucose tolerance test Methods 0.000 description 8
• 239000004031 partial agonist Substances 0.000 description 8
• NVMHDJQDTCMXLH-UHFFFAOYSA-N propan-2-yl piperidine-1-carboxylate Chemical compound CC(C)OC(=O)N1CCCCC1 NVMHDJQDTCMXLH-UHFFFAOYSA-N 0.000 description 8
• DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 8
• 235000002639 sodium chloride Nutrition 0.000 description 8
• 229940124530 sulfonamide Drugs 0.000 description 8
• 150000003456 sulfonamides Chemical class 0.000 description 8
• UOUFRTFWWBCVPV-UHFFFAOYSA-N tert-butyl 4-(2,4-dioxo-1H-thieno[3,2-d]pyrimidin-3-yl)piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(CC1)n1c(=O)[nH]c2ccsc2c1=O UOUFRTFWWBCVPV-UHFFFAOYSA-N 0.000 description 8
• 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 7
• 206010020772 Hypertension Diseases 0.000 description 7
• 208000006011 Stroke Diseases 0.000 description 7
• 230000015572 biosynthetic process Effects 0.000 description 7
• 239000002775 capsule Substances 0.000 description 7
• 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 description 7
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 7
• 125000000392 cycloalkenyl group Chemical group 0.000 description 7
• 125000003709 fluoroalkyl group Chemical group 0.000 description 7
• 208000015122 neurodegenerative disease Diseases 0.000 description 7
• 239000000546 pharmaceutical excipient Substances 0.000 description 7
• 239000000243 solution Substances 0.000 description 7
• 239000003826 tablet Substances 0.000 description 7
• 238000002560 therapeutic procedure Methods 0.000 description 7
• SYOKIDBDQMKNDQ-XWTIBIIYSA-N vildagliptin Chemical compound C1C(O)(C2)CC(C3)CC1CC32NCC(=O)N1CCC[C@H]1C#N SYOKIDBDQMKNDQ-XWTIBIIYSA-N 0.000 description 7
• ZSOPWZQRZHWYFY-NUXPJIRBSA-N (2s,3s)-2-amino-3-methyl-1-(1,3-thiazolidin-3-yl)pentan-1-one;(e)-but-2-enedioic acid Chemical compound OC(=O)\C=C\C(O)=O.CC[C@H](C)[C@H](N)C(=O)N1CCSC1 ZSOPWZQRZHWYFY-NUXPJIRBSA-N 0.000 description 6
• VFFZWMWTUSXDCB-ZDUSSCGKSA-N 6-[2-[[2-[(2s)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]ethylamino]pyridine-3-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC1=CC=C(C#N)C=N1 VFFZWMWTUSXDCB-ZDUSSCGKSA-N 0.000 description 6
• 208000031226 Hyperlipidaemia Diseases 0.000 description 6
• 150000001412 amines Chemical class 0.000 description 6
• 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 6
• 125000005605 benzo group Chemical group 0.000 description 6
• 229910052794 bromium Inorganic materials 0.000 description 6
• 208000026106 cerebrovascular disease Diseases 0.000 description 6
• 239000003795 chemical substances by application Substances 0.000 description 6
• 125000005843 halogen group Chemical group 0.000 description 6
• 239000001257 hydrogen Substances 0.000 description 6
• 150000002484 inorganic compounds Chemical class 0.000 description 6
• 229910010272 inorganic material Inorganic materials 0.000 description 6
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 6
• 230000003287 optical effect Effects 0.000 description 6
• 150000002894 organic compounds Chemical class 0.000 description 6
• 230000037361 pathway Effects 0.000 description 6
• 150000003839 salts Chemical class 0.000 description 6
• 238000000926 separation method Methods 0.000 description 6
• 238000003786 synthesis reaction Methods 0.000 description 6
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
• 206010022489 Insulin Resistance Diseases 0.000 description 5
• 208000001145 Metabolic Syndrome Diseases 0.000 description 5
• 241001465754 Metazoa Species 0.000 description 5
• 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 5
• 230000001419 dependent effect Effects 0.000 description 5
• 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 5
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 5
• 125000004474 heteroalkylene group Chemical group 0.000 description 5
• 125000005842 heteroatom Chemical group 0.000 description 5
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 5
• 238000004519 manufacturing process Methods 0.000 description 5
• 206010027175 memory impairment Diseases 0.000 description 5
• 208000010125 myocardial infarction Diseases 0.000 description 5
• 125000003831 tetrazolyl group Chemical group 0.000 description 5
• 150000003573 thiols Chemical class 0.000 description 5
• MAUMSNABMVEOGP-UHFFFAOYSA-N (methyl-$l^{2}-azanyl)methane Chemical compound C[N]C MAUMSNABMVEOGP-UHFFFAOYSA-N 0.000 description 4
• DNUTZBZXLPWRJG-UHFFFAOYSA-N 1-Piperidine carboxylic acid Chemical compound OC(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-N 0.000 description 4
• DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
• 208000010444 Acidosis Diseases 0.000 description 4
• 208000002177 Cataract Diseases 0.000 description 4
• 208000007342 Diabetic Nephropathies Diseases 0.000 description 4
• 208000032131 Diabetic Neuropathies Diseases 0.000 description 4
• 206010012689 Diabetic retinopathy Diseases 0.000 description 4
• 208000013600 Diabetic vascular disease Diseases 0.000 description 4
• 108010016626 Dipeptides Proteins 0.000 description 4
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
• 108010010803 Gelatin Proteins 0.000 description 4
• 208000002705 Glucose Intolerance Diseases 0.000 description 4
• 206010018473 Glycosuria Diseases 0.000 description 4
• ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
• 206010027417 Metabolic acidosis Diseases 0.000 description 4
• 241000699666 Mus <mouse, genus> Species 0.000 description 4
• KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 4
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 4
• 102000014384 Type C Phospholipases Human genes 0.000 description 4
• 108010079194 Type C Phospholipases Proteins 0.000 description 4
• FKCMADOPPWWGNZ-YUMQZZPRSA-N [(2r)-1-[(2s)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic acid Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1B(O)O FKCMADOPPWWGNZ-YUMQZZPRSA-N 0.000 description 4
• 238000009825 accumulation Methods 0.000 description 4
• 239000004480 active ingredient Substances 0.000 description 4
• ZSBOMTDTBDDKMP-OAHLLOKOSA-N alogliptin Chemical compound C=1C=CC=C(C#N)C=1CN1C(=O)N(C)C(=O)C=C1N1CCC[C@@H](N)C1 ZSBOMTDTBDDKMP-OAHLLOKOSA-N 0.000 description 4
• 238000010171 animal model Methods 0.000 description 4
• 230000001413 cellular effect Effects 0.000 description 4
• 239000002299 complementary DNA Substances 0.000 description 4
• 208000029078 coronary artery disease Diseases 0.000 description 4
• 125000000000 cycloalkoxy group Chemical group 0.000 description 4
• 208000033679 diabetic kidney disease Diseases 0.000 description 4
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
• 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 4
• 125000001153 fluoro group Chemical group F* 0.000 description 4
• 239000008273 gelatin Substances 0.000 description 4
• 229920000159 gelatin Polymers 0.000 description 4
• 235000019322 gelatine Nutrition 0.000 description 4
• 235000011852 gelatine desserts Nutrition 0.000 description 4
• 230000035780 glucosuria Effects 0.000 description 4
• 125000005223 heteroarylcarbonyl group Chemical group 0.000 description 4
• 150000002431 hydrogen Chemical group 0.000 description 4
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
• VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
• CKJNUZNMWOVDFN-UHFFFAOYSA-N methanone Chemical compound O=[CH-] CKJNUZNMWOVDFN-UHFFFAOYSA-N 0.000 description 4
• 230000004048 modification Effects 0.000 description 4
• 238000012986 modification Methods 0.000 description 4
• 125000004430 oxygen atom Chemical group O* 0.000 description 4
• 208000033808 peripheral neuropathy Diseases 0.000 description 4
• 230000000144 pharmacologic effect Effects 0.000 description 4
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 4
• 229920000642 polymer Polymers 0.000 description 4
• 201000009104 prediabetes syndrome Diseases 0.000 description 4
• 108090000623 proteins and genes Proteins 0.000 description 4
• 150000003254 radicals Chemical class 0.000 description 4
• QGJUIPDUBHWZPV-SGTAVMJGSA-N saxagliptin Chemical compound C1C(C2)CC(C3)CC2(O)CC13[C@H](N)C(=O)N1[C@H](C#N)C[C@@H]2C[C@@H]21 QGJUIPDUBHWZPV-SGTAVMJGSA-N 0.000 description 4
• 230000019491 signal transduction Effects 0.000 description 4
• 230000002194 synthesizing effect Effects 0.000 description 4
• ZHUTVLURGLOKMO-ZETCQYMHSA-N (2s)-1-acetylpyrrolidine-2-carbonitrile Chemical compound CC(=O)N1CCC[C@H]1C#N ZHUTVLURGLOKMO-ZETCQYMHSA-N 0.000 description 3
• WCRLBFHWFPELKW-YUMQZZPRSA-N (2s,3s)-2-amino-3-methyl-1-(1,3-thiazolidin-3-yl)pentan-1-one Chemical group CC[C@H](C)[C@H](N)C(=O)N1CCSC1 WCRLBFHWFPELKW-YUMQZZPRSA-N 0.000 description 3
• JSYGLDMGERSRPC-FQUUOJAGSA-N (2s,4s)-4-fluoro-1-[2-[[(1r,3s)-3-(1,2,4-triazol-1-ylmethyl)cyclopentyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical group C1[C@@H](F)C[C@@H](C#N)N1C(=O)CN[C@H]1C[C@@H](CN2N=CN=C2)CC1 JSYGLDMGERSRPC-FQUUOJAGSA-N 0.000 description 3
• ORLCYMQZIPSODD-UHFFFAOYSA-N 1-chloro-2-[chloro(2,2,2-trichloroethoxy)phosphoryl]oxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(=O)OCC(Cl)(Cl)Cl ORLCYMQZIPSODD-UHFFFAOYSA-N 0.000 description 3
• IHBAVXVTGLANPI-QMMMGPOBSA-N 2-amino-3-methyl-1-pyrrolidin-1-yl-butan-1-one Chemical group CC(C)[C@H](N)C(=O)N1CCCC1 IHBAVXVTGLANPI-QMMMGPOBSA-N 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• 208000024827 Alzheimer disease Diseases 0.000 description 3
• 206010010904 Convulsion Diseases 0.000 description 3
• 102100036968 Dipeptidyl peptidase 8 Human genes 0.000 description 3
• 102100036969 Dipeptidyl peptidase 9 Human genes 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 101000804947 Homo sapiens Dipeptidyl peptidase 8 Proteins 0.000 description 3
• 101000804945 Homo sapiens Dipeptidyl peptidase 9 Proteins 0.000 description 3
• 208000023105 Huntington disease Diseases 0.000 description 3
• 208000026072 Motor neurone disease Diseases 0.000 description 3
• 208000018737 Parkinson disease Diseases 0.000 description 3
• 208000014675 Prion-associated disease Diseases 0.000 description 3
• 101710178372 Prolyl endopeptidase Proteins 0.000 description 3
• 102100023832 Prolyl endopeptidase FAP Human genes 0.000 description 3
• 101710129873 Prolyl endopeptidase FAP Proteins 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 241000700159 Rattus Species 0.000 description 3
• 208000030886 Traumatic Brain injury Diseases 0.000 description 3
• DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 3
• 102000030621 adenylate cyclase Human genes 0.000 description 3
• 108060000200 adenylate cyclase Proteins 0.000 description 3
• 125000003368 amide group Chemical group 0.000 description 3
• 125000003277 amino group Chemical group 0.000 description 3
• LDXYBEHACFJIEL-HNNXBMFYSA-N anagliptin Chemical group C=1N2N=C(C)C=C2N=CC=1C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N LDXYBEHACFJIEL-HNNXBMFYSA-N 0.000 description 3
• 239000005557 antagonist Substances 0.000 description 3
• 238000013459 approach Methods 0.000 description 3
• 125000005129 aryl carbonyl group Chemical group 0.000 description 3
• 125000004429 atom Chemical group 0.000 description 3
• BMWITAUNXBHIPO-OZZZDHQUSA-N benzenesulfonic acid;(2s,4s)-4-fluoro-1-[2-[(1-hydroxy-2-methylpropan-2-yl)amino]acetyl]pyrrolidine-2-carbonitrile Chemical group OS(=O)(=O)C1=CC=CC=C1.OCC(C)(C)NCC(=O)N1C[C@@H](F)C[C@H]1C#N BMWITAUNXBHIPO-OZZZDHQUSA-N 0.000 description 3
• 239000011230 binding agent Substances 0.000 description 3
• 230000006931 brain damage Effects 0.000 description 3
• 231100000874 brain damage Toxicity 0.000 description 3
• 208000029028 brain injury Diseases 0.000 description 3
• PCDHSSHKDZYLLI-UHFFFAOYSA-N butan-1-one Chemical compound CCC[C]=O PCDHSSHKDZYLLI-UHFFFAOYSA-N 0.000 description 3
• 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
• 239000011203 carbon fibre reinforced carbon Substances 0.000 description 3
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 125000001309 chloro group Chemical group Cl* 0.000 description 3
• 235000012000 cholesterol Nutrition 0.000 description 3
• 125000002993 cycloalkylene group Chemical group 0.000 description 3
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
• 230000007812 deficiency Effects 0.000 description 3
• 230000002950 deficient Effects 0.000 description 3
• 230000006735 deficit Effects 0.000 description 3
• 108090000212 dipeptidyl peptidase II Proteins 0.000 description 3
• 201000010099 disease Diseases 0.000 description 3
• RUJPPJYDHHAEEK-UHFFFAOYSA-N ethyl piperidine-4-carboxylate Chemical compound CCOC(=O)C1CCNCC1 RUJPPJYDHHAEEK-UHFFFAOYSA-N 0.000 description 3
• 231100000318 excitotoxic Toxicity 0.000 description 3
• 230000003492 excitotoxic effect Effects 0.000 description 3
• 230000014101 glucose homeostasis Effects 0.000 description 3
• 230000002641 glycemic effect Effects 0.000 description 3
• 230000036541 health Effects 0.000 description 3
• 238000009396 hybridization Methods 0.000 description 3
• 238000001727 in vivo Methods 0.000 description 3
• 239000000859 incretin Substances 0.000 description 3
• 230000003914 insulin secretion Effects 0.000 description 3
• 229940125425 inverse agonist Drugs 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• 208000005264 motor neuron disease Diseases 0.000 description 3
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
• WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 3
• 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 3
• 125000005010 perfluoroalkyl group Chemical group 0.000 description 3
• 239000008177 pharmaceutical agent Substances 0.000 description 3
• 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 3
• 230000036470 plasma concentration Effects 0.000 description 3
• 229920001223 polyethylene glycol Polymers 0.000 description 3
• 239000000843 powder Substances 0.000 description 3
• 238000002360 preparation method Methods 0.000 description 3
• 235000018102 proteins Nutrition 0.000 description 3
• 102000004169 proteins and genes Human genes 0.000 description 3
• UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 3
• 238000003757 reverse transcription PCR Methods 0.000 description 3
• 108010033693 saxagliptin Proteins 0.000 description 3
• 229960004937 saxagliptin Drugs 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 208000020431 spinal cord injury Diseases 0.000 description 3
• 239000000758 substrate Substances 0.000 description 3
• 238000013268 sustained release Methods 0.000 description 3
• 239000012730 sustained-release form Substances 0.000 description 3
• 108010009573 talabostat Proteins 0.000 description 3
• 239000000454 talc Substances 0.000 description 3
• 229910052623 talc Inorganic materials 0.000 description 3
• RQCNHUCCQJMSRG-UHFFFAOYSA-N tert-butyl piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCCC1 RQCNHUCCQJMSRG-UHFFFAOYSA-N 0.000 description 3
• 230000001225 therapeutic effect Effects 0.000 description 3
• 230000009529 traumatic brain injury Effects 0.000 description 3
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
• 229920002554 vinyl polymer Polymers 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• UYDMQNYSUYFELE-UHFFFAOYSA-N (6-chloropyridin-2-yl)-[4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)C=2N=C(Cl)C=CC=2)=NC=N1 UYDMQNYSUYFELE-UHFFFAOYSA-N 0.000 description 2
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
• VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
• SCENPVNZDKGPCK-UHFFFAOYSA-N 2-(4-bromophenyl)-6-methyl-n-(4-methylphenyl)pyrimidin-4-amine Chemical compound C1=CC(C)=CC=C1NC1=CC(C)=NC(C=2C=CC(Br)=CC=2)=N1 SCENPVNZDKGPCK-UHFFFAOYSA-N 0.000 description 2
• LJBXYRCLWXBLNO-UHFFFAOYSA-N 2-(4-bromophenyl)-6-methyl-n-phenylpyrimidin-4-amine Chemical compound N=1C(C=2C=CC(Br)=CC=2)=NC(C)=CC=1NC1=CC=CC=C1 LJBXYRCLWXBLNO-UHFFFAOYSA-N 0.000 description 2
• OHSJFWDPQZRDTI-UHFFFAOYSA-N 2-(4-bromophenyl)-n,6-dimethylpyrimidin-4-amine Chemical compound CNC1=CC(C)=NC(C=2C=CC(Br)=CC=2)=N1 OHSJFWDPQZRDTI-UHFFFAOYSA-N 0.000 description 2
• URRKHLWROGLWPY-UHFFFAOYSA-N 2-(4-bromophenyl)-n-(4-methoxyphenyl)-6-methylpyrimidin-4-amine Chemical compound C1=CC(OC)=CC=C1NC1=CC(C)=NC(C=2C=CC(Br)=CC=2)=N1 URRKHLWROGLWPY-UHFFFAOYSA-N 0.000 description 2
• MIWZYXUIFUTYGV-UHFFFAOYSA-N 2-(4-bromophenyl)-n-cyclohexyl-6-methylpyrimidin-4-amine Chemical compound N=1C(C=2C=CC(Br)=CC=2)=NC(C)=CC=1NC1CCCCC1 MIWZYXUIFUTYGV-UHFFFAOYSA-N 0.000 description 2
• ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
• USVVDIXKJGUICW-UHFFFAOYSA-N 2-[4-[(6-methyl-2-phenylpyrimidin-4-yl)amino]phenyl]ethanol Chemical compound N=1C(C=2C=CC=CC=2)=NC(C)=CC=1NC1=CC=C(CCO)C=C1 USVVDIXKJGUICW-UHFFFAOYSA-N 0.000 description 2
• DQDOQWDMORTGOE-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-thiophen-2-ylethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CS1 DQDOQWDMORTGOE-UHFFFAOYSA-N 0.000 description 2
• IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
• TWQUDCYVXFEJJM-UHFFFAOYSA-N 2-methylpropyl 4-[9-(6-methylsulfonylpyridin-3-yl)purin-6-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC(C)C)CCC1OC1=NC=NC2=C1N=CN2C1=CC=C(S(C)(=O)=O)N=C1 TWQUDCYVXFEJJM-UHFFFAOYSA-N 0.000 description 2
• YOIFNWZCTVHWLF-UHFFFAOYSA-N 3-[[[2-(4-bromophenyl)-6-methylpyrimidin-4-yl]amino]methyl]-1h-pyridin-2-one Chemical compound N=1C(C=2C=CC(Br)=CC=2)=NC(C)=CC=1NCC1=CC=CNC1=O YOIFNWZCTVHWLF-UHFFFAOYSA-N 0.000 description 2
• 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 2
• AETWQHDDGJXVKU-UHFFFAOYSA-N 4-[2-[[2-(4-bromophenyl)-6-methylpyrimidin-4-yl]amino]ethyl]-1h-pyridin-2-one Chemical compound N=1C(C=2C=CC(Br)=CC=2)=NC(C)=CC=1NCCC=1C=CNC(=O)C=1 AETWQHDDGJXVKU-UHFFFAOYSA-N 0.000 description 2
• MZUWWJBWFHRTJA-UHFFFAOYSA-N 4-[[[2-(4-bromophenyl)-6-ethylpyrimidin-4-yl]amino]methyl]-1h-pyridin-2-one Chemical compound N=1C(C=2C=CC(Br)=CC=2)=NC(CC)=CC=1NCC=1C=CNC(=O)C=1 MZUWWJBWFHRTJA-UHFFFAOYSA-N 0.000 description 2
• JMRGHLDQKHXRES-UHFFFAOYSA-N 5-[[2-(4-bromophenyl)-6-ethylpyrimidin-4-yl]amino]pentan-1-ol Chemical compound CCC1=CC(NCCCCCO)=NC(C=2C=CC(Br)=CC=2)=N1 JMRGHLDQKHXRES-UHFFFAOYSA-N 0.000 description 2
• LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
• 102100031786 Adiponectin Human genes 0.000 description 2
• 108010076365 Adiponectin Proteins 0.000 description 2
• 102000003808 Adiponectin Receptors Human genes 0.000 description 2
• 108090000179 Adiponectin Receptors Proteins 0.000 description 2
• 108700028369 Alleles Proteins 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 2
• 206010008190 Cerebrovascular accident Diseases 0.000 description 2
• VOPWNXZWBYDODV-UHFFFAOYSA-N Chlorodifluoromethane Chemical compound FC(F)Cl VOPWNXZWBYDODV-UHFFFAOYSA-N 0.000 description 2
• 208000017667 Chronic Disease Diseases 0.000 description 2
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
• 101000887162 Gallus gallus Gallinacin-5 Proteins 0.000 description 2
• 101000887166 Gallus gallus Gallinacin-7 Proteins 0.000 description 2
• 108010004460 Gastric Inhibitory Polypeptide Proteins 0.000 description 2
• 102100039994 Gastric inhibitory polypeptide Human genes 0.000 description 2
• 229920000084 Gum arabic Polymers 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
• 108090001061 Insulin Proteins 0.000 description 2
• 102000004877 Insulin Human genes 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
• CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
• PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 2
• KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
• SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
• 101000608768 Rattus norvegicus Galectin-5 Proteins 0.000 description 2
• YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
• QAGMBTAACMQRSS-MTULOOOASA-N [(2r,3s)-3,5-diacetyloxyoxolan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@H]1OC(OC(C)=O)C[C@@H]1OC(C)=O QAGMBTAACMQRSS-MTULOOOASA-N 0.000 description 2
• 235000010489 acacia gum Nutrition 0.000 description 2
• 239000000205 acacia gum Substances 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• 239000000443 aerosol Substances 0.000 description 2
• 125000002877 alkyl aryl group Chemical group 0.000 description 2
• 125000005596 alkyl carboxamido group Chemical group 0.000 description 2
• 125000005907 alkyl ester group Chemical group 0.000 description 2
• 125000005213 alkyl heteroaryl group Chemical group 0.000 description 2
• 150000001408 amides Chemical class 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• 125000003710 aryl alkyl group Chemical group 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 230000008512 biological response Effects 0.000 description 2
• ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 2
• 210000004556 brain Anatomy 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• 229910052791 calcium Inorganic materials 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000011651 chromium Substances 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• 230000006552 constitutive activation Effects 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• 125000004122 cyclic group Chemical group 0.000 description 2
• 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 2
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
• 230000003247 decreasing effect Effects 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
• 239000008298 dragée Substances 0.000 description 2
• ZUHWCQOSEKJJSX-UHFFFAOYSA-N ethyl 1-[5-[4-(3-methoxy-3-oxopropanoyl)phenoxy]-2-nitrophenyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=CC(OC=2C=CC(=CC=2)C(=O)CC(=O)OC)=CC=C1[N+]([O-])=O ZUHWCQOSEKJJSX-UHFFFAOYSA-N 0.000 description 2
• LJBGACMVHUTXDX-UHFFFAOYSA-N ethyl 2-[4-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]piperazin-1-yl]acetate Chemical compound C1CN(CC(=O)OCC)CCN1C1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O LJBGACMVHUTXDX-UHFFFAOYSA-N 0.000 description 2
• 238000013213 extrapolation Methods 0.000 description 2
• 229910052731 fluorine Inorganic materials 0.000 description 2
• 230000006870 function Effects 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
• 229940088597 hormone Drugs 0.000 description 2
• 239000005556 hormone Substances 0.000 description 2
• 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
• MGXWVYUBJRZYPE-YUGYIWNOSA-N incretin Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=C(O)C=C1 MGXWVYUBJRZYPE-YUGYIWNOSA-N 0.000 description 2
• 238000002347 injection Methods 0.000 description 2
• 239000007924 injection Substances 0.000 description 2
• 229940125396 insulin Drugs 0.000 description 2
• 229910052740 iodine Inorganic materials 0.000 description 2
• AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 230000028252 learning or memory Effects 0.000 description 2
• 239000000314 lubricant Substances 0.000 description 2
• 235000019359 magnesium stearate Nutrition 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
• 229960003105 metformin Drugs 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
• 210000002569 neuron Anatomy 0.000 description 2
• 229960003966 nicotinamide Drugs 0.000 description 2
• 239000011570 nicotinamide Substances 0.000 description 2
• 239000011664 nicotinic acid Substances 0.000 description 2
• 229960003512 nicotinic acid Drugs 0.000 description 2
• 150000002825 nitriles Chemical class 0.000 description 2
• 125000004433 nitrogen atom Chemical group N* 0.000 description 2
• BGMNLFPSYRWARV-UHFFFAOYSA-N o-(2-pyridin-4-ylethyl) benzenecarbothioate Chemical compound C=1C=CC=CC=1C(=S)OCCC1=CC=NC=C1 BGMNLFPSYRWARV-UHFFFAOYSA-N 0.000 description 2
• HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 description 2
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
• KXERLBHFEQKNSM-UHFFFAOYSA-N propan-2-yl 4-[2-(2,5-difluoro-4-propoxyanilino)pyridin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(F)C(OCCC)=CC(F)=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)C)=CC=N1 KXERLBHFEQKNSM-UHFFFAOYSA-N 0.000 description 2
• CRTLDMZSAOIYMJ-UHFFFAOYSA-N propan-2-yl 4-[3-(2-fluoro-4-methylsulfonylphenyl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC(C1=NN2C)=NC=NC1=C2C1=CC=C(S(C)(=O)=O)C=C1F CRTLDMZSAOIYMJ-UHFFFAOYSA-N 0.000 description 2
• XDCRJVJNAYJUBG-UHFFFAOYSA-N propan-2-yl 4-[3-[2-fluoro-4-(propanoylsulfamoyl)phenyl]-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C1=C2N=CN=C(OC3CCN(CC3)C(=O)OC(C)C)C2=NN1C XDCRJVJNAYJUBG-UHFFFAOYSA-N 0.000 description 2
• ITOGFNYAJTTZDR-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-4-methylsulfonylanilino)-5-methylpyrimidin-4-yl]sulfanylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1SC1=NC=NC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C ITOGFNYAJTTZDR-UHFFFAOYSA-N 0.000 description 2
• LSAQYHDOWUSTHV-UHFFFAOYSA-N propan-2-yl 4-[6-(4-cyano-2-fluoroanilino)-5-ethynylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=CC=2)C#N)F)=C1C#C LSAQYHDOWUSTHV-UHFFFAOYSA-N 0.000 description 2
• INTNXIDUHOVLQP-UHFFFAOYSA-N propan-2-yl 4-[8-(2-fluoro-4-methylsulfonylphenyl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C(C=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CC=C12 INTNXIDUHOVLQP-UHFFFAOYSA-N 0.000 description 2
• OQCZPTRFZZIPOK-UHFFFAOYSA-N propan-2-yl 4-[8-(2-fluoro-4-methylsulfonylphenyl)quinolin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC=NC2=C(C=3C(=CC(=CC=3)S(C)(=O)=O)F)C=CC=C12 OQCZPTRFZZIPOK-UHFFFAOYSA-N 0.000 description 2
• UDTSUHFSHOVKDF-UHFFFAOYSA-N propan-2-yl 4-[8-(4-cyano-2-fluorophenyl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C(C=3C(=CC(=CC=3)C#N)F)N=CC=C12 UDTSUHFSHOVKDF-UHFFFAOYSA-N 0.000 description 2
• PQTLETSHCOHPFJ-UHFFFAOYSA-N propan-2-yl 4-[8-(4-methylsulfanylphenyl)quinolin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=CC(SC)=CC=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C(=O)OC(C)C)CC1 PQTLETSHCOHPFJ-UHFFFAOYSA-N 0.000 description 2
• CSQUXAFZTZMEEV-UHFFFAOYSA-N propan-2-yl 4-[8-[2-fluoro-4-(propanoylsulfamoyl)phenyl]pyrido[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C(C1=NC=N2)=NC=CC1=C2OC1CCN(C(=O)OC(C)C)CC1 CSQUXAFZTZMEEV-UHFFFAOYSA-N 0.000 description 2
• VRKJJBNLZPWRNH-UHFFFAOYSA-N propan-2-yl 4-[9-[2-fluoro-4-(propanoylsulfamoyl)phenyl]purin-6-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1N1C2=NC=NC(OC3CCN(CC3)C(=O)OC(C)C)=C2N=C1 VRKJJBNLZPWRNH-UHFFFAOYSA-N 0.000 description 2
• JKZKXXAGJHLJPM-UHFFFAOYSA-N propan-2-yl 4-[[cyclopropyl-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1CN(C=1C(=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)N=CN=1)C)C1CC1 JKZKXXAGJHLJPM-UHFFFAOYSA-N 0.000 description 2
• XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 2
• 230000001105 regulatory effect Effects 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 239000000600 sorbitol Substances 0.000 description 2
• 235000010356 sorbitol Nutrition 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 230000005062 synaptic transmission Effects 0.000 description 2
• 235000012222 talc Nutrition 0.000 description 2
• IUORNUVLBGKOPB-UHFFFAOYSA-N tert-butyl 3-[[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxymethyl]pyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1COC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O IUORNUVLBGKOPB-UHFFFAOYSA-N 0.000 description 2
• LNSPBFXCTHPXMV-UHFFFAOYSA-N tert-butyl 4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=CC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC=N1 LNSPBFXCTHPXMV-UHFFFAOYSA-N 0.000 description 2
• MOWTZYWSBQQDOW-UHFFFAOYSA-N tert-butyl 4-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O MOWTZYWSBQQDOW-UHFFFAOYSA-N 0.000 description 2
• JYRWUSXRTGACLY-UHFFFAOYSA-N tert-butyl 4-[[3-(4-methylsulfonylphenyl)-[1,2]oxazolo[4,5-d]pyrimidin-7-yl]oxy]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=NC=NC2=C1ON=C2C1=CC=C(S(C)(=O)=O)C=C1 JYRWUSXRTGACLY-UHFFFAOYSA-N 0.000 description 2
• YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 2
• 229940124597 therapeutic agent Drugs 0.000 description 2
• 210000001519 tissue Anatomy 0.000 description 2
• 231100000027 toxicology Toxicity 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 238000010361 transduction Methods 0.000 description 2
• 230000026683 transduction Effects 0.000 description 2
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
• QOMLWUOJCBLHPI-UHFFFAOYSA-N (1-cyclopentyl-3-methyl-1-oxopentan-2-yl)azanium;chloride Chemical compound [Cl-].CCC(C)C([NH3+])C(=O)C1CCCC1 QOMLWUOJCBLHPI-UHFFFAOYSA-N 0.000 description 1
• GNXFVIIWULQUBL-UHFFFAOYSA-N (2-chloropyridin-3-yl)-[4-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)C=2C(=NC=CC=2)Cl)=C1[N+]([O-])=O GNXFVIIWULQUBL-UHFFFAOYSA-N 0.000 description 1
• XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
• SUTRBBYEBJZKSL-HXUWFJFHSA-N (2r)-1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-methyl-2-(methylamino)butan-1-one Chemical compound C1CN(C(=O)[C@@H](C(C)C)NC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C SUTRBBYEBJZKSL-HXUWFJFHSA-N 0.000 description 1
• VLBCUWGXCWKKEA-FERBBOLQSA-N (2s)-1-[2-[[2-methyl-1-[(6-phenylpyridin-2-yl)amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile;hydrochloride Chemical compound Cl.N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=1)=CC=CC=1C1=CC=CC=C1 VLBCUWGXCWKKEA-FERBBOLQSA-N 0.000 description 1
• BXAZNJCLCXBVJT-KRWDZBQOSA-N (2s)-1-[2-[[4-(1,3-dihydroisoindol-2-yl)-2-methyl-4-oxobutan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1C2=CC=CC=C2CN1C(=O)CC(C)(C)NCC(=O)N1CCC[C@H]1C#N BXAZNJCLCXBVJT-KRWDZBQOSA-N 0.000 description 1
• SWKGZJAAGSVROJ-MWLCHTKSSA-N (3r)-4-[(3r)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-methyl-1,4-diazepan-2-one Chemical compound C1CCNC(=O)[C@@H](C)N1C(=O)C[C@H](N)CC1=CC(F)=C(F)C=C1F SWKGZJAAGSVROJ-MWLCHTKSSA-N 0.000 description 1
• NVAUAEAIPCUOBK-UHFFFAOYSA-N (5-methyl-2-propan-2-ylcyclohexyl) 4-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC(C)C1CCC(C)CC1OC(=O)N1CCC(OC=2C(=C(NC=3C=CC(=CC=3)S(C)(=O)=O)N=CN=2)[N+]([O-])=O)CC1 NVAUAEAIPCUOBK-UHFFFAOYSA-N 0.000 description 1
• CPZYECLLEHOQPD-UHFFFAOYSA-N (6-bromopyridin-2-yl)-[4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidin-1-yl]methanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)C=2N=C(Br)C=CC=2)=NC=N1 CPZYECLLEHOQPD-UHFFFAOYSA-N 0.000 description 1
• 125000006656 (C2-C4) alkenyl group Chemical group 0.000 description 1
• 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 description 1
• XOIYZMDJFLKIEI-UHFFFAOYSA-N (hydroxysulfonimidoyl)oxybenzene Chemical compound NS(=O)(=O)OC1=CC=CC=C1 XOIYZMDJFLKIEI-UHFFFAOYSA-N 0.000 description 1
• FIARMZDBEGVMLV-UHFFFAOYSA-N 1,1,2,2,2-pentafluoroethanolate Chemical group [O-]C(F)(F)C(F)(F)F FIARMZDBEGVMLV-UHFFFAOYSA-N 0.000 description 1
• 150000000180 1,2-diols Chemical class 0.000 description 1
• BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
• BOVGTQGAOIONJV-BETUJISGSA-N 1-[(3ar,6as)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]-3-(4-methylphenyl)sulfonylurea Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1C[C@H]2CCC[C@H]2C1 BOVGTQGAOIONJV-BETUJISGSA-N 0.000 description 1
• VOQZIYNVRLBGCV-UHFFFAOYSA-N 1-[4-(1-benzylazetidin-3-yl)oxy-6-[(6-methylsulfonylpyridin-3-yl)amino]pyrimidin-5-yl]ethanone Chemical compound N1=CN=C(OC2CN(CC=3C=CC=CC=3)C2)C(C(=O)C)=C1NC1=CC=C(S(C)(=O)=O)N=C1 VOQZIYNVRLBGCV-UHFFFAOYSA-N 0.000 description 1
• PZJDKUSWONJXFN-UHFFFAOYSA-N 1-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]hexan-1-one Chemical compound C1=CC(C(=O)CCCCC)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CCC)CC2)=C1 PZJDKUSWONJXFN-UHFFFAOYSA-N 0.000 description 1
• FTMRLCTWSIIMHS-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-2-[4-(trifluoromethoxy)phenoxy]propan-1-one Chemical compound C1CC(OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)CCN1C(=O)C(C)OC1=CC=C(OC(F)(F)F)C=C1 FTMRLCTWSIIMHS-UHFFFAOYSA-N 0.000 description 1
• RNAIEELRXPBMCX-UHFFFAOYSA-N 1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]butan-2-one Chemical compound C1CN(CC(=O)CC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C RNAIEELRXPBMCX-UHFFFAOYSA-N 0.000 description 1
• BOJAZRUVYNCACQ-UHFFFAOYSA-N 1-[4-[6-[4-(3-methyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-5-nitropyrimidin-4-yl]oxyphenyl]butan-2-one Chemical compound C1=CC(CC(=O)CC)=CC=C1OC1=NC=NC(N2CCC(CC2)C=2ON=C(C)N=2)=C1[N+]([O-])=O BOJAZRUVYNCACQ-UHFFFAOYSA-N 0.000 description 1
• IBNIPRMVXVNXAW-UHFFFAOYSA-N 1-[4-[[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]amino]piperidin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCC1NC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O IBNIPRMVXVNXAW-UHFFFAOYSA-N 0.000 description 1
• 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
• NJSKVJJGYLYIAN-UHFFFAOYSA-N 1-methylpyrazolo[4,3-d]pyrimidine Chemical compound C1=NC=C2N(C)N=CC2=N1 NJSKVJJGYLYIAN-UHFFFAOYSA-N 0.000 description 1
• 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
• HSVYHERZYHUMAW-UHFFFAOYSA-N 2,2,2-trichloroethyl 4-[[methyl-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methyl]amino]methyl]piperidine-1-carboxylate Chemical compound N=1C(C=2C=CN=CC=2)=NOC=1CN(C)CC1CCN(C(=O)OCC(Cl)(Cl)Cl)CC1 HSVYHERZYHUMAW-UHFFFAOYSA-N 0.000 description 1
• 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
• YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
• HZLYOTVRSZDGNJ-UHFFFAOYSA-N 2,5-difluoro-4-[2-methyl-7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[4,3-d]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C3=NN(C)C(C=4C(=CC(=C(F)C=4)S(N)(=O)=O)F)=C3N=CN=2)=N1 HZLYOTVRSZDGNJ-UHFFFAOYSA-N 0.000 description 1
• WPMXDGHWZGOXMK-UHFFFAOYSA-N 2-(4-bromophenyl)-6-ethyl-n-(pyridin-2-ylmethyl)pyrimidin-4-amine Chemical compound N=1C(C=2C=CC(Br)=CC=2)=NC(CC)=CC=1NCC1=CC=CC=N1 WPMXDGHWZGOXMK-UHFFFAOYSA-N 0.000 description 1
• NUXVWURWVUYDCY-UHFFFAOYSA-N 2-(4-bromophenyl)-6-ethyl-n-[(4-fluorophenyl)methyl]pyrimidin-4-amine Chemical compound N=1C(C=2C=CC(Br)=CC=2)=NC(CC)=CC=1NCC1=CC=C(F)C=C1 NUXVWURWVUYDCY-UHFFFAOYSA-N 0.000 description 1
• OKGRXAGCJBIGJA-UHFFFAOYSA-N 2-(4-bromophenyl)-6-methyl-n-(pyridin-3-ylmethyl)pyrimidin-4-amine Chemical compound N=1C(C=2C=CC(Br)=CC=2)=NC(C)=CC=1NCC1=CC=CN=C1 OKGRXAGCJBIGJA-UHFFFAOYSA-N 0.000 description 1
• QCBRMYPYWZWNBS-UHFFFAOYSA-N 2-(4-bromophenyl)-n-[2-(4-chlorophenyl)ethyl]-6-ethylpyrimidin-4-amine Chemical compound N=1C(C=2C=CC(Br)=CC=2)=NC(CC)=CC=1NCCC1=CC=C(Cl)C=C1 QCBRMYPYWZWNBS-UHFFFAOYSA-N 0.000 description 1
• BZQSVOJMQLADPO-UHFFFAOYSA-N 2-[1-[2-nitro-5-[4-(1,2,4-triazol-1-yl)phenoxy]phenyl]piperidin-4-yl]sulfanylpyridine Chemical compound C1=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=CC=C1OC(C=C1)=CC=C1N1C=NC=N1 BZQSVOJMQLADPO-UHFFFAOYSA-N 0.000 description 1
• FVDQYAZTBFZBHS-UHFFFAOYSA-N 2-[2-[(5-nitropyridin-2-yl)amino]ethylamino]-1-pyrrolidin-1-ylethanone;dihydrochloride Chemical compound Cl.Cl.N1=CC([N+](=O)[O-])=CC=C1NCCNCC(=O)N1CCCC1 FVDQYAZTBFZBHS-UHFFFAOYSA-N 0.000 description 1
• JOCFTBJGHSJPQS-UHFFFAOYSA-N 2-[4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidin-1-yl]-1-[4-(trifluoromethoxy)phenyl]ethanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CCN(CC(=O)C=4C=CC(OC(F)(F)F)=CC=4)CC3)=C2C=N1 JOCFTBJGHSJPQS-UHFFFAOYSA-N 0.000 description 1
• KMRWDTYHXJTJMK-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-(3-fluorophenyl)ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CC(F)=C1 KMRWDTYHXJTJMK-UHFFFAOYSA-N 0.000 description 1
• XBUBBGIMTPSSQO-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-(4-fluorophenyl)ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=C(F)C=C1 XBUBBGIMTPSSQO-UHFFFAOYSA-N 0.000 description 1
• PIOXBAXAQIPSJC-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-(4-methoxyphenyl)ethanone Chemical compound C1=CC(OC)=CC=C1C(=O)CN1CCC(OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)CC1 PIOXBAXAQIPSJC-UHFFFAOYSA-N 0.000 description 1
• HYARXWARKOIYRN-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-(4-methylphenyl)ethanone Chemical compound C1=CC(C)=CC=C1C(=O)CN1CCC(OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)CC1 HYARXWARKOIYRN-UHFFFAOYSA-N 0.000 description 1
• MJQKSBDLAPJBIJ-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-(4-methylsulfonylphenyl)ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=C(S(C)(=O)=O)C=C1 MJQKSBDLAPJBIJ-UHFFFAOYSA-N 0.000 description 1
• UDOJPPPKOOURIB-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-(5-phenylthiophen-2-yl)ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C(S1)=CC=C1C1=CC=CC=C1 UDOJPPPKOOURIB-UHFFFAOYSA-N 0.000 description 1
• NSHHEMAHAAEYJH-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-[3-(trifluoromethyl)phenyl]ethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CC(C(F)(F)F)=C1 NSHHEMAHAAEYJH-UHFFFAOYSA-N 0.000 description 1
• ILUJEJKVTTZYGJ-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-phenylethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CC=C1 ILUJEJKVTTZYGJ-UHFFFAOYSA-N 0.000 description 1
• KBRFTJUEHZNTLD-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-pyridin-2-ylethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CC=N1 KBRFTJUEHZNTLD-UHFFFAOYSA-N 0.000 description 1
• HUBNTPOXFSZGTG-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-pyridin-3-ylethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=CN=C1 HUBNTPOXFSZGTG-UHFFFAOYSA-N 0.000 description 1
• VQAKENAYCYDJEL-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-pyridin-4-ylethanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)C1=CC=NC=C1 VQAKENAYCYDJEL-UHFFFAOYSA-N 0.000 description 1
• XZXFZWYWQSKEFG-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-n-(4-methoxyphenyl)acetamide Chemical compound C1=CC(OC)=CC=C1NC(=O)CN1CCC(OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)CC1 XZXFZWYWQSKEFG-UHFFFAOYSA-N 0.000 description 1
• VTXXGGZSMRSJOR-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-n-(4-propan-2-ylphenyl)acetamide Chemical compound C1=CC(C(C)C)=CC=C1NC(=O)CN1CCC(OC=2C(=C(OC=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CN=2)C)CC1 VTXXGGZSMRSJOR-UHFFFAOYSA-N 0.000 description 1
• KIPAKJCXFDIVGX-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-n-[3-(trifluoromethyl)phenyl]acetamide Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)NC1=CC=CC(C(F)(F)F)=C1 KIPAKJCXFDIVGX-UHFFFAOYSA-N 0.000 description 1
• PIFHIJHFTFGODF-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-n-[4-(trifluoromethyl)phenyl]acetamide Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)NC1=CC=C(C(F)(F)F)C=C1 PIFHIJHFTFGODF-UHFFFAOYSA-N 0.000 description 1
• SATVVULHAHBBOR-UHFFFAOYSA-N 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-n-phenylacetamide Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)NC1=CC=CC=C1 SATVVULHAHBBOR-UHFFFAOYSA-N 0.000 description 1
• YRGWSWGFAVVROS-UHFFFAOYSA-N 2-[4-[amino-[2-(4-cyano-1,3-thiazolidin-3-yl)-2-oxoethyl]amino]piperidin-1-yl]-n-(5-chloropyridin-2-yl)acetamide;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.C1CN(CC(=O)NC=2N=CC(Cl)=CC=2)CCC1N(N)CC(=O)N1CSCC1C#N YRGWSWGFAVVROS-UHFFFAOYSA-N 0.000 description 1
• YVCMBGPPTCBEDP-UHFFFAOYSA-N 2-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]-5-(trifluoromethyl)pyridine Chemical compound C1CC(CCC)CCN1C1=CC(OC=2N=CC(=CC=2)C(F)(F)F)=CC=C1[N+]([O-])=O YVCMBGPPTCBEDP-UHFFFAOYSA-N 0.000 description 1
• XGFMFTPUMQOVCG-UHFFFAOYSA-N 2-[7-but-2-ynyl-2,6-dioxo-1-(2-phenylethyl)-8-piperazin-1-ylpurin-3-yl]-n-prop-2-ynylacetamide;hydrochloride Chemical compound Cl.O=C1C=2N(CC#CC)C(N3CCNCC3)=NC=2N(CC(=O)NCC#C)C(=O)N1CCC1=CC=CC=C1 XGFMFTPUMQOVCG-UHFFFAOYSA-N 0.000 description 1
• PHJKYNSEJIZCAD-UHFFFAOYSA-N 2-[[2-(3-aminopiperidin-1-yl)-6,7-dimethoxy-4-oxoquinazolin-3-yl]methyl]benzonitrile Chemical compound C=1C=CC=C(C#N)C=1CN1C(=O)C=2C=C(OC)C(OC)=CC=2N=C1N1CCCC(N)C1 PHJKYNSEJIZCAD-UHFFFAOYSA-N 0.000 description 1
• JYJXSHCMXPJVMD-UHFFFAOYSA-N 2-[[2-(4-bromophenyl)-6-methylpyrimidin-4-yl]-methylamino]ethanol Chemical compound OCCN(C)C1=CC(C)=NC(C=2C=CC(Br)=CC=2)=N1 JYJXSHCMXPJVMD-UHFFFAOYSA-N 0.000 description 1
• MCPSLCJANOFXEW-UHFFFAOYSA-N 2-[[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]methyl]prop-2-enoic acid Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC1CCN(CC(=C)C(O)=O)CC1 MCPSLCJANOFXEW-UHFFFAOYSA-N 0.000 description 1
• XJNKUWDMCBZMTG-UHFFFAOYSA-N 2-[[8-(3-aminopiperidin-1-yl)-1,3-dimethyl-2,6-dioxopurin-7-yl]methyl]benzonitrile Chemical compound C=1C=CC=C(C#N)C=1CN1C=2C(=O)N(C)C(=O)N(C)C=2N=C1N1CCCC(N)C1 XJNKUWDMCBZMTG-UHFFFAOYSA-N 0.000 description 1
• 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
• 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
• NPSJHQMIVNJLNN-UHFFFAOYSA-N 2-ethylhexyl 4-nitrobenzoate Chemical compound CCCCC(CC)COC(=O)C1=CC=C([N+]([O-])=O)C=C1 NPSJHQMIVNJLNN-UHFFFAOYSA-N 0.000 description 1
• 239000004808 2-ethylhexylester Substances 0.000 description 1
• OXQQEFDRMLHYQD-UHFFFAOYSA-N 2-fluoro-5-[[6-[methyl-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]methyl]amino]pyrimidin-4-yl]amino]benzoic acid Chemical compound C=1C(NC=2C=C(C(F)=CC=2)C(O)=O)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 OXQQEFDRMLHYQD-UHFFFAOYSA-N 0.000 description 1
• 125000006040 2-hexenyl group Chemical group 0.000 description 1
• PGRVGFHSZHVGTA-UHFFFAOYSA-N 2-methoxyethyl piperidine-1-carboxylate Chemical compound COCCOC(=O)N1CCCCC1 PGRVGFHSZHVGTA-UHFFFAOYSA-N 0.000 description 1
• 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
• MWGKFCJRULSBHG-UHFFFAOYSA-N 2-methylpropyl 4-[5-acetyl-6-[(6-methylsulfonylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC(C)C)CCC1OC1=NC=NC(NC=2C=NC(=CC=2)S(C)(=O)=O)=C1C(C)=O MWGKFCJRULSBHG-UHFFFAOYSA-N 0.000 description 1
• QABYRZYSSGZTSE-UHFFFAOYSA-N 2-methylpropyl 4-[5-cyano-6-(4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC(C)C)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1C#N QABYRZYSSGZTSE-UHFFFAOYSA-N 0.000 description 1
• OOAXQDLZILCXRS-UHFFFAOYSA-N 2-methylpropyl 4-[[[2-(2-fluoro-4-methylsulfonylanilino)pyridin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC(C)C)CCC1CN(C)C1=CC=NC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1 OOAXQDLZILCXRS-UHFFFAOYSA-N 0.000 description 1
• VHACZHHSMYGNGZ-UHFFFAOYSA-N 2-methylpropyl 4-[[[4-(2-fluoro-4-methylsulfonylanilino)pyridin-2-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC(C)C)CCC1CN(C)C1=CC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=CC=N1 VHACZHHSMYGNGZ-UHFFFAOYSA-N 0.000 description 1
• BBHFEIIKBPQBBO-UHFFFAOYSA-N 2-methylpropyl 4-[[[6-(2,5-difluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC(C)C)CCC1CN(C)C1=CC(NC=2C(=CC=C(F)C=2)F)=NC=N1 BBHFEIIKBPQBBO-UHFFFAOYSA-N 0.000 description 1
• NVUQKMAPUURLFA-UHFFFAOYSA-N 2-methylpropyl 4-[[[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC(C)C)CCC1CN(C)C1=CC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC=N1 NVUQKMAPUURLFA-UHFFFAOYSA-N 0.000 description 1
• ADOQAKPZJKBUNP-UHFFFAOYSA-N 2-methylpropyl 4-[[[6-(4-carbamimidoyl-2-fluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC(C)C)CCC1CN(C)C1=CC(NC=2C(=CC(=CC=2)C(N)=N)F)=NC=N1 ADOQAKPZJKBUNP-UHFFFAOYSA-N 0.000 description 1
• PALIZNPDKQBDGM-UHFFFAOYSA-N 2-methylpropyl 4-[[[6-[2-fluoro-4-(n'-hydroxycarbamimidoyl)anilino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC(C)C)CCC1CN(C)C1=CC(NC=2C(=CC(=CC=2)C(=N)NO)F)=NC=N1 PALIZNPDKQBDGM-UHFFFAOYSA-N 0.000 description 1
• HTOQALXUSKONGW-UHFFFAOYSA-N 2-methylpropyl cyclohexanecarboxylate Chemical compound CC(C)COC(=O)C1CCCCC1 HTOQALXUSKONGW-UHFFFAOYSA-N 0.000 description 1
• DRAOAGJWRFYINJ-UHFFFAOYSA-N 2-methylpyrazolo[4,3-d]pyrimidine Chemical compound N1=CN=CC2=NN(C)C=C21 DRAOAGJWRFYINJ-UHFFFAOYSA-N 0.000 description 1
• 125000006024 2-pentenyl group Chemical group 0.000 description 1
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
• 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
• WFRWDJZTEDLJAW-UHFFFAOYSA-N 3,3-dimethyl-1-[4-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypiperidin-1-yl]butan-1-one Chemical compound C1CN(C(=O)CC(C)(C)C)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O WFRWDJZTEDLJAW-UHFFFAOYSA-N 0.000 description 1
• NMMXMFFMHIZMPW-UHFFFAOYSA-N 3-(aminomethyl)-4-(2,4-dichlorophenyl)-7,8-dimethoxy-5h-indeno[1,2-b]pyridin-2-amine Chemical compound C1=2C=C(OC)C(OC)=CC=2CC2=C1N=C(N)C(CN)=C2C1=CC=C(Cl)C=C1Cl NMMXMFFMHIZMPW-UHFFFAOYSA-N 0.000 description 1
• DTBDAFLSBDGPEA-UHFFFAOYSA-N 3-Methylquinoline Natural products C1=CC=CC2=CC(C)=CN=C21 DTBDAFLSBDGPEA-UHFFFAOYSA-N 0.000 description 1
• HYJRMMRMBZXKQZ-UHFFFAOYSA-N 3-[(2-methylpropan-2-yl)oxy]-n-[4-[[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]amino]cyclohexyl]propanamide Chemical compound C1CC(NC(=O)CCOC(C)(C)C)CCC1NC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 HYJRMMRMBZXKQZ-UHFFFAOYSA-N 0.000 description 1
• YKMUTVOCLPDFMQ-UHFFFAOYSA-N 3-[(3-chloroimidazo[1,2-a]pyridin-2-yl)methylsulfonyl]-n,n-dimethyl-1,2,4-triazole-1-carboxamide Chemical compound CN(C)C(=O)N1C=NC(S(=O)(=O)CC2=C(N3C=CC=CC3=N2)Cl)=N1 YKMUTVOCLPDFMQ-UHFFFAOYSA-N 0.000 description 1
• WWNKXJCYOXVTGI-UHFFFAOYSA-N 3-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]-2-oxopropanoic acid Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(CC(=O)C(O)=O)=CC=2)=CC=C1[N+]([O-])=O WWNKXJCYOXVTGI-UHFFFAOYSA-N 0.000 description 1
• CEQVJPOYQDBGNE-UHFFFAOYSA-N 3-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]propanoic acid Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(CCC(O)=O)=CC=2)=CC=C1[N+]([O-])=O CEQVJPOYQDBGNE-UHFFFAOYSA-N 0.000 description 1
• LWNRMDVXXLXCFI-UHFFFAOYSA-N 3-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-oxopropane-1-sulfonic acid Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC1CCN(C(=O)CCS(O)(=O)=O)CC1 LWNRMDVXXLXCFI-UHFFFAOYSA-N 0.000 description 1
• IVZCZIQKXOTBQW-UHFFFAOYSA-N 3-[[2-(4-bromophenyl)-6-methylpyrimidin-4-yl]amino]propanenitrile Chemical compound CC1=CC(NCCC#N)=NC(C=2C=CC(Br)=CC=2)=N1 IVZCZIQKXOTBQW-UHFFFAOYSA-N 0.000 description 1
• ILSMGGRXRKWAEN-UHFFFAOYSA-N 3-amino-1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-4-methylpentan-1-one Chemical compound C1CN(C(=O)CC(N)C(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C ILSMGGRXRKWAEN-UHFFFAOYSA-N 0.000 description 1
• 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
• 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
• DMPWVCFHSLELGH-UHFFFAOYSA-N 3-fluoro-4-[1-methyl-7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[4,3-d]pyrimidin-3-yl]benzonitrile Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2C=3N(C)N=C(C=3N=CN=2)C=2C(=CC(=CC=2)C#N)F)=N1 DMPWVCFHSLELGH-UHFFFAOYSA-N 0.000 description 1
• KZMAXLPGELOJRP-UHFFFAOYSA-N 3-fluoro-4-[5-methyl-6-(1-propan-2-yloxycarbonylpiperidin-4-yl)oxypyrimidin-4-yl]oxybenzenesulfonic acid Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(O)(=O)=O)F)=C1C KZMAXLPGELOJRP-UHFFFAOYSA-N 0.000 description 1
• GYVQSDVQPGRVGW-UHFFFAOYSA-N 3-fluoro-4-[5-methyl-6-(1-propan-2-yloxycarbonylpiperidin-4-yl)oxypyrimidin-4-yl]oxybenzoic acid Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)C(O)=O)F)=C1C GYVQSDVQPGRVGW-UHFFFAOYSA-N 0.000 description 1
• OSXMHOSXOJEASP-UHFFFAOYSA-N 3-fluoro-4-[7-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)cyclohexyl]oxypyrazolo[1,5-a]pyrimidin-3-yl]benzenesulfonamide Chemical compound CC(C)C1=NOC(C2CCC(CC2)OC=2N3N=CC(=C3N=CC=2)C=2C(=CC(=CC=2)S(N)(=O)=O)F)=N1 OSXMHOSXOJEASP-UHFFFAOYSA-N 0.000 description 1
• 125000006041 3-hexenyl group Chemical group 0.000 description 1
• 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• DMNXUHOKZFMWPQ-UHFFFAOYSA-N 4-(1-benzylazetidin-3-yl)oxy-1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C2=NC=NC(OC3CN(CC=4C=CC=CC=4)C3)=C2C=N1 DMNXUHOKZFMWPQ-UHFFFAOYSA-N 0.000 description 1
• MBPWZHDZEVESMX-UHFFFAOYSA-N 4-(1-butylpiperidin-4-yl)oxy-6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidine Chemical compound C1CN(CCCC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C MBPWZHDZEVESMX-UHFFFAOYSA-N 0.000 description 1
• AZQKDCFSKVWQQO-UHFFFAOYSA-N 4-(1-formylpiperidin-4-yl)oxy-6-(4-methylsulfonylanilino)pyrimidine-5-carbonitrile Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C=O)=C1C#N AZQKDCFSKVWQQO-UHFFFAOYSA-N 0.000 description 1
• VIOOOBWVQCZXIP-UHFFFAOYSA-N 4-(2,4-difluorophenoxy)-5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidine Chemical compound N1=CN=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=C1OC1=CC=C(F)C=C1F VIOOOBWVQCZXIP-UHFFFAOYSA-N 0.000 description 1
• XZFAFVUDTHKWTH-UHFFFAOYSA-N 4-(2-fluoro-4-methylsulfonylphenoxy)-5-methyl-6-piperidin-4-yloxypyrimidine Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC1CCNCC1 XZFAFVUDTHKWTH-UHFFFAOYSA-N 0.000 description 1
• HSWSVHVEPTZPHW-UHFFFAOYSA-N 4-(2-fluoro-4-methylsulfonylphenoxy)-6-(1-hexylpiperidin-4-yl)oxy-5-methylpyrimidine Chemical compound C1CN(CCCCCC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C HSWSVHVEPTZPHW-UHFFFAOYSA-N 0.000 description 1
• SWLAMJPTOQZTAE-UHFFFAOYSA-N 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]benzoic acid Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(C(O)=O)C=C1 SWLAMJPTOQZTAE-UHFFFAOYSA-N 0.000 description 1
• HNCAHNKUINZSCO-UHFFFAOYSA-N 4-[2-[[2-(4-chloro-2,5-difluorophenyl)-6-ethylpyrimidin-4-yl]amino]ethyl]-1h-pyridin-2-one Chemical compound N=1C(C=2C(=CC(Cl)=C(F)C=2)F)=NC(CC)=CC=1NCCC=1C=CNC(=O)C=1 HNCAHNKUINZSCO-UHFFFAOYSA-N 0.000 description 1
• TYFYZGCZDVZRRY-UHFFFAOYSA-N 4-[3-(4-cyano-2-fluorophenyl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylic acid Chemical compound N=1C=NC2=C(C=3C(=CC(=CC=3)C#N)F)N(C)N=C2C=1OC1CCN(C(O)=O)CC1 TYFYZGCZDVZRRY-UHFFFAOYSA-N 0.000 description 1
• QTVLQPAOZWHNFH-UHFFFAOYSA-N 4-[4-[2-nitro-5-(4-propylpiperidin-1-yl)phenoxy]phenyl]butan-2-one Chemical compound C1CC(CCC)CCN1C1=CC=C([N+]([O-])=O)C(OC=2C=CC(CCC(C)=O)=CC=2)=C1 QTVLQPAOZWHNFH-UHFFFAOYSA-N 0.000 description 1
• HIBOMQBOJFSMRJ-UHFFFAOYSA-N 4-[4-[3-[4-(methoxymethyl)piperidin-1-yl]-4-nitrophenoxy]phenyl]butan-2-one Chemical compound C1CC(COC)CCN1C1=CC(OC=2C=CC(CCC(C)=O)=CC=2)=CC=C1[N+]([O-])=O HIBOMQBOJFSMRJ-UHFFFAOYSA-N 0.000 description 1
• QAQHPPBTEWEEJM-UHFFFAOYSA-N 4-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]butan-2-one Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(CCC(C)=O)=CC=2)=CC=C1[N+]([O-])=O QAQHPPBTEWEEJM-UHFFFAOYSA-N 0.000 description 1
• JFIDBMRSEIBNAE-UHFFFAOYSA-N 4-[4-[4-nitro-3-(4-pyridin-2-ylsulfanylpiperidin-1-yl)phenoxy]phenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)SC=2N=CC=CC=2)=C1 JFIDBMRSEIBNAE-UHFFFAOYSA-N 0.000 description 1
• CQDBBMXEJJUGIO-UHFFFAOYSA-N 4-[4-[5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-yl]oxyphenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=NC=NC(N2CCC(CC2)SC=2N=CC=CC=2)=C1[N+]([O-])=O CQDBBMXEJJUGIO-UHFFFAOYSA-N 0.000 description 1
• MBFIERWVMWYQNG-UHFFFAOYSA-N 4-[4-[5-nitro-6-[4-(propoxymethyl)piperidin-1-yl]pyrimidin-4-yl]oxyphenyl]butan-2-one Chemical compound C1CC(COCCC)CCN1C1=NC=NC(OC=2C=CC(CCC(C)=O)=CC=2)=C1[N+]([O-])=O MBFIERWVMWYQNG-UHFFFAOYSA-N 0.000 description 1
• KZDBVWHQNGGDHM-UHFFFAOYSA-N 4-[4-[5-nitro-6-[4-[2-(trifluoromethyl)phenoxy]piperidin-1-yl]pyrimidin-4-yl]oxyphenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=NC=NC(N2CCC(CC2)OC=2C(=CC=CC=2)C(F)(F)F)=C1[N+]([O-])=O KZDBVWHQNGGDHM-UHFFFAOYSA-N 0.000 description 1
• UZBYFVFRWANJMR-UHFFFAOYSA-N 4-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-4-oxobutanoic acid Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC1CCN(C(=O)CCC(O)=O)CC1 UZBYFVFRWANJMR-UHFFFAOYSA-N 0.000 description 1
• JRFBERKQAWMFIA-UHFFFAOYSA-N 4-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]butanoic acid Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC1CCN(CCCC(O)=O)CC1 JRFBERKQAWMFIA-UHFFFAOYSA-N 0.000 description 1
• IFQNJVZMNAJLGZ-UHFFFAOYSA-N 4-[4-[6-[4-(4-fluorobenzoyl)piperidin-1-yl]-5-nitropyrimidin-4-yl]oxyphenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=NC=NC(N2CCC(CC2)C(=O)C=2C=CC(F)=CC=2)=C1[N+]([O-])=O IFQNJVZMNAJLGZ-UHFFFAOYSA-N 0.000 description 1
• IAGAGOZYIUZZGA-UHFFFAOYSA-N 4-[5-ethynyl-6-(2-fluoro-4-methoxyphenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(OC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C#C IAGAGOZYIUZZGA-UHFFFAOYSA-N 0.000 description 1
• WEDVKQHNZJJEMJ-UHFFFAOYSA-N 4-[5-methyl-6-(1-propan-2-yloxycarbonylpiperidin-4-yl)oxypyrimidin-4-yl]oxybenzenesulfonic acid Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C=CC(=CC=2)S(O)(=O)=O)=C1C WEDVKQHNZJJEMJ-UHFFFAOYSA-N 0.000 description 1
• LALUSZJQFLDTQB-UHFFFAOYSA-N 4-[6-[(6-chloro-2-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound ClC1=CC=C(C(=N1)C)NC1=CC(=NC=N1)OC1CCN(CC1)C(=O)O LALUSZJQFLDTQB-UHFFFAOYSA-N 0.000 description 1
• PBZCCTVBFWHART-UHFFFAOYSA-N 4-[6-[2,5-difluoro-4-(2-morpholin-4-ylethylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1OC1=CC(NC=2C(=CC(NCCN3CCOCC3)=C(F)C=2)F)=NC=N1 PBZCCTVBFWHART-UHFFFAOYSA-N 0.000 description 1
• NGMCRNJTMDUGAJ-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(2-methoxyethoxy)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound FC1=CC(OCCOC)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C NGMCRNJTMDUGAJ-UHFFFAOYSA-N 0.000 description 1
• TTXPUPVGESBECN-UHFFFAOYSA-N 4-[6-[2-fluoro-4-(propylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CCCNC1=CC(F)=C(NC2=NC=NC(OC3CCN(CC3)C(O)=O)=C2)C=C1 TTXPUPVGESBECN-UHFFFAOYSA-N 0.000 description 1
• GBFVSCASGJDRGW-UHFFFAOYSA-N 4-[6-[6-(2-hydroxyethylsulfanyl)-2-methylpyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylic acid Chemical compound CC1=NC(SCCO)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(O)=O)=C1C GBFVSCASGJDRGW-UHFFFAOYSA-N 0.000 description 1
• GHLZCPGUOZCNKM-UHFFFAOYSA-N 4-[[5-ethynyl-6-[1-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]oxypyrimidin-4-yl]amino]-3-fluorobenzonitrile Chemical compound CC(C)C1=NOC(N2CCC(CC2)OC=2C(=C(NC=3C(=CC(=CC=3)C#N)F)N=CN=2)C#C)=N1 GHLZCPGUOZCNKM-UHFFFAOYSA-N 0.000 description 1
• WIDDVPZOIJBVHG-UHFFFAOYSA-N 4-[[[6-(2-chlorophenoxy)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound ClC1=C(OC2=CC(=NC=N2)N(C)CC2CCN(CC2)C(=O)O)C=CC=C1 WIDDVPZOIJBVHG-UHFFFAOYSA-N 0.000 description 1
• NNKIQHFIZLJVAQ-UHFFFAOYSA-N 4-[[[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylic acid Chemical compound C=1C(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC=NC=1N(C)CC1CCN(C(O)=O)CC1 NNKIQHFIZLJVAQ-UHFFFAOYSA-N 0.000 description 1
• PWPGNRSGDHULDD-UHFFFAOYSA-N 4-[[methyl-[6-[(6-methylsulfonylpyridin-3-yl)amino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylic acid Chemical compound CS(=O)(=O)C1=CC=C(C=N1)NC1=CC(=NC=N1)N(C)CC1CCN(CC1)C(=O)O PWPGNRSGDHULDD-UHFFFAOYSA-N 0.000 description 1
• FAAZAHIRCXGFFM-UHFFFAOYSA-N 4-amino-5-oxo-5-pyrrolidin-1-ylpentanamide Chemical compound NC(=O)CCC(N)C(=O)N1CCCC1 FAAZAHIRCXGFFM-UHFFFAOYSA-N 0.000 description 1
• NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 description 1
• IJJJJYONDAGQSM-UHFFFAOYSA-N 4-fluoro-3-[[6-[methyl-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]methyl]amino]pyrimidin-4-yl]amino]benzoic acid Chemical compound C=1C(NC=2C(=CC=C(C=2)C(O)=O)F)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 IJJJJYONDAGQSM-UHFFFAOYSA-N 0.000 description 1
• 125000006042 4-hexenyl group Chemical group 0.000 description 1
• NQEVYZKSODGUEK-UHFFFAOYSA-N 4-pentylcyclohexan-1-amine Chemical compound CCCCCC1CCC(N)CC1 NQEVYZKSODGUEK-UHFFFAOYSA-N 0.000 description 1
• 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
• RCJFINNFYUNFGH-UHFFFAOYSA-N 5-(aminomethyl)-6-(2,4-dichlorophenyl)-2-(3,5-dimethoxyphenyl)pyrimidin-4-amine Chemical compound COC1=CC(OC)=CC(C=2N=C(C(CN)=C(N)N=2)C=2C(=CC(Cl)=CC=2)Cl)=C1 RCJFINNFYUNFGH-UHFFFAOYSA-N 0.000 description 1
• GMBQUUCZMIXCEQ-UHFFFAOYSA-N 5-(aminomethyl)-6-(2,4-dichlorophenyl)-2-n-(2-methoxyethyl)-2-n-methylpyrimidine-2,4-diamine Chemical compound COCCN(C)C1=NC(N)=C(CN)C(C=2C(=CC(Cl)=CC=2)Cl)=N1 GMBQUUCZMIXCEQ-UHFFFAOYSA-N 0.000 description 1
• HPPQAPANBWHEBE-UHFFFAOYSA-N 5-[1-[6-(4-methylsulfonylphenoxy)pyrimidin-4-yl]piperidin-4-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(C2CCN(CC2)C=2N=CN=C(OC=3C=CC(=CC=3)S(C)(=O)=O)C=2)=N1 HPPQAPANBWHEBE-UHFFFAOYSA-N 0.000 description 1
• RITBCWAHCDXGLH-UHFFFAOYSA-N 5-[2-[[2-(4-bromophenyl)-6-ethylpyrimidin-4-yl]amino]ethyl]-1h-pyridin-2-one Chemical compound N=1C(C=2C=CC(Br)=CC=2)=NC(CC)=CC=1NCCC=1C=CC(=O)NC=1 RITBCWAHCDXGLH-UHFFFAOYSA-N 0.000 description 1
• UJBGOVWMNPUHQR-UHFFFAOYSA-N 5-[2-[[6-methyl-2-(2,4,5-trifluorophenyl)pyrimidin-4-yl]amino]ethyl]-1h-pyridin-2-one Chemical compound N=1C(C=2C(=CC(F)=C(F)C=2)F)=NC(C)=CC=1NCCC=1C=CC(=O)NC=1 UJBGOVWMNPUHQR-UHFFFAOYSA-N 0.000 description 1
• JOMRUCMOWQYVPH-UHFFFAOYSA-N 5-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-4-oxopentanenitrile Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC1CCN(CC(=O)CCC#N)CC1 JOMRUCMOWQYVPH-UHFFFAOYSA-N 0.000 description 1
• AUZWGLPRXPPHDO-UHFFFAOYSA-N 5-bromo-1-[4-nitro-3-(4-propylpiperidin-1-yl)phenyl]pyridin-2-one Chemical compound C1CC(CCC)CCN1C1=CC(N2C(C=CC(Br)=C2)=O)=CC=C1[N+]([O-])=O AUZWGLPRXPPHDO-UHFFFAOYSA-N 0.000 description 1
• HZOHXUIECWRSJH-UHFFFAOYSA-N 5-ethylsulfonyl-2-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]aniline Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C(=CC(=CC=2)S(=O)(=O)CC)N)=CC=C1[N+]([O-])=O HZOHXUIECWRSJH-UHFFFAOYSA-N 0.000 description 1
• 125000006163 5-membered heteroaryl group Chemical group 0.000 description 1
• ASBQCOPKXJXJBA-UHFFFAOYSA-N 6-(1-hexylpiperidin-4-yl)oxy-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1CN(CCCCCC)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O ASBQCOPKXJXJBA-UHFFFAOYSA-N 0.000 description 1
• VNACOBVZDCLAEV-GXKRWWSZSA-N 6-[2-[[2-[(2s)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]ethylamino]pyridine-3-carbonitrile;dihydrochloride Chemical compound Cl.Cl.N1([C@@H](CCC1)C#N)C(=O)CNCCNC1=CC=C(C#N)C=N1 VNACOBVZDCLAEV-GXKRWWSZSA-N 0.000 description 1
• XNYVGGJJENHRBZ-LBPRGKRZSA-N 6-[2-[[2-[(3s)-3-cyano-3,4-dihydropyrazol-2-yl]-2-oxoethyl]amino]ethylamino]pyridine-3-carbonitrile Chemical compound N1([C@@H](CC=N1)C#N)C(=O)CNCCNC1=CC=C(C#N)C=N1 XNYVGGJJENHRBZ-LBPRGKRZSA-N 0.000 description 1
• JDZXKBQMDMCTHL-UHFFFAOYSA-N 6-[4-(1-benzofuran-2-yl)piperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)C=2OC3=CC=CC=C3C=2)=C1[N+]([O-])=O JDZXKBQMDMCTHL-UHFFFAOYSA-N 0.000 description 1
• KJDUMAGHWCUSGS-UHFFFAOYSA-N 6-[4-(4-fluorophenoxy)piperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)OC=2C=CC(F)=CC=2)=C1[N+]([O-])=O KJDUMAGHWCUSGS-UHFFFAOYSA-N 0.000 description 1
• FDZXALFHMXKKKG-UHFFFAOYSA-N 6-[4-(benzenesulfonyl)piperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)S(=O)(=O)C=2C=CC=CC=2)=C1[N+]([O-])=O FDZXALFHMXKKKG-UHFFFAOYSA-N 0.000 description 1
• JYKUNRUMBUJEAK-UHFFFAOYSA-N 6-[4-(ethoxymethyl)piperidin-1-yl]-n-(4-methylsulfonylphenyl)-5-nitropyrimidin-4-amine Chemical compound C1CC(COCC)CCN1C1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O JYKUNRUMBUJEAK-UHFFFAOYSA-N 0.000 description 1
• JIHCRQVJCJRYIB-KBPBESRZSA-N 6-[[2-[[2-[(2s,4s)-2-cyano-4-fluoropyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]amino]-n,n-dimethylpyridine-3-sulfonamide Chemical compound N1=CC(S(=O)(=O)N(C)C)=CC=C1NCC(C)(C)NCC(=O)N1[C@H](C#N)C[C@H](F)C1 JIHCRQVJCJRYIB-KBPBESRZSA-N 0.000 description 1
• RNPWVVWMMDDDDF-UHFFFAOYSA-N 6-n-(4-methylsulfonylphenyl)-5-nitro-4-n-piperidin-4-ylpyrimidine-4,6-diamine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(NC2CCNCC2)=C1[N+]([O-])=O RNPWVVWMMDDDDF-UHFFFAOYSA-N 0.000 description 1
• 125000003341 7 membered heterocyclic group Chemical group 0.000 description 1
• YDWBSAMIOHUVDL-UHFFFAOYSA-N 8-(3-aminopiperidin-1-yl)-1-(benzo[c][1,8]naphthyridin-6-ylmethyl)-7-but-2-ynyl-3-methylpurine-2,6-dione Chemical compound N=1C=2N(C)C(=O)N(CC=3C4=CC=CC=C4C4=CC=CN=C4N=3)C(=O)C=2N(CC#CC)C=1N1CCCC(N)C1 YDWBSAMIOHUVDL-UHFFFAOYSA-N 0.000 description 1
• 244000215068 Acacia senegal Species 0.000 description 1
• 208000030090 Acute Disease Diseases 0.000 description 1
• 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
• 229940123208 Biguanide Drugs 0.000 description 1
• XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
• ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
• GGBJHURWWWLEQH-UHFFFAOYSA-N Butyl-cyclohexane Natural products CCCCC1CCCCC1 GGBJHURWWWLEQH-UHFFFAOYSA-N 0.000 description 1
• LDARMEAYYFGMCX-UHFFFAOYSA-N C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C2=NN(C)C(O)=C2)=CC=C1[N+]([O-])=O Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C2=NN(C)C(O)=C2)=CC=C1[N+]([O-])=O LDARMEAYYFGMCX-UHFFFAOYSA-N 0.000 description 1
• 101100294115 Caenorhabditis elegans nhr-4 gene Proteins 0.000 description 1
• 208000024172 Cardiovascular disease Diseases 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 239000004375 Dextrin Substances 0.000 description 1
• 229920001353 Dextrin Polymers 0.000 description 1
• 102000003779 Dipeptidyl-peptidases and tripeptidyl-peptidases Human genes 0.000 description 1
• 108090000194 Dipeptidyl-peptidases and tripeptidyl-peptidases Proteins 0.000 description 1
• WVAUNDQKCNTSGC-PKLMIRHRSA-N FC(C(=O)O)(F)F.N[C@@H](C(=O)N1CC2=NC3=C(N2CC1)C=CC(=C3)Cl)CCC3=C(C=CC(=C3)F)F Chemical compound FC(C(=O)O)(F)F.N[C@@H](C(=O)N1CC2=NC3=C(N2CC1)C=CC(=C3)Cl)CCC3=C(C=CC(=C3)F)F WVAUNDQKCNTSGC-PKLMIRHRSA-N 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 101000887167 Gallus gallus Gallinacin-6 Proteins 0.000 description 1
• 101000887235 Gallus gallus Gallinacin-9 Proteins 0.000 description 1
• FAEKWTJYAYMJKF-QHCPKHFHSA-N GlucoNorm Chemical compound C1=C(C(O)=O)C(OCC)=CC(CC(=O)N[C@@H](CC(C)C)C=2C(=CC=CC=2)N2CCCCC2)=C1 FAEKWTJYAYMJKF-QHCPKHFHSA-N 0.000 description 1
• 108091006065 Gs proteins Proteins 0.000 description 1
• 101000908391 Homo sapiens Dipeptidyl peptidase 4 Proteins 0.000 description 1
• 101000886868 Homo sapiens Gastric inhibitory polypeptide Proteins 0.000 description 1
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 108010073961 Insulin Aspart Proteins 0.000 description 1
• 108010057186 Insulin Glargine Proteins 0.000 description 1
• 108010065920 Insulin Lispro Proteins 0.000 description 1
• COCFEDIXXNGUNL-RFKWWTKHSA-N Insulin glargine Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)NCC(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 COCFEDIXXNGUNL-RFKWWTKHSA-N 0.000 description 1
• 102100034343 Integrase Human genes 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• IVUGBSGLHRJSSP-UHFFFAOYSA-N LimKi 3 Chemical compound S1C(NC(=O)C(C)C)=NC=C1C1=CC(C(F)F)=NN1C1=C(Cl)C=CC=C1Cl IVUGBSGLHRJSSP-UHFFFAOYSA-N 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• IBAQFPQHRJAVAV-ULAWRXDQSA-N Miglitol Chemical compound OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO IBAQFPQHRJAVAV-ULAWRXDQSA-N 0.000 description 1
• 101100113933 Mus musculus Cmklr2 gene Proteins 0.000 description 1
• 101000608766 Mus musculus Galectin-6 Proteins 0.000 description 1
• VINUCGMBDUMYON-UHFFFAOYSA-N N-[4-(2-ethoxyethoxy)-2-fluorophenyl]-5-methyl-6-piperidin-4-yloxypyrimidin-4-amine Chemical compound C(C)OCCOC1=CC(=C(C=C1)NC1=C(C(=NC=N1)OC1CCNCC1)C)F VINUCGMBDUMYON-UHFFFAOYSA-N 0.000 description 1
• FBCPZMVZUVBASZ-GOSISDBHSA-N N[C@@H](C(=O)N1CC2=C(CC1)SC(=N2)C2=CC=C(C=C2)F)CCC2=C(C=CC(=C2)F)F Chemical compound N[C@@H](C(=O)N1CC2=C(CC1)SC(=N2)C2=CC=C(C=C2)F)CCC2=C(C=CC(=C2)F)F FBCPZMVZUVBASZ-GOSISDBHSA-N 0.000 description 1
• YWPIWQMWXVNZPI-GFCCVEGCSA-N N[C@@H](C(=O)N1CSCC1)CCC1=C(C=C(C(=C1)F)F)F Chemical compound N[C@@H](C(=O)N1CSCC1)CCC1=C(C=C(C(=C1)F)F)F YWPIWQMWXVNZPI-GFCCVEGCSA-N 0.000 description 1
• 108090000189 Neuropeptides Proteins 0.000 description 1
• 108091028043 Nucleic acid sequence Proteins 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 101150037263 PIP2 gene Proteins 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 229940122344 Peptidase inhibitor Drugs 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 208000018262 Peripheral vascular disease Diseases 0.000 description 1
• 239000004372 Polyvinyl alcohol Substances 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 102000035554 Proglucagon Human genes 0.000 description 1
• 108010058003 Proglucagon Proteins 0.000 description 1
• ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 1
• 102100024447 Prostaglandin E2 receptor EP3 subtype Human genes 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 208000017442 Retinal disease Diseases 0.000 description 1
• 206010038923 Retinopathy Diseases 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 101100262439 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) UBA2 gene Proteins 0.000 description 1
• 229920002125 Sokalan® Polymers 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical group C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 229940100389 Sulfonylurea Drugs 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
• 244000299461 Theobroma cacao Species 0.000 description 1
• 235000009470 Theobroma cacao Nutrition 0.000 description 1
• FZNCGRZWXLXZSZ-CIQUZCHMSA-N Voglibose Chemical compound OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O FZNCGRZWXLXZSZ-CIQUZCHMSA-N 0.000 description 1
• AYBBTCLLYOYTHS-MRXNPFEDSA-N [(3r)-oxolan-3-yl] 4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1C(=O)O[C@@H]1CCOC1 AYBBTCLLYOYTHS-MRXNPFEDSA-N 0.000 description 1
• AYBBTCLLYOYTHS-INIZCTEOSA-N [(3s)-oxolan-3-yl] 4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1C(=O)O[C@H]1CCOC1 AYBBTCLLYOYTHS-INIZCTEOSA-N 0.000 description 1
• VAEPOXPGUPMLJK-UHFFFAOYSA-N [4-[2-nitro-5-(4-propylpiperidin-1-yl)phenoxy]phenyl]-phenylmethanone Chemical compound C1CC(CCC)CCN1C1=CC=C([N+]([O-])=O)C(OC=2C=CC(=CC=2)C(=O)C=2C=CC=CC=2)=C1 VAEPOXPGUPMLJK-UHFFFAOYSA-N 0.000 description 1
• WVUDQXPBMXVYBW-UHFFFAOYSA-N [4-[4-nitro-3-(4-propylpiperidin-1-yl)anilino]phenyl]-phenylmethanone Chemical compound C1CC(CCC)CCN1C1=CC(NC=2C=CC(=CC=2)C(=O)C=2C=CC=CC=2)=CC=C1[N+]([O-])=O WVUDQXPBMXVYBW-UHFFFAOYSA-N 0.000 description 1
• BKBQNDQOCUNTTO-UHFFFAOYSA-N [4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidin-1-yl]-(5-methylpyridin-3-yl)methanone Chemical compound CC1=CN=CC(C(=O)N2CCC(CC2)OC=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)=C1 BKBQNDQOCUNTTO-UHFFFAOYSA-N 0.000 description 1
• JXSSKFQIDFWXDP-UHFFFAOYSA-N [4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidin-1-yl]-(6-fluoropyridin-2-yl)methanone Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)C=2N=C(F)C=CC=2)=NC=N1 JXSSKFQIDFWXDP-UHFFFAOYSA-N 0.000 description 1
• XTKWSNOOMQGGJJ-UHFFFAOYSA-N [4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidin-1-yl]-(6-methylpyridin-2-yl)methanone Chemical compound CC1=CC=CC(C(=O)N2CCC(CC2)OC=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)=N1 XTKWSNOOMQGGJJ-UHFFFAOYSA-N 0.000 description 1
• HDOUIWSXXJZLNT-UHFFFAOYSA-N [4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-[6-(2-pyrrolidin-1-ylethyl)pyridin-3-yl]methanone Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1C(=O)C(C=N1)=CC=C1CCN1CCCC1 HDOUIWSXXJZLNT-UHFFFAOYSA-N 0.000 description 1
• ZOGSDONAVGUYKY-UHFFFAOYSA-N [4-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypiperidin-1-yl]-pyridin-3-ylmethanone Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)C=2C=NC=CC=2)=C1[N+]([O-])=O ZOGSDONAVGUYKY-UHFFFAOYSA-N 0.000 description 1
• QAPFFCFTJRQZLR-UHFFFAOYSA-N [6-chloro-2-(2-methylpropyl)-4-phenylquinolin-3-yl]methanamine Chemical compound NCC=1C(CC(C)C)=NC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 QAPFFCFTJRQZLR-UHFFFAOYSA-N 0.000 description 1
• YQIZXSKIMBCUSY-ZDUSSCGKSA-N [[(2S)-2-amino-3-methylbutanoyl]-propylamino] benzoate Chemical compound CC(C)[C@H](N)C(=O)N(CCC)OC(=O)C1=CC=CC=C1 YQIZXSKIMBCUSY-ZDUSSCGKSA-N 0.000 description 1
• 229960002632 acarbose Drugs 0.000 description 1
• XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
• LPIURYDEKDUCPE-UHFFFAOYSA-N acetaldehyde 2,2,2-trifluoroacetic acid Chemical compound CC=O.OC(=O)C(F)(F)F LPIURYDEKDUCPE-UHFFFAOYSA-N 0.000 description 1
• ZVDDJPSHRNMSKV-UHFFFAOYSA-N acetaldehyde;hydrochloride Chemical compound Cl.CC=O ZVDDJPSHRNMSKV-UHFFFAOYSA-N 0.000 description 1
• AXJDEHNQPMZKOS-UHFFFAOYSA-N acetylazanium;chloride Chemical compound [Cl-].CC([NH3+])=O AXJDEHNQPMZKOS-UHFFFAOYSA-N 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 230000001070 adhesive effect Effects 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
• HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
• XXXHSQBVHSJQKS-UHFFFAOYSA-N amino benzoate Chemical compound NOC(=O)C1=CC=CC=C1 XXXHSQBVHSJQKS-UHFFFAOYSA-N 0.000 description 1
• MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 description 1
• 239000007900 aqueous suspension Substances 0.000 description 1
• 210000001367 artery Anatomy 0.000 description 1
• 125000005533 aryl carboxamido group Chemical group 0.000 description 1
• 125000004104 aryloxy group Chemical group 0.000 description 1
• 125000004273 azetidin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])C1([H])* 0.000 description 1
• 125000004567 azetidin-3-yl group Chemical group N1CC(C1)* 0.000 description 1
• 125000004267 aziridin-2-yl group Chemical group [H]N1C([H])([H])C1([H])* 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
• 239000003124 biologic agent Substances 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 125000001246 bromo group Chemical group Br* 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 description 1
• 235000014121 butter Nutrition 0.000 description 1
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 230000003491 cAMP production Effects 0.000 description 1
• 159000000007 calcium salts Chemical class 0.000 description 1
• 239000007963 capsule composition Substances 0.000 description 1
• 125000004432 carbon atom Chemical group C* 0.000 description 1
• 150000001723 carbon free-radicals Chemical class 0.000 description 1
• 125000002843 carboxylic acid group Chemical group 0.000 description 1
• 230000003293 cardioprotective effect Effects 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 238000006555 catalytic reaction Methods 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 125000004775 chlorodifluoromethyl group Chemical group FC(F)(Cl)* 0.000 description 1
• 229940046374 chromium picolinate Drugs 0.000 description 1
• GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 description 1
• 208000020832 chronic kidney disease Diseases 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 208000010877 cognitive disease Diseases 0.000 description 1
• 230000001149 cognitive effect Effects 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 229940125773 compound 10 Drugs 0.000 description 1
• 229940125898 compound 5 Drugs 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 239000002285 corn oil Substances 0.000 description 1
• 235000005687 corn oil Nutrition 0.000 description 1
• 235000012343 cottonseed oil Nutrition 0.000 description 1
• 239000002385 cottonseed oil Substances 0.000 description 1
• 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
• GCFAUZGWPDYAJN-UHFFFAOYSA-N cyclohexyl 3-phenylprop-2-enoate Chemical compound C=1C=CC=CC=1C=CC(=O)OC1CCCCC1 GCFAUZGWPDYAJN-UHFFFAOYSA-N 0.000 description 1
• OFAUDLLOLVJRBX-UHFFFAOYSA-N cyclopentyl 4-[methyl-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)methyl]amino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC2CCCC2)CCC1N(C)CC(ON=1)=NC=1C1=CC=NC=C1 OFAUDLLOLVJRBX-UHFFFAOYSA-N 0.000 description 1
• MKKLYVIKFVIRKV-UHFFFAOYSA-N cyclopentyl piperidine-1-carboxylate Chemical compound C1CCCCN1C(=O)OC1CCCC1 MKKLYVIKFVIRKV-UHFFFAOYSA-N 0.000 description 1
• 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
• 230000008021 deposition Effects 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 229960000633 dextran sulfate Drugs 0.000 description 1
• 235000019425 dextrin Nutrition 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 125000005265 dialkylamine group Chemical group 0.000 description 1
• 150000004985 diamines Chemical class 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
• 230000006806 disease prevention Effects 0.000 description 1
• 239000007884 disintegrant Substances 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 239000000890 drug combination Substances 0.000 description 1
• 238000012377 drug delivery Methods 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 230000001804 emulsifying effect Effects 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 239000006274 endogenous ligand Substances 0.000 description 1
• CHNUOJQWGUIOLD-NFZZJPOKSA-N epalrestat Chemical compound C=1C=CC=CC=1\C=C(/C)\C=C1/SC(=S)N(CC(O)=O)C1=O CHNUOJQWGUIOLD-NFZZJPOKSA-N 0.000 description 1
• 229950010170 epalrestat Drugs 0.000 description 1
• CHNUOJQWGUIOLD-UHFFFAOYSA-N epalrestate Natural products C=1C=CC=CC=1C=C(C)C=C1SC(=S)N(CC(O)=O)C1=O CHNUOJQWGUIOLD-UHFFFAOYSA-N 0.000 description 1
• RSOJSFYJLQADDM-UHFFFAOYSA-N ethanesulfonamide Chemical compound [CH2]CS(N)(=O)=O RSOJSFYJLQADDM-UHFFFAOYSA-N 0.000 description 1
• 235000019441 ethanol Nutrition 0.000 description 1
• JFDVGACPVMKGDT-UHFFFAOYSA-N ethyl 1-[2-nitro-5-[4-(3-oxobutyl)phenoxy]phenyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=CC(OC=2C=CC(CCC(C)=O)=CC=2)=CC=C1[N+]([O-])=O JFDVGACPVMKGDT-UHFFFAOYSA-N 0.000 description 1
• MAISMEIJSAHGQK-UHFFFAOYSA-N ethyl 1-[6-(2-benzoyl-5-methoxyphenoxy)-5-nitropyrimidin-4-yl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=NC=NC(OC=2C(=CC=C(OC)C=2)C(=O)C=2C=CC=CC=2)=C1[N+]([O-])=O MAISMEIJSAHGQK-UHFFFAOYSA-N 0.000 description 1
• RYIPABQIIBFYJC-UHFFFAOYSA-N ethyl 1-[6-(4-morpholin-4-ylsulfonylanilino)-5-nitropyrimidin-4-yl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=NC=NC(NC=2C=CC(=CC=2)S(=O)(=O)N2CCOCC2)=C1[N+]([O-])=O RYIPABQIIBFYJC-UHFFFAOYSA-N 0.000 description 1
• USWBOYMNSYZWNF-UHFFFAOYSA-N ethyl 1-[6-[4-(2,5-dioxoimidazolidin-4-yl)phenoxy]-5-nitropyrimidin-4-yl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=NC=NC(OC=2C=CC(=CC=2)C2C(NC(=O)N2)=O)=C1[N+]([O-])=O USWBOYMNSYZWNF-UHFFFAOYSA-N 0.000 description 1
• UJVINEOZGFNBAZ-UHFFFAOYSA-N ethyl 2-[4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]piperazin-1-yl]acetate Chemical compound C1CN(CC(=O)OCC)CCN1C1=CC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC=N1 UJVINEOZGFNBAZ-UHFFFAOYSA-N 0.000 description 1
• GVBFWCNJDPQJJX-UHFFFAOYSA-N ethyl 2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]acetate Chemical compound C1CN(CC(=O)OCC)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C GVBFWCNJDPQJJX-UHFFFAOYSA-N 0.000 description 1
• XSJKPDMYTHWJBA-UHFFFAOYSA-N ethyl 3-[4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]piperazin-1-yl]propanoate Chemical compound C1CN(CCC(=O)OCC)CCN1C1=CC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC=N1 XSJKPDMYTHWJBA-UHFFFAOYSA-N 0.000 description 1
• HNESUBILRWZIJH-UHFFFAOYSA-N ethyl 4-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O HNESUBILRWZIJH-UHFFFAOYSA-N 0.000 description 1
• 125000004494 ethyl ester group Chemical group 0.000 description 1
• 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
• 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
• 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 210000001723 extracellular space Anatomy 0.000 description 1
• 239000010685 fatty oil Substances 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 235000019634 flavors Nutrition 0.000 description 1
• 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
• WTDFFADXONGQOM-UHFFFAOYSA-N formaldehyde;hydrochloride Chemical compound Cl.O=C WTDFFADXONGQOM-UHFFFAOYSA-N 0.000 description 1
• 239000003205 fragrance Substances 0.000 description 1
• VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical compound [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• 230000030136 gastric emptying Effects 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 229960004580 glibenclamide Drugs 0.000 description 1
• 229960000346 gliclazide Drugs 0.000 description 1
• WIGIZIANZCJQQY-RUCARUNLSA-N glimepiride Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C=C1 WIGIZIANZCJQQY-RUCARUNLSA-N 0.000 description 1
• 229960004346 glimepiride Drugs 0.000 description 1
• ZJJXGWJIGJFDTL-UHFFFAOYSA-N glipizide Chemical compound C1=NC(C)=CN=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZJJXGWJIGJFDTL-UHFFFAOYSA-N 0.000 description 1
• 229960001381 glipizide Drugs 0.000 description 1
• ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 1
• 229940074045 glyceryl distearate Drugs 0.000 description 1
• 229940075507 glyceryl monostearate Drugs 0.000 description 1
• 150000002334 glycols Chemical class 0.000 description 1
• 125000003147 glycosyl group Chemical group 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 238000005469 granulation Methods 0.000 description 1
• 230000003179 granulation Effects 0.000 description 1
• 210000002216 heart Anatomy 0.000 description 1
• 125000006342 heptafluoro i-propyl group Chemical group FC(F)(F)C(F)(*)C(F)(F)F 0.000 description 1
• 125000006341 heptafluoro n-propyl group Chemical group FC(F)(F)C(F)(F)C(F)(F)* 0.000 description 1
• 125000005553 heteroaryloxy group Chemical group 0.000 description 1
• 125000005143 heteroarylsulfonyl group Chemical group 0.000 description 1
• WNRQPCUGRUFHED-DETKDSODSA-N humalog Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 WNRQPCUGRUFHED-DETKDSODSA-N 0.000 description 1
• 102000045598 human DPP4 Human genes 0.000 description 1
• 102000052820 human GPR1 Human genes 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 150000004677 hydrates Chemical class 0.000 description 1
• 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 208000006575 hypertriglyceridemia Diseases 0.000 description 1
• KVOVCEPPQJRTOB-UHFFFAOYSA-N imidazo[4,5-d]pyridazin-4-one Chemical compound O=C1N=NC=C2N=CN=C12 KVOVCEPPQJRTOB-UHFFFAOYSA-N 0.000 description 1
• 230000003116 impacting effect Effects 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
• RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
• 230000004941 influx Effects 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229960004717 insulin aspart Drugs 0.000 description 1
• 239000004026 insulin derivative Substances 0.000 description 1
• 229960002869 insulin glargine Drugs 0.000 description 1
• 229960002068 insulin lispro Drugs 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 230000004068 intracellular signaling Effects 0.000 description 1
• 210000003093 intracellular space Anatomy 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 238000007914 intraventricular administration Methods 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 125000002346 iodo group Chemical group I* 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 210000004153 islets of langerhan Anatomy 0.000 description 1
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
• 229940047889 isobutyramide Drugs 0.000 description 1
• 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 229950003188 isovaleryl diethylamide Drugs 0.000 description 1
• ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
• 125000000468 ketone group Chemical group 0.000 description 1
• 208000017169 kidney disease Diseases 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 239000004922 lacquer Substances 0.000 description 1
• 239000010410 layer Substances 0.000 description 1
• 125000003473 lipid group Chemical group 0.000 description 1
• 229940057995 liquid paraffin Drugs 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
• 239000001095 magnesium carbonate Substances 0.000 description 1
• 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
• 235000014380 magnesium carbonate Nutrition 0.000 description 1
• 239000000395 magnesium oxide Substances 0.000 description 1
• CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
• 235000012245 magnesium oxide Nutrition 0.000 description 1
• AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 239000002609 medium Substances 0.000 description 1
• 229950004994 meglitinide Drugs 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
• QPBAZGXESLNBNB-UHFFFAOYSA-N methyl 3-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]-3-oxopropanoate Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C(=O)CC(=O)OC)=CC=C1[N+]([O-])=O QPBAZGXESLNBNB-UHFFFAOYSA-N 0.000 description 1
• 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
• 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 229960001110 miglitol Drugs 0.000 description 1
• 230000000116 mitigating effect Effects 0.000 description 1
• 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
• YHTCRDZWZDSNEK-UHFFFAOYSA-N n-(2,3-difluorophenyl)-5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-amine Chemical compound N1=CN=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=C1NC1=CC=CC(F)=C1F YHTCRDZWZDSNEK-UHFFFAOYSA-N 0.000 description 1
• PHPWNIYPVPWOAB-UHFFFAOYSA-N n-(2,4-difluorophenyl)-5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-amine Chemical compound N1=CN=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=C1NC1=CC=C(F)C=C1F PHPWNIYPVPWOAB-UHFFFAOYSA-N 0.000 description 1
• YUFYAEHJBXIROF-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-(3-fluorophenoxy)piperidin-1-yl]pyrimidin-4-amine Chemical compound FC1=CC(S(=O)(=O)C)=CC=C1NC1=CC(N2CCC(CC2)OC=2C=C(F)C=CC=2)=NC=N1 YUFYAEHJBXIROF-UHFFFAOYSA-N 0.000 description 1
• LFPNPPGSLLQXGJ-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-(4-propan-2-yloxyphenyl)piperazin-1-yl]pyrimidin-4-amine Chemical compound C1=CC(OC(C)C)=CC=C1N1CCN(C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)CC1 LFPNPPGSLLQXGJ-UHFFFAOYSA-N 0.000 description 1
• VUKQHKDAHXXKSA-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-(4-propan-2-yloxyphenyl)piperidin-1-yl]pyrimidin-4-amine Chemical compound C1=CC(OC(C)C)=CC=C1C1CCN(C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)CC1 VUKQHKDAHXXKSA-UHFFFAOYSA-N 0.000 description 1
• JWGXGGINTZAFIH-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-(5-propan-2-yloxypyridin-2-yl)oxypiperidin-1-yl]pyrimidin-4-amine Chemical compound N1=CC(OC(C)C)=CC=C1OC1CCN(C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)CC1 JWGXGGINTZAFIH-UHFFFAOYSA-N 0.000 description 1
• AQINFDXRZLDTQZ-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-(5-propan-2-yloxypyridin-2-yl)piperazin-1-yl]pyrimidin-4-amine Chemical compound N1=CC(OC(C)C)=CC=C1N1CCN(C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)CC1 AQINFDXRZLDTQZ-UHFFFAOYSA-N 0.000 description 1
• IZYFTJSFCBZZCB-UHFFFAOYSA-N n-(2-fluoro-4-methylsulfonylphenyl)-6-[4-[4-(2-methylpropyl)phenyl]piperidin-1-yl]pyrimidin-4-amine Chemical compound C1=CC(CC(C)C)=CC=C1C1CCN(C=2N=CN=C(NC=3C(=CC(=CC=3)S(C)(=O)=O)F)C=2)CC1 IZYFTJSFCBZZCB-UHFFFAOYSA-N 0.000 description 1
• PNJPNSJBUQKWSL-UHFFFAOYSA-N n-(2-fluorophenyl)-5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-amine Chemical compound N1=CN=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=C1NC1=CC=CC=C1F PNJPNSJBUQKWSL-UHFFFAOYSA-N 0.000 description 1
• XCTTVNSXEHWZBI-UHFFFAOYSA-N n-(2-methylpropyl)formamide Chemical compound CC(C)CNC=O XCTTVNSXEHWZBI-UHFFFAOYSA-N 0.000 description 1
• MPRPMZLALGYKSX-UHFFFAOYSA-N n-(3,5-dichlorophenyl)-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]acetamide Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)NC1=CC(Cl)=CC(Cl)=C1 MPRPMZLALGYKSX-UHFFFAOYSA-N 0.000 description 1
• XYTXYHSAIKDPLR-UHFFFAOYSA-N n-(3-chlorophenyl)-2-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]acetamide Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(C)=C1OC(CC1)CCN1CC(=O)NC1=CC=CC(Cl)=C1 XYTXYHSAIKDPLR-UHFFFAOYSA-N 0.000 description 1
• OOONYVYHCUTMFO-UHFFFAOYSA-N n-(3-methoxyphenyl)-5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyrimidin-4-amine Chemical compound COC1=CC=CC(NC=2C(=C(N3CCC(CC3)SC=3N=CC=CC=3)N=CN=2)[N+]([O-])=O)=C1 OOONYVYHCUTMFO-UHFFFAOYSA-N 0.000 description 1
• UJRCZTGQLYANFT-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-(4-pyridin-4-ylsulfanylpiperidin-1-yl)pyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC2)SC=2C=CN=CC=2)=C1[N+]([O-])=O UJRCZTGQLYANFT-UHFFFAOYSA-N 0.000 description 1
• VSOQVHPVCDOSJI-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-[1-(pyridin-2-ylmethyl)piperidin-4-yl]oxypyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCN(CC=3N=CC=CC=3)CC2)=C1[N+]([O-])=O VSOQVHPVCDOSJI-UHFFFAOYSA-N 0.000 description 1
• RUPYSDFXVSXHKA-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-[4-(pyridin-2-ylmethyl)piperidin-1-yl]pyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(N2CCC(CC=3N=CC=CC=3)CC2)=C1[N+]([O-])=O RUPYSDFXVSXHKA-UHFFFAOYSA-N 0.000 description 1
• LFEOJANOTHGPSD-UHFFFAOYSA-N n-(4-methylsulfonylphenyl)-5-nitro-6-piperidin-4-yloxypyrimidin-4-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NC1=NC=NC(OC2CCNCC2)=C1[N+]([O-])=O LFEOJANOTHGPSD-UHFFFAOYSA-N 0.000 description 1
• UFWPCJQMQTUXJL-CQSZACIVSA-N n-[(2r)-1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-1-oxopropan-2-yl]acetamide Chemical compound C1CN(C(=O)[C@H](NC(C)=O)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C UFWPCJQMQTUXJL-CQSZACIVSA-N 0.000 description 1
• AFSBDRXRSQPBOJ-NRFANRHFSA-N n-[(2s)-1-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidin-1-yl]-3-methyl-1-oxobutan-2-yl]acetamide Chemical compound C1CN(C(=O)[C@@H](NC(C)=O)C(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C AFSBDRXRSQPBOJ-NRFANRHFSA-N 0.000 description 1
• TVIJQHMKOZWOFV-UHFFFAOYSA-N n-[2-[2-[8-(3-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-2,6-dioxopurin-1-yl]acetyl]phenyl]formamide Chemical compound O=C1C=2N(CC#CC)C(N3CC(N)CCC3)=NC=2N(C)C(=O)N1CC(=O)C1=CC=CC=C1NC=O TVIJQHMKOZWOFV-UHFFFAOYSA-N 0.000 description 1
• WQSFNEBZRWLSSJ-UHFFFAOYSA-N n-[4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]oxycyclohexyl]-3-methylbutanamide Chemical compound C1CC(NC(=O)CC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C WQSFNEBZRWLSSJ-UHFFFAOYSA-N 0.000 description 1
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 125000006095 n-butyl sulfinyl group Chemical group 0.000 description 1
• 125000006126 n-butyl sulfonyl group Chemical group 0.000 description 1
• OLLZXQIFCRIRMH-UHFFFAOYSA-N n-methylbutanamide Chemical compound CCCC(=O)NC OLLZXQIFCRIRMH-UHFFFAOYSA-N 0.000 description 1
• HXXAUIXTYRHFNO-UHFFFAOYSA-N n-methylpyridine-2-carboxamide Chemical compound CNC(=O)C1=CC=CC=N1 HXXAUIXTYRHFNO-UHFFFAOYSA-N 0.000 description 1
• 125000006124 n-propyl sulfonyl group Chemical group 0.000 description 1
• SUUDTPGCUKBECW-UHFFFAOYSA-N n-propylformamide Chemical compound CCCNC=O SUUDTPGCUKBECW-UHFFFAOYSA-N 0.000 description 1
• 125000001624 naphthyl group Chemical group 0.000 description 1
• OELFLUMRDSZNSF-BRWVUGGUSA-N nateglinide Chemical compound C1C[C@@H](C(C)C)CC[C@@H]1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-BRWVUGGUSA-N 0.000 description 1
• 229960000698 nateglinide Drugs 0.000 description 1
• 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 201000001119 neuropathy Diseases 0.000 description 1
• 230000007823 neuropathy Effects 0.000 description 1
• 230000004112 neuroprotection Effects 0.000 description 1
• 125000006344 nonafluoro n-butyl group Chemical group FC(F)(F)C(F)(F)C(F)(F)C(F)(F)* 0.000 description 1
• VOMXSOIBEJBQNF-UTTRGDHVSA-N novorapid Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 VOMXSOIBEJBQNF-UTTRGDHVSA-N 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 239000003791 organic solvent mixture Substances 0.000 description 1
• 150000002902 organometallic compounds Chemical class 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• OTYQDZLBJHMSHS-UHFFFAOYSA-N oxadiazole-5-carboxylic acid Chemical compound OC(=O)C1=CN=NO1 OTYQDZLBJHMSHS-UHFFFAOYSA-N 0.000 description 1
• CDXVUROVRIFQMV-UHFFFAOYSA-N oxo(diphenoxy)phosphanium Chemical compound C=1C=CC=CC=1O[P+](=O)OC1=CC=CC=C1 CDXVUROVRIFQMV-UHFFFAOYSA-N 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 239000001814 pectin Substances 0.000 description 1
• 235000010987 pectin Nutrition 0.000 description 1
• 229920001277 pectin Polymers 0.000 description 1
• 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
• 125000005981 pentynyl group Chemical group 0.000 description 1
• 239000000813 peptide hormone Substances 0.000 description 1
• 230000002263 peptidergic effect Effects 0.000 description 1
• 239000000816 peptidomimetic Substances 0.000 description 1
• 229940124531 pharmaceutical excipient Drugs 0.000 description 1
• AOGCNGQOLXBQSH-UHFFFAOYSA-N phenanthridin-8-amine Chemical compound C1=CC=C2C3=CC=C(N)C=C3C=NC2=C1 AOGCNGQOLXBQSH-UHFFFAOYSA-N 0.000 description 1
• WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• IBBMAWULFFBRKK-UHFFFAOYSA-N picolinamide Chemical compound NC(=O)C1=CC=CC=N1 IBBMAWULFFBRKK-UHFFFAOYSA-N 0.000 description 1
• 229960005095 pioglitazone Drugs 0.000 description 1
• 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 239000004014 plasticizer Substances 0.000 description 1
• 239000008389 polyethoxylated castor oil Substances 0.000 description 1
• 238000006116 polymerization reaction Methods 0.000 description 1
• 229920002451 polyvinyl alcohol Polymers 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 239000000047 product Substances 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• YDGNBFJBDXKHJA-UHFFFAOYSA-N propan-2-yl 2-[6-[2,5-difluoro-4-(propylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C(C)(C)OC(=O)N1C(CCCC1)OC1=NC=NC(=C1)NC1=C(C=C(C(=C1)F)NCCC)F YDGNBFJBDXKHJA-UHFFFAOYSA-N 0.000 description 1
• BJWIPLHTDJQSMJ-UHFFFAOYSA-N propan-2-yl 4-[1-[4-(oxolan-2-ylmethylamino)phenyl]pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1C=NN2C(C=C1)=CC=C1NCC1OCCC1 BJWIPLHTDJQSMJ-UHFFFAOYSA-N 0.000 description 1
• VLSHTPJNQQKCJM-UHFFFAOYSA-N propan-2-yl 4-[2-(2-fluoro-4-methylsulfonylanilino)-3-methylpyridin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC=NC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C VLSHTPJNQQKCJM-UHFFFAOYSA-N 0.000 description 1
• WTFZEZMAEDSYRC-UHFFFAOYSA-N propan-2-yl 4-[2-(2-fluoro-4-methylsulfonylanilino)pyridin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC=NC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1 WTFZEZMAEDSYRC-UHFFFAOYSA-N 0.000 description 1
• KBLJCVRPWDNHPJ-UHFFFAOYSA-N propan-2-yl 4-[2-[2,5-difluoro-4-(2-propan-2-yloxyethyl)phenoxy]-3-methylpyridin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(F)C(CCOC(C)C)=CC(F)=C1OC1=NC=CC(OC2CCN(CC2)C(=O)OC(C)C)=C1C KBLJCVRPWDNHPJ-UHFFFAOYSA-N 0.000 description 1
• CEUZULGFNSAYSX-UHFFFAOYSA-N propan-2-yl 4-[2-[[4-fluoro-6-(2-propan-2-yloxyethyl)pyridin-3-yl]amino]-3-methylpyridin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=NC(CCOC(C)C)=CC(F)=C1NC1=NC=CC(OC2CCN(CC2)C(=O)OC(C)C)=C1C CEUZULGFNSAYSX-UHFFFAOYSA-N 0.000 description 1
• TVWJKAPXKYMIST-UHFFFAOYSA-N propan-2-yl 4-[3-(2,5-difluoro-4-methylsulfonylphenyl)-1-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1N(C)N=C2C1=CC(F)=C(S(C)(=O)=O)C=C1F TVWJKAPXKYMIST-UHFFFAOYSA-N 0.000 description 1
• FICUNAVENAGHSW-UHFFFAOYSA-N propan-2-yl 4-[3-(2,5-difluoro-4-methylsulfonylphenyl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC(C1=NN2C)=NC=NC1=C2C1=CC(F)=C(S(C)(=O)=O)C=C1F FICUNAVENAGHSW-UHFFFAOYSA-N 0.000 description 1
• WNVAPVSUXGJFCF-UHFFFAOYSA-N propan-2-yl 4-[3-(2,5-difluoro-4-sulfamoylphenyl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC(C1=NN2C)=NC=NC1=C2C1=CC(F)=C(S(N)(=O)=O)C=C1F WNVAPVSUXGJFCF-UHFFFAOYSA-N 0.000 description 1
• IZLNAWPPSYEGLB-UHFFFAOYSA-N propan-2-yl 4-[3-(2-fluoro-4-methylsulfonylphenyl)-1-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1N(C)N=C2C1=CC=C(S(C)(=O)=O)C=C1F IZLNAWPPSYEGLB-UHFFFAOYSA-N 0.000 description 1
• BNRHGCQRZKENKK-UHFFFAOYSA-N propan-2-yl 4-[3-(2-fluoro-4-sulfamoylphenyl)-1-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1N(C)N=C2C1=CC=C(S(N)(=O)=O)C=C1F BNRHGCQRZKENKK-UHFFFAOYSA-N 0.000 description 1
• DRJMANHBGGZYIE-UHFFFAOYSA-N propan-2-yl 4-[3-(2-fluoro-4-sulfamoylphenyl)-2-methylpyrazolo[1,5-a]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC=NC2=C(C=3C(=CC(=CC=3)S(N)(=O)=O)F)C(C)=NN12 DRJMANHBGGZYIE-UHFFFAOYSA-N 0.000 description 1
• LZMFUNVBORTUEU-UHFFFAOYSA-N propan-2-yl 4-[3-(2-fluoro-4-sulfamoylphenyl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC(C1=NN2C)=NC=NC1=C2C1=CC=C(S(N)(=O)=O)C=C1F LZMFUNVBORTUEU-UHFFFAOYSA-N 0.000 description 1
• RRXGWPVJHVBXTG-UHFFFAOYSA-N propan-2-yl 4-[3-(4-fluoro-6-methoxypyridin-3-yl)-1-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1=NC(OC)=CC(F)=C1C(C1=NC=N2)=NN(C)C1=C2OC1CCN(C(=O)OC(C)C)CC1 RRXGWPVJHVBXTG-UHFFFAOYSA-N 0.000 description 1
• VGVSGIKDAKCPJT-UHFFFAOYSA-N propan-2-yl 4-[3-(4-fluoro-6-methoxypyridin-3-yl)-2-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1=NC(OC)=CC(F)=C1C1=C2N=CN=C(OC3CCN(CC3)C(=O)OC(C)C)C2=NN1C VGVSGIKDAKCPJT-UHFFFAOYSA-N 0.000 description 1
• JEMQEWNBKODNCJ-UHFFFAOYSA-N propan-2-yl 4-[3-[2-fluoro-4-(propanoylsulfamoyl)phenyl]-1-methylpyrazolo[4,3-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C(C1=NC=N2)=NN(C)C1=C2OC1CCN(C(=O)OC(C)C)CC1 JEMQEWNBKODNCJ-UHFFFAOYSA-N 0.000 description 1
• IRHPLMSUIKDMNJ-UHFFFAOYSA-N propan-2-yl 4-[4-(2,5-difluoro-4-propoxyanilino)pyridin-2-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(F)C(OCCC)=CC(F)=C1NC1=CC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1 IRHPLMSUIKDMNJ-UHFFFAOYSA-N 0.000 description 1
• HXNTVPOOUIAYTL-UHFFFAOYSA-N propan-2-yl 4-[4-(2-fluoro-4-methylsulfonylanilino)pyridin-2-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=CC=N1 HXNTVPOOUIAYTL-UHFFFAOYSA-N 0.000 description 1
• XOFFKTUZMXASTG-UHFFFAOYSA-N propan-2-yl 4-[5-(4,5-dihydro-1h-imidazol-2-yl)-6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C1=NCCN1 XOFFKTUZMXASTG-UHFFFAOYSA-N 0.000 description 1
• XJELELVSKDQYKQ-UHFFFAOYSA-N propan-2-yl 4-[5-[5-(aminomethyl)-4,5-dihydro-1,3-oxazol-2-yl]-6-(2-fluoro-4-methylsulfonylphenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C1=NCC(CN)O1 XJELELVSKDQYKQ-UHFFFAOYSA-N 0.000 description 1
• BACDBFZAELZCNI-UHFFFAOYSA-N propan-2-yl 4-[5-amino-6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1N BACDBFZAELZCNI-UHFFFAOYSA-N 0.000 description 1
• IIWJSOPCZMPNBO-UHFFFAOYSA-N propan-2-yl 4-[5-cyano-6-(2-fluoro-4-morpholin-4-ylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=CC=2)N2CCOCC2)F)=C1C#N IIWJSOPCZMPNBO-UHFFFAOYSA-N 0.000 description 1
• UVCUVCOHDKPTOG-UHFFFAOYSA-N propan-2-yl 4-[5-cyano-6-(2-fluoro-4-propoxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(OCCC)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C#N UVCUVCOHDKPTOG-UHFFFAOYSA-N 0.000 description 1
• ZGOPWDALEZDINW-UHFFFAOYSA-N propan-2-yl 4-[5-cyano-6-(4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1C#N ZGOPWDALEZDINW-UHFFFAOYSA-N 0.000 description 1
• YVXGVLKPEQJEPG-UHFFFAOYSA-N propan-2-yl 4-[5-cyano-6-[2-fluoro-4-(2-pyrrolidin-1-ylethylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(NCCN3CCCC3)=CC=2)F)=C1C#N YVXGVLKPEQJEPG-UHFFFAOYSA-N 0.000 description 1
• VRVXDOBTSLINTI-UHFFFAOYSA-N propan-2-yl 4-[5-cyano-6-[2-fluoro-4-(3-methylbutylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(NCCC(C)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C#N VRVXDOBTSLINTI-UHFFFAOYSA-N 0.000 description 1
• WEUFCMGXSAILNL-UHFFFAOYSA-N propan-2-yl 4-[5-cyano-6-[2-fluoro-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=CC=2)N2CCN(C)CC2)F)=C1C#N WEUFCMGXSAILNL-UHFFFAOYSA-N 0.000 description 1
• OJWWCLRQAYXWHQ-UHFFFAOYSA-N propan-2-yl 4-[5-cyano-6-[2-fluoro-4-(propan-2-ylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(NC(C)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C#N OJWWCLRQAYXWHQ-UHFFFAOYSA-N 0.000 description 1
• ULKZWDWAKWQMCA-UHFFFAOYSA-N propan-2-yl 4-[5-cyano-6-[2-fluoro-4-(propylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(NCCC)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C#N ULKZWDWAKWQMCA-UHFFFAOYSA-N 0.000 description 1
• RJHKZBZJQXUFBL-UHFFFAOYSA-N propan-2-yl 4-[5-cyano-6-[4-[2-(dimethylamino)ethylamino]-2-fluoroanilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(NCCN(C)C)=CC=2)F)=C1C#N RJHKZBZJQXUFBL-UHFFFAOYSA-N 0.000 description 1
• GMIOZGYLKIQXSX-UHFFFAOYSA-N propan-2-yl 4-[5-cyano-6-[[6-(propylamino)pyridin-3-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=NC(NCCC)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C#N GMIOZGYLKIQXSX-UHFFFAOYSA-N 0.000 description 1
• GLEFIHVIKTXUSU-UHFFFAOYSA-N propan-2-yl 4-[5-cyclopropyl-6-(2-fluoro-4-methylsulfonylphenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C1CC1 GLEFIHVIKTXUSU-UHFFFAOYSA-N 0.000 description 1
• BLJFHEBWFZVSLY-UHFFFAOYSA-N propan-2-yl 4-[5-cyclopropyl-6-[2,5-difluoro-4-[2-(4-methoxypiperidin-1-yl)ethyl]phenoxy]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CC(OC)CCN1CCC(C(=C1)F)=CC(F)=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C1CC1 BLJFHEBWFZVSLY-UHFFFAOYSA-N 0.000 description 1
• DWGLJNMTLMWAGV-UHFFFAOYSA-N propan-2-yl 4-[5-ethyl-6-(2-fluoro-4-methylsulfonylphenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound N1=CN=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)C(CC)=C1OC1CCN(C(=O)OC(C)C)CC1 DWGLJNMTLMWAGV-UHFFFAOYSA-N 0.000 description 1
• BRCVBBIOAMGPAQ-UHFFFAOYSA-N propan-2-yl 4-[5-ethynyl-6-(2-fluoro-4-methylsulfonylphenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C#C BRCVBBIOAMGPAQ-UHFFFAOYSA-N 0.000 description 1
• CXIDIXBNGNNZDR-UHFFFAOYSA-N propan-2-yl 4-[5-ethynyl-6-(6-methoxy-4-methylpyridin-3-yl)oxypyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=NC(OC)=CC(C)=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C#C CXIDIXBNGNNZDR-UHFFFAOYSA-N 0.000 description 1
• QZAUTLFIZHJZLP-UHFFFAOYSA-N propan-2-yl 4-[5-ethynyl-6-[2-fluoro-4-(4-methoxypyridin-2-yl)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound COC1=CC=NC(C=2C=C(F)C(NC=3C(=C(OC4CCN(CC4)C(=O)OC(C)C)N=CN=3)C#C)=CC=2)=C1 QZAUTLFIZHJZLP-UHFFFAOYSA-N 0.000 description 1
• VMYYVPPNLLDXRG-AREMUKBSSA-N propan-2-yl 4-[5-ethynyl-6-[2-fluoro-4-[2-[(2r)-2-methoxypiperidin-1-yl]ethyl]phenoxy]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CO[C@@H]1CCCCN1CCC(C=C1F)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C#C VMYYVPPNLLDXRG-AREMUKBSSA-N 0.000 description 1
• PHMKVMKWZAJTMK-UHFFFAOYSA-N propan-2-yl 4-[5-ethynyl-6-[2-methyl-6-(2-propan-2-yloxyethyl)pyridin-3-yl]oxypyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(CCOC(C)C)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C#C PHMKVMKWZAJTMK-UHFFFAOYSA-N 0.000 description 1
• VXAYEYXNJNTNAB-UHFFFAOYSA-N propan-2-yl 4-[5-methyl-6-(2-methyl-6-pentylpyridin-3-yl)oxypyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(CCCCC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C VXAYEYXNJNTNAB-UHFFFAOYSA-N 0.000 description 1
• UAJJBUQONDWWPA-UHFFFAOYSA-N propan-2-yl 4-[5-methyl-6-(4-methylsulfonylphenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C=CC(=CC=2)S(C)(=O)=O)=C1C UAJJBUQONDWWPA-UHFFFAOYSA-N 0.000 description 1
• OMFIOAPERIXSTF-UHFFFAOYSA-N propan-2-yl 4-[5-methyl-6-[(2-methyl-6-morpholin-4-ylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=NC(=CC=2)N2CCOCC2)C)=C1C OMFIOAPERIXSTF-UHFFFAOYSA-N 0.000 description 1
• VAUJLOXTAATAGO-UHFFFAOYSA-N propan-2-yl 4-[5-methyl-6-[(4-methyl-6-morpholin-4-ylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=NC=2)N2CCOCC2)C)=C1C VAUJLOXTAATAGO-UHFFFAOYSA-N 0.000 description 1
• SFFCCSGCCWMUIC-UHFFFAOYSA-N propan-2-yl 4-[5-methyl-6-[2-methyl-6-(2-methylsulfonylethylamino)pyridin-3-yl]oxypyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=NC(NCCS(C)(=O)=O)=CC=2)C)=C1C SFFCCSGCCWMUIC-UHFFFAOYSA-N 0.000 description 1
• RLTJJAPYYDVBHI-UHFFFAOYSA-N propan-2-yl 4-[5-methyl-6-[2-methyl-6-(2-propan-2-yloxyethyl)pyridin-3-yl]oxypyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(CCOC(C)C)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C RLTJJAPYYDVBHI-UHFFFAOYSA-N 0.000 description 1
• ZPWICAYIOJFSAF-UHFFFAOYSA-N propan-2-yl 4-[5-methyl-6-[2-methyl-6-(2-propan-2-yloxyethylamino)pyridin-3-yl]oxypyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(NCCOC(C)C)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C ZPWICAYIOJFSAF-UHFFFAOYSA-N 0.000 description 1
• BHJOPJYQRQJFEX-UHFFFAOYSA-N propan-2-yl 4-[5-methyl-6-[2-methyl-6-(2-pyridin-2-ylethoxy)pyridin-3-yl]oxypyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=NC(OCCC=3N=CC=CC=3)=CC=2)C)=C1C BHJOPJYQRQJFEX-UHFFFAOYSA-N 0.000 description 1
• YEFYWAQUIUARHT-UHFFFAOYSA-N propan-2-yl 4-[5-methyl-6-[2-methyl-6-(3-methylsulfonylpyrrolidin-1-yl)pyridin-3-yl]oxypyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=NC(=CC=2)N2CC(CC2)S(C)(=O)=O)C)=C1C YEFYWAQUIUARHT-UHFFFAOYSA-N 0.000 description 1
• PXAAOZABLFMNNP-UHFFFAOYSA-N propan-2-yl 4-[5-methyl-6-[2-methyl-6-[methyl(2-propan-2-yloxyethyl)amino]pyridin-3-yl]oxypyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(N(C)CCOC(C)C)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C PXAAOZABLFMNNP-UHFFFAOYSA-N 0.000 description 1
• GUWYXKOISXHDFW-UHFFFAOYSA-N propan-2-yl 4-[6-(2,4-difluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(F)=CC=2)F)=NC=N1 GUWYXKOISXHDFW-UHFFFAOYSA-N 0.000 description 1
• NSLQLEXVLQPFCZ-UHFFFAOYSA-N propan-2-yl 4-[6-(2,4-difluorophenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(F)=CC=2)F)=C1C NSLQLEXVLQPFCZ-UHFFFAOYSA-N 0.000 description 1
• JFNMLXDOGLEQEN-UHFFFAOYSA-N propan-2-yl 4-[6-(2,4-dimethoxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound COC1=CC(OC)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)C)=NC=N1 JFNMLXDOGLEQEN-UHFFFAOYSA-N 0.000 description 1
• FUVPFNOSJYGLPK-UHFFFAOYSA-N propan-2-yl 4-[6-(2,5-difluoro-4-morpholin-4-ylanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=C(F)C=2)N2CCOCC2)F)=C1C FUVPFNOSJYGLPK-UHFFFAOYSA-N 0.000 description 1
• GZOICCSYUATVNE-UHFFFAOYSA-N propan-2-yl 4-[6-(2,5-difluoro-4-morpholin-4-ylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(=C(F)C=2)N2CCOCC2)F)=NC=N1 GZOICCSYUATVNE-UHFFFAOYSA-N 0.000 description 1
• LDHMSVQGFURJOB-UHFFFAOYSA-N propan-2-yl 4-[6-(2,5-difluoro-4-propoxyanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(F)C(OCCC)=CC(F)=C1NC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C LDHMSVQGFURJOB-UHFFFAOYSA-N 0.000 description 1
• MVZDLBRCXWICSU-UHFFFAOYSA-N propan-2-yl 4-[6-(2,5-difluoro-4-propoxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(F)C(OCCC)=CC(F)=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)C)=NC=N1 MVZDLBRCXWICSU-UHFFFAOYSA-N 0.000 description 1
• BUYCSNSVGYVXMK-UHFFFAOYSA-N propan-2-yl 4-[6-(2,5-difluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC=C(F)C=2)F)=NC=N1 BUYCSNSVGYVXMK-UHFFFAOYSA-N 0.000 description 1
• RZNXBVHAECXNBV-UHFFFAOYSA-N propan-2-yl 4-[6-(2,5-difluorophenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(OC=2C(=CC=C(F)C=2)F)=NC=N1 RZNXBVHAECXNBV-UHFFFAOYSA-N 0.000 description 1
• NHOPPOBAPJWQNM-UHFFFAOYSA-N propan-2-yl 4-[6-(2-ethynylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC=CC=2)C#C)=NC=N1 NHOPPOBAPJWQNM-UHFFFAOYSA-N 0.000 description 1
• JLWYHPYPRUVGBA-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-3-sulfamoylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=C(C=CC=2)S(N)(=O)=O)F)=C1C JLWYHPYPRUVGBA-UHFFFAOYSA-N 0.000 description 1
• VOYBGWALQDKVPD-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-4-iodoanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(I)=CC=2)F)=C1C VOYBGWALQDKVPD-UHFFFAOYSA-N 0.000 description 1
• DMTFDIDWLOADAJ-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-4-iodoanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(I)=CC=2)F)=NC=N1 DMTFDIDWLOADAJ-UHFFFAOYSA-N 0.000 description 1
• SUECYWWAVKOOKM-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-4-methylsulfonylanilino)-2-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC(C)=N1 SUECYWWAVKOOKM-UHFFFAOYSA-N 0.000 description 1
• YHHAHJJSDRQSRI-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-4-methylsulfonylanilino)-5-(n'-hydroxycarbamimidoyl)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C(=N)NO YHHAHJJSDRQSRI-UHFFFAOYSA-N 0.000 description 1
• CETAULDFJQHIIO-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-4-methylsulfonylanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C CETAULDFJQHIIO-UHFFFAOYSA-N 0.000 description 1
• YZOGMKANXVWJME-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-4-methylsulfonylanilino)pyridin-2-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC=CC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=N1 YZOGMKANXVWJME-UHFFFAOYSA-N 0.000 description 1
• PSTAUCWYFNORSZ-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC=N1 PSTAUCWYFNORSZ-UHFFFAOYSA-N 0.000 description 1
• YLKMXWNAASOYEM-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-(methanesulfonamido)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1NS(C)(=O)=O YLKMXWNAASOYEM-UHFFFAOYSA-N 0.000 description 1
• DNEKWRVZWQYSII-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-4-morpholin-4-ylanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=CC=2)N2CCOCC2)F)=C1C DNEKWRVZWQYSII-UHFFFAOYSA-N 0.000 description 1
• PKUSJNJJEBPHPA-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-4-morpholin-4-ylphenoxy)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(OC=2C(=CC(=CC=2)N2CCOCC2)F)=NC=N1 PKUSJNJJEBPHPA-UHFFFAOYSA-N 0.000 description 1
• AUPWVYJZIQROJT-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-4-sulfamoylphenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)S(N)(=O)=O)F)=C1C AUPWVYJZIQROJT-UHFFFAOYSA-N 0.000 description 1
• NGTDHYBTHFNKGF-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluoro-5-methylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC=C(C)C=2)F)=NC=N1 NGTDHYBTHFNKGF-UHFFFAOYSA-N 0.000 description 1
• WRUCYROGZMLUFE-UHFFFAOYSA-N propan-2-yl 4-[6-(2-fluorophenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC=CC=2)F)=C1C WRUCYROGZMLUFE-UHFFFAOYSA-N 0.000 description 1
• KTTHKFLPLSIIND-UHFFFAOYSA-N propan-2-yl 4-[6-(3,5-dimethoxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound COC1=CC(OC)=CC(NC=2N=CN=C(OC3CCN(CC3)C(=O)OC(C)C)C=2)=C1 KTTHKFLPLSIIND-UHFFFAOYSA-N 0.000 description 1
• MDEPAGKGQIJMAG-UHFFFAOYSA-N propan-2-yl 4-[6-(3-fluoro-4-hydroxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C=C(F)C(O)=CC=2)=NC=N1 MDEPAGKGQIJMAG-UHFFFAOYSA-N 0.000 description 1
• HHJLPEHOPPUZJJ-UHFFFAOYSA-N propan-2-yl 4-[6-(4-acetamido-3-methylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C=C(C)C(NC(C)=O)=CC=2)=NC=N1 HHJLPEHOPPUZJJ-UHFFFAOYSA-N 0.000 description 1
• RYCBZUIEKBLZGV-UHFFFAOYSA-N propan-2-yl 4-[6-(4-bromo-2,5-difluoroanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(Br)=C(F)C=2)F)=C1C RYCBZUIEKBLZGV-UHFFFAOYSA-N 0.000 description 1
• CMXAMJYUNZOYQN-UHFFFAOYSA-N propan-2-yl 4-[6-(4-bromo-2-fluorophenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(Br)=CC=2)F)=C1C CMXAMJYUNZOYQN-UHFFFAOYSA-N 0.000 description 1
• WBDSWKYSCKAMGZ-UHFFFAOYSA-N propan-2-yl 4-[6-(4-carbamimidoyl-2,5-difluoroanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=C(F)C=2)C(N)=N)F)=C1C WBDSWKYSCKAMGZ-UHFFFAOYSA-N 0.000 description 1
• VWBNSZCNUFREEU-UHFFFAOYSA-N propan-2-yl 4-[6-(4-carbamoyl-2,5-difluoroanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=C(F)C=2)C(N)=O)F)=C1C VWBNSZCNUFREEU-UHFFFAOYSA-N 0.000 description 1
• MBRPHWHMCQYIGF-UHFFFAOYSA-N propan-2-yl 4-[6-(4-carbamoyl-2-fluorophenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)C(N)=O)F)=C1C MBRPHWHMCQYIGF-UHFFFAOYSA-N 0.000 description 1
• IIKFADUSHOWPEI-UHFFFAOYSA-N propan-2-yl 4-[6-(4-cyano-2,5-difluoroanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=C(F)C=2)C#N)F)=C1C IIKFADUSHOWPEI-UHFFFAOYSA-N 0.000 description 1
• YYTDPKRUHUGFKM-UHFFFAOYSA-N propan-2-yl 4-[6-(4-cyano-2-fluoroanilino)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=CC=2)C#N)F)=C1C YYTDPKRUHUGFKM-UHFFFAOYSA-N 0.000 description 1
• BFWSSKYVKIASLC-UHFFFAOYSA-N propan-2-yl 4-[6-(4-cyano-2-fluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(=CC=2)C#N)F)=NC=N1 BFWSSKYVKIASLC-UHFFFAOYSA-N 0.000 description 1
• RROARNPQYHNTRB-UHFFFAOYSA-N propan-2-yl 4-[6-(4-cyano-2-fluorophenoxy)-5-ethynylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)C#N)F)=C1C#C RROARNPQYHNTRB-UHFFFAOYSA-N 0.000 description 1
• VRPRJOLHBHNXHS-UHFFFAOYSA-N propan-2-yl 4-[6-(4-cyano-2-fluorophenoxy)-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)C#N)F)=C1C VRPRJOLHBHNXHS-UHFFFAOYSA-N 0.000 description 1
• ZQYTXFVRULDIDI-UHFFFAOYSA-N propan-2-yl 4-[6-(4-cyano-2-methylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(=CC=2)C#N)C)=NC=N1 ZQYTXFVRULDIDI-UHFFFAOYSA-N 0.000 description 1
• LSLZRIQSKKPDLX-UHFFFAOYSA-N propan-2-yl 4-[6-(4-cyano-3-methoxyanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(C#N)C(OC)=CC(NC=2N=CN=C(OC3CCN(CC3)C(=O)OC(C)C)C=2)=C1 LSLZRIQSKKPDLX-UHFFFAOYSA-N 0.000 description 1
• KGEKANHOHUUFPI-UHFFFAOYSA-N propan-2-yl 4-[6-(4-iodo-2-methylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(I)=CC=2)C)=NC=N1 KGEKANHOHUUFPI-UHFFFAOYSA-N 0.000 description 1
• IQGGCUIATABGSF-UHFFFAOYSA-N propan-2-yl 4-[6-(4-methoxy-2-methylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=CC(OC)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)C)=NC=N1 IQGGCUIATABGSF-UHFFFAOYSA-N 0.000 description 1
• RDLIZLWKOVXEBQ-UHFFFAOYSA-N propan-2-yl 4-[6-(4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C=CC(=CC=2)S(C)(=O)=O)=NC=N1 RDLIZLWKOVXEBQ-UHFFFAOYSA-N 0.000 description 1
• LCKTXROVVZLEIV-UHFFFAOYSA-N propan-2-yl 4-[6-(4-piperidin-1-ylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C=CC(=CC=2)N2CCCCC2)=NC=N1 LCKTXROVVZLEIV-UHFFFAOYSA-N 0.000 description 1
• YJITXWBXZZJMMH-UHFFFAOYSA-N propan-2-yl 4-[6-(5-iodopyridin-2-yl)oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2N=CC(I)=CC=2)=C1C YJITXWBXZZJMMH-UHFFFAOYSA-N 0.000 description 1
• CLODCVKGSVBCJT-UHFFFAOYSA-N propan-2-yl 4-[6-(6-chloro-2-methylpyridin-3-yl)oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=NC(Cl)=CC=2)C)=C1C CLODCVKGSVBCJT-UHFFFAOYSA-N 0.000 description 1
• VBTKBUZLFSWDGM-UHFFFAOYSA-N propan-2-yl 4-[6-(n-acetyl-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(N(C(C)=O)C=2C=CC(=CC=2)S(C)(=O)=O)=NC=N1 VBTKBUZLFSWDGM-UHFFFAOYSA-N 0.000 description 1
• GMMNFFBWOIDBJZ-UHFFFAOYSA-N propan-2-yl 4-[6-(pyridin-3-ylamino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C=NC=CC=2)=NC=N1 GMMNFFBWOIDBJZ-UHFFFAOYSA-N 0.000 description 1
• NWDXYBFROZSNDM-UHFFFAOYSA-N propan-2-yl 4-[6-[(1-oxo-2,3-dihydroinden-5-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C=C3CCC(=O)C3=CC=2)=NC=N1 NWDXYBFROZSNDM-UHFFFAOYSA-N 0.000 description 1
• QPXITXVALQPHRS-UHFFFAOYSA-N propan-2-yl 4-[6-[(2,6-dimethylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=NC(C)=CC=2)C)=NC=N1 QPXITXVALQPHRS-UHFFFAOYSA-N 0.000 description 1
• VIAFFAAKTXVMPH-UHFFFAOYSA-N propan-2-yl 4-[6-[(2-chloro-6-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=NC(C)=CC=2)Cl)=NC=N1 VIAFFAAKTXVMPH-UHFFFAOYSA-N 0.000 description 1
• NBGSHWUJZYVYON-UHFFFAOYSA-N propan-2-yl 4-[6-[(2-methylquinolin-6-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C=C3C=CC(C)=NC3=CC=2)=NC=N1 NBGSHWUJZYVYON-UHFFFAOYSA-N 0.000 description 1
• MNCLYWGBVZPWBW-UHFFFAOYSA-N propan-2-yl 4-[6-[(2-methylsulfanyl-1,3-benzothiazol-6-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C2SC(SC)=NC2=CC=C1NC(N=CN=1)=CC=1OC1CCN(C(=O)OC(C)C)CC1 MNCLYWGBVZPWBW-UHFFFAOYSA-N 0.000 description 1
• HUFHYMFDZNCAIZ-UHFFFAOYSA-N propan-2-yl 4-[6-[(2-phenylpyrazol-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2N(N=CC=2)C=2C=CC=CC=2)=NC=N1 HUFHYMFDZNCAIZ-UHFFFAOYSA-N 0.000 description 1
• LGKZUVYLBVGYDD-UHFFFAOYSA-N propan-2-yl 4-[6-[(3,5-dimethyl-1,2-oxazol-4-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC2=C(ON=C2C)C)=NC=N1 LGKZUVYLBVGYDD-UHFFFAOYSA-N 0.000 description 1
• YZNTXXIRSQUESH-UHFFFAOYSA-N propan-2-yl 4-[6-[(5-carbamoylpyridin-2-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2N=CC(=CC=2)C(N)=O)=NC=N1 YZNTXXIRSQUESH-UHFFFAOYSA-N 0.000 description 1
• VFRMOBNVNQRJHQ-UHFFFAOYSA-N propan-2-yl 4-[6-[(5-cyclopropyl-1h-pyrazol-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC2=NNC(=C2)C2CC2)=NC=N1 VFRMOBNVNQRJHQ-UHFFFAOYSA-N 0.000 description 1
• LKIWURSDKHECEH-UHFFFAOYSA-N propan-2-yl 4-[6-[(5-oxo-1-phenyl-4h-pyrazol-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2CC(=O)N(N=2)C=2C=CC=CC=2)=NC=N1 LKIWURSDKHECEH-UHFFFAOYSA-N 0.000 description 1
• UIWIZRHAFOBCIU-UHFFFAOYSA-N propan-2-yl 4-[6-[(5-pyridin-2-ylthiophen-2-yl)methylamino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NCC=2SC(=CC=2)C=2N=CC=CC=2)=NC=N1 UIWIZRHAFOBCIU-UHFFFAOYSA-N 0.000 description 1
• IHGHQSGRWVNGMP-UHFFFAOYSA-N propan-2-yl 4-[6-[(5-tert-butyl-1h-pyrazol-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC2=NNC(=C2)C(C)(C)C)=NC=N1 IHGHQSGRWVNGMP-UHFFFAOYSA-N 0.000 description 1
• AZOJZEMNGYADTQ-UHFFFAOYSA-N propan-2-yl 4-[6-[(6-chloro-2-methylpyridin-3-yl)amino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=NC(Cl)=CC=2)C)=C1C AZOJZEMNGYADTQ-UHFFFAOYSA-N 0.000 description 1
• JDJIIACNAVDGRO-UHFFFAOYSA-N propan-2-yl 4-[6-[(6-chloro-4-fluoropyridin-3-yl)amino]-5-cyanopyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(Cl)=NC=2)F)=C1C#N JDJIIACNAVDGRO-UHFFFAOYSA-N 0.000 description 1
• ZLAWJAASCHLJCK-UHFFFAOYSA-N propan-2-yl 4-[6-[(6-chloro-4-methylpyridin-3-yl)amino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(Cl)=NC=2)C)=C1C ZLAWJAASCHLJCK-UHFFFAOYSA-N 0.000 description 1
• CHCHICVCXQQXGO-UHFFFAOYSA-N propan-2-yl 4-[6-[(6-ethoxypyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=NC(OCC)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)C)=NC=N1 CHCHICVCXQQXGO-UHFFFAOYSA-N 0.000 description 1
• VICUPXPMUPUSLE-UHFFFAOYSA-N propan-2-yl 4-[6-[(6-methoxy-2-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(OC)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)C)=NC=N1 VICUPXPMUPUSLE-UHFFFAOYSA-N 0.000 description 1
• GGYUKZAQLVTASR-UHFFFAOYSA-N propan-2-yl 4-[6-[(6-methoxy-5-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(C)C(OC)=NC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)C)=NC=N1 GGYUKZAQLVTASR-UHFFFAOYSA-N 0.000 description 1
• XAEYTTRKVBAYIB-UHFFFAOYSA-N propan-2-yl 4-[6-[(6-methyl-1h-pyrazolo[3,4-b]pyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C3=CC=C(C)N=C3NN=2)=NC=N1 XAEYTTRKVBAYIB-UHFFFAOYSA-N 0.000 description 1
• RLRZXOMUGOGMKA-UHFFFAOYSA-N propan-2-yl 4-[6-[2,3-difluoro-4-(2-methylsulfonylethyl)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=C(F)C(CCS(C)(=O)=O)=CC=2)F)=C1C RLRZXOMUGOGMKA-UHFFFAOYSA-N 0.000 description 1
• BMQSCHGXCKJSKE-UHFFFAOYSA-N propan-2-yl 4-[6-[2,3-difluoro-4-(2-methylsulfonylethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=C(F)C(CCS(C)(=O)=O)=CC=2)F)=C1C BMQSCHGXCKJSKE-UHFFFAOYSA-N 0.000 description 1
• CTOMSGBVBCDWOU-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(2-methoxyethoxy)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(F)C(OCCOC)=CC(F)=C1NC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C CTOMSGBVBCDWOU-UHFFFAOYSA-N 0.000 description 1
• BDAMTBLEWDZXRW-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(2-methoxyethylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(F)C(NCCOC)=CC(F)=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)C)=NC=N1 BDAMTBLEWDZXRW-UHFFFAOYSA-N 0.000 description 1
• BBVNUJZNCLCSPS-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(2-methylsulfonylethyl)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(CCS(C)(=O)=O)=C(F)C=2)F)=C1C BBVNUJZNCLCSPS-UHFFFAOYSA-N 0.000 description 1
• TWOGYGUGMDXEQY-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(2-methylsulfonylethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCS(C)(=O)=O)=C(F)C=2)F)=C1C TWOGYGUGMDXEQY-UHFFFAOYSA-N 0.000 description 1
• QYMAMNRZZIRWOD-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(OCCN3CCOCC3)=C(F)C=2)F)=NC=N1 QYMAMNRZZIRWOD-UHFFFAOYSA-N 0.000 description 1
• JNLNGMYUDUZZRW-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(2-morpholin-4-ylethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCN3CCOCC3)=C(F)C=2)F)=C1C JNLNGMYUDUZZRW-UHFFFAOYSA-N 0.000 description 1
• CLUPQVQBTZWALO-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(=C(F)C=2)N2CCN(C)CC2)F)=NC=N1 CLUPQVQBTZWALO-UHFFFAOYSA-N 0.000 description 1
• AXIAZYZEGMRUNR-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(n'-hydroxycarbamimidoyl)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=C(F)C=2)C(=N)NO)F)=C1C AXIAZYZEGMRUNR-UHFFFAOYSA-N 0.000 description 1
• DOBNBZHQAKHFLH-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(oxolan-2-ylmethoxy)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(OCC3OCCC3)=C(F)C=2)F)=NC=N1 DOBNBZHQAKHFLH-UHFFFAOYSA-N 0.000 description 1
• CVCJKAXSNXNZRB-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(oxolan-2-ylmethylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(NCC3OCCC3)=C(F)C=2)F)=NC=N1 CVCJKAXSNXNZRB-UHFFFAOYSA-N 0.000 description 1
• VEBXRJLVZHNWFN-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-(trifluoromethoxy)phenoxy]-5-prop-1-ynylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound N1=CN=C(OC=2C(=CC(OC(F)(F)F)=C(F)C=2)F)C(C#CC)=C1OC1CCN(C(=O)OC(C)C)CC1 VEBXRJLVZHNWFN-UHFFFAOYSA-N 0.000 description 1
• LHRXVSBKWNDCJF-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-[2-(3-methoxypiperidin-1-yl)ethyl]phenoxy]-5-ethynylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1C(OC)CCCN1CCC(C(=C1)F)=CC(F)=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C#C LHRXVSBKWNDCJF-UHFFFAOYSA-N 0.000 description 1
• CNVZZGBGSOXLBJ-UHFFFAOYSA-N propan-2-yl 4-[6-[2,5-difluoro-4-[2-(3-methoxypiperidin-1-yl)ethyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1C(OC)CCCN1CCC(C(=C1)F)=CC(F)=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C CNVZZGBGSOXLBJ-UHFFFAOYSA-N 0.000 description 1
• PQMPXRBXPGQFAG-UHFFFAOYSA-N propan-2-yl 4-[6-[2-(2,5-difluorophenoxy)ethylamino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NCCOC=2C(=CC=C(F)C=2)F)=NC=N1 PQMPXRBXPGQFAG-UHFFFAOYSA-N 0.000 description 1
• HAXGOWDKEMRTJS-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-hydroxyethoxy)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(OCCO)=CC=2)F)=C1C HAXGOWDKEMRTJS-UHFFFAOYSA-N 0.000 description 1
• YMLFKNYAQKEKMT-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-hydroxyethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCO)=CC=2)F)=C1C YMLFKNYAQKEKMT-UHFFFAOYSA-N 0.000 description 1
• IOIOUGPZHCNRGS-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-methoxyethylcarbamoyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(C(=O)NCCOC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C IOIOUGPZHCNRGS-UHFFFAOYSA-N 0.000 description 1
• RNCHRLLIKRUBPX-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-methylsulfonylethoxy)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(OCCS(C)(=O)=O)=CC=2)F)=C1C RNCHRLLIKRUBPX-UHFFFAOYSA-N 0.000 description 1
• OAZAGUDHDAWCOR-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-methylsulfonylethyl)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(CCS(C)(=O)=O)=CC=2)F)=C1C OAZAGUDHDAWCOR-UHFFFAOYSA-N 0.000 description 1
• VGCRHIKAKZKWOF-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-methylsulfonylethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCS(C)(=O)=O)=CC=2)F)=C1C VGCRHIKAKZKWOF-UHFFFAOYSA-N 0.000 description 1
• AJHLWZLACIOZMR-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-methylsulfonylethylamino)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(NCCS(C)(=O)=O)=CC=2)F)=C1C AJHLWZLACIOZMR-UHFFFAOYSA-N 0.000 description 1
• XVLAZRKHCAGQJJ-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-morpholin-4-ylethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCN3CCOCC3)=CC=2)F)=C1C XVLAZRKHCAGQJJ-UHFFFAOYSA-N 0.000 description 1
• UNPIQRIPQOOGHZ-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-phosphonooxyethyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCOP(O)(O)=O)=CC=2)F)=C1C UNPIQRIPQOOGHZ-UHFFFAOYSA-N 0.000 description 1
• CHSMDZOJSOXXBI-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-propan-2-yloxyethoxy)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(OCCOC(C)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C CHSMDZOJSOXXBI-UHFFFAOYSA-N 0.000 description 1
• XPJGMUJGHYDECJ-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-propan-2-yloxyethoxy)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(OCCOC(C)C)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C XPJGMUJGHYDECJ-UHFFFAOYSA-N 0.000 description 1
• HOQBUTBSIIHOCH-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-propan-2-yloxyethylamino)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(NCCOC(C)C)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C HOQBUTBSIIHOCH-UHFFFAOYSA-N 0.000 description 1
• ZXPCYPDCHABJBF-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-propan-2-yloxyethylsulfamoyl)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(S(=O)(=O)NCCOC(C)C)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C ZXPCYPDCHABJBF-UHFFFAOYSA-N 0.000 description 1
• UEZRYSSOLPIHEX-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-pyridin-2-ylethoxy)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(OCCC=3N=CC=CC=3)=CC=2)F)=C1C UEZRYSSOLPIHEX-UHFFFAOYSA-N 0.000 description 1
• LHDMASOMIFRFMQ-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-pyrrolidin-1-ylethylcarbamoyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)C(=O)NCCN2CCCC2)F)=C1C LHDMASOMIFRFMQ-UHFFFAOYSA-N 0.000 description 1
• NSROGMISPOBHDP-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(2-sulfamoylethyl)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(CCS(N)(=O)=O)=CC=2)F)=C1C NSROGMISPOBHDP-UHFFFAOYSA-N 0.000 description 1
• PGKJGOFQPMALGJ-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(3-methoxypropoxy)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(OCCCOC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C PGKJGOFQPMALGJ-UHFFFAOYSA-N 0.000 description 1
• GZZYBQOCRCVABA-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(4-propan-2-ylpiperazine-1-carbonyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)C(=O)N2CCN(CC2)C(C)C)F)=C1C GZZYBQOCRCVABA-UHFFFAOYSA-N 0.000 description 1
• CZZOGDHQLJVGGT-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(5-methoxypyridin-2-yl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound N1=CC(OC)=CC=C1C(C=C1F)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C CZZOGDHQLJVGGT-UHFFFAOYSA-N 0.000 description 1
• JHJZKZFLAKFXNO-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(6-methoxypyridin-3-yl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=NC(OC)=CC=C1C(C=C1F)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C JHJZKZFLAKFXNO-UHFFFAOYSA-N 0.000 description 1
• YHHNQILYCFQVQT-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(hydroxycarbamoyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)C(=O)NO)F)=C1C YHHNQILYCFQVQT-UHFFFAOYSA-N 0.000 description 1
• UMCWFDFYNNIRQR-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(oxan-4-yloxy)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(OC3CCOCC3)=CC=2)F)=C1C UMCWFDFYNNIRQR-UHFFFAOYSA-N 0.000 description 1
• MTKZPBCCWLLISS-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(oxolan-2-ylmethoxy)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(OCC3OCCC3)=CC=2)F)=C1C MTKZPBCCWLLISS-UHFFFAOYSA-N 0.000 description 1
• IIIXUUQXURBVAR-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(oxolan-2-ylmethylamino)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(NCC3OCCC3)=CC=2)F)=C1C IIIXUUQXURBVAR-UHFFFAOYSA-N 0.000 description 1
• CMQOFQFAKRAPHM-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(propan-2-ylamino)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(NC(C)C)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)C)=NC=N1 CMQOFQFAKRAPHM-UHFFFAOYSA-N 0.000 description 1
• BOJBCSGXZJNGMP-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(propylamino)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(NCCC)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C BOJBCSGXZJNGMP-UHFFFAOYSA-N 0.000 description 1
• DKKNGXJPBDPDPJ-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(pyridin-2-ylmethoxy)anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(OCC=3N=CC=CC=3)=CC=2)F)=C1C DKKNGXJPBDPDPJ-UHFFFAOYSA-N 0.000 description 1
• MZRJRANLKQTSCY-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-(pyridine-2-carbonyl)phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(=CC=2)C(=O)C=2N=CC=CC=2)F)=C1C MZRJRANLKQTSCY-UHFFFAOYSA-N 0.000 description 1
• IPDOEFHZTJEYFN-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[(1-hydroxycyclopropyl)methyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CC3(O)CC3)=CC=2)F)=C1C IPDOEFHZTJEYFN-UHFFFAOYSA-N 0.000 description 1
• OCSZWDWXPKBLIU-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[2-(2-hydroxyethylamino)-2-oxoethyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CC(=O)NCCO)=CC=2)F)=C1C OCSZWDWXPKBLIU-UHFFFAOYSA-N 0.000 description 1
• TZLYKVMHYOOBQU-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[2-(2-methylpropoxy)ethoxy]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(OCCOCC(C)C)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C TZLYKVMHYOOBQU-UHFFFAOYSA-N 0.000 description 1
• YINYSPDYVHSOMY-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[2-(2-methylsulfonylpyrrolidin-1-yl)-2-oxoethyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CC(=O)N3C(CCC3)S(C)(=O)=O)=CC=2)F)=C1C YINYSPDYVHSOMY-UHFFFAOYSA-N 0.000 description 1
• HXSYZXQFYPIFBR-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[2-(3-hydroxypiperidin-1-yl)-2-oxoethyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CC(=O)N3CC(O)CCC3)=CC=2)F)=C1C HXSYZXQFYPIFBR-UHFFFAOYSA-N 0.000 description 1
• ZCPRPRVOYMCSSS-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[2-(4-methoxypiperidin-1-yl)ethyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CC(OC)CCN1CCC(C=C1F)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C ZCPRPRVOYMCSSS-UHFFFAOYSA-N 0.000 description 1
• OLMMVFWYFBTBAH-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[2-(propanoylsulfamoyl)ethyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(CCS(=O)(=O)NC(=O)CC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C OLMMVFWYFBTBAH-UHFFFAOYSA-N 0.000 description 1
• DCTPZDGHGAHJOX-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[2-[(2-methylpropan-2-yl)oxy]ethoxy]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(OCCOC(C)(C)C)=CC=2)F)=C1C DCTPZDGHGAHJOX-UHFFFAOYSA-N 0.000 description 1
• MDNMAQOAUPPAKQ-HSZRJFAPSA-N propan-2-yl 4-[6-[2-fluoro-4-[2-[(3r)-3-methoxypiperidin-1-yl]ethyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1[C@H](OC)CCCN1CCC(C=C1F)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C MDNMAQOAUPPAKQ-HSZRJFAPSA-N 0.000 description 1
• KSVUUENBLNDRQS-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[2-oxo-2-(oxolan-2-ylmethylamino)ethyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CC(=O)NCC3OCCC3)=CC=2)F)=C1C KSVUUENBLNDRQS-UHFFFAOYSA-N 0.000 description 1
• FZVLKVYJGJARPW-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[5-(propan-2-yloxymethyl)-1,2,4-oxadiazol-3-yl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound O1C(COC(C)C)=NC(C=2C=C(F)C(OC=3C(=C(OC4CCN(CC4)C(=O)OC(C)C)N=CN=3)C)=CC=2)=N1 FZVLKVYJGJARPW-UHFFFAOYSA-N 0.000 description 1
• UDGWHUHAPZHZRS-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[methoxy(methyl)carbamoyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(C(=O)N(C)OC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C UDGWHUHAPZHZRS-UHFFFAOYSA-N 0.000 description 1
• NMNURQZBLKKXDM-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[methyl(2-methylsulfonylethyl)amino]anilino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=CC(=CC=2)N(C)CCS(C)(=O)=O)F)=C1C NMNURQZBLKKXDM-UHFFFAOYSA-N 0.000 description 1
• AJZUWEHTCVVXJG-UHFFFAOYSA-N propan-2-yl 4-[6-[2-fluoro-4-[n'-(2-propan-2-yloxyethyl)carbamimidoyl]phenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(C(=N)NCCOC(C)C)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C AJZUWEHTCVVXJG-UHFFFAOYSA-N 0.000 description 1
• FHNOVVOBPTWJPP-UHFFFAOYSA-N propan-2-yl 4-[6-[3-(trifluoromethoxy)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C=C(OC(F)(F)F)C=CC=2)=NC=N1 FHNOVVOBPTWJPP-UHFFFAOYSA-N 0.000 description 1
• BUOFPIKGFFDFBG-UHFFFAOYSA-N propan-2-yl 4-[6-[4-(2-amino-2-oxoethyl)-2-fluorophenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CC(N)=O)=CC=2)F)=C1C BUOFPIKGFFDFBG-UHFFFAOYSA-N 0.000 description 1
• HMGKNQLILIKVCU-UHFFFAOYSA-N propan-2-yl 4-[6-[4-(2-cyclopropyloxyethoxy)-2-fluorophenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(OCCOC3CC3)=CC=2)F)=C1C HMGKNQLILIKVCU-UHFFFAOYSA-N 0.000 description 1
• VODFVJZYYILJHH-UHFFFAOYSA-N propan-2-yl 4-[6-[4-(2-ethoxyethoxy)-2-fluorophenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(OCCOCC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C VODFVJZYYILJHH-UHFFFAOYSA-N 0.000 description 1
• VDRWOOXQVTYBGM-UHFFFAOYSA-N propan-2-yl 4-[6-[4-(butylamino)-2,5-difluoroanilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(F)C(NCCCC)=CC(F)=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)C)=NC=N1 VDRWOOXQVTYBGM-UHFFFAOYSA-N 0.000 description 1
• VYAHXCMINHUNRB-UHFFFAOYSA-N propan-2-yl 4-[6-[4-(ethylamino)-2-fluoroanilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(NCC)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)C)=NC=N1 VYAHXCMINHUNRB-UHFFFAOYSA-N 0.000 description 1
• VLEWEXAJLISORE-UHFFFAOYSA-N propan-2-yl 4-[6-[4-[2-(dimethylamino)-2-oxoethyl]-2-fluorophenoxy]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CC(=O)N(C)C)=CC=2)F)=C1C VLEWEXAJLISORE-UHFFFAOYSA-N 0.000 description 1
• MFGMJLPMHJBFQX-UHFFFAOYSA-N propan-2-yl 4-[6-[4-[2-(dimethylamino)ethoxy]-2,5-difluoroanilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(OCCN(C)C)=C(F)C=2)F)=NC=N1 MFGMJLPMHJBFQX-UHFFFAOYSA-N 0.000 description 1
• NUAHGRCIOZSGKL-UHFFFAOYSA-N propan-2-yl 4-[6-[4-chloro-2-(trifluoromethoxy)anilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CC(Cl)=CC=2)OC(F)(F)F)=NC=N1 NUAHGRCIOZSGKL-UHFFFAOYSA-N 0.000 description 1
• WGEATORUYINAEO-UHFFFAOYSA-N propan-2-yl 4-[6-[4-fluoro-6-(2-methylsulfonylethyl)pyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCS(C)(=O)=O)=NC=2)F)=C1C WGEATORUYINAEO-UHFFFAOYSA-N 0.000 description 1
• CXXCDNSAIZTFEO-UHFFFAOYSA-N propan-2-yl 4-[6-[4-fluoro-6-(2-morpholin-4-ylethyl)pyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=CC(CCN3CCOCC3)=NC=2)F)=C1C CXXCDNSAIZTFEO-UHFFFAOYSA-N 0.000 description 1
• JWMZGUNZIJMGJJ-UHFFFAOYSA-N propan-2-yl 4-[6-[6-(2-cyclopropyloxyethylamino)-2-methylpyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=NC(NCCOC3CC3)=CC=2)C)=C1C JWMZGUNZIJMGJJ-UHFFFAOYSA-N 0.000 description 1
• RFJSAXOECRNQBN-UHFFFAOYSA-N propan-2-yl 4-[6-[6-(2-hydroxyethylamino)-2-methylpyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=NC(NCCO)=CC=2)C)=C1C RFJSAXOECRNQBN-UHFFFAOYSA-N 0.000 description 1
• QLLZZXJBHZBUTF-UHFFFAOYSA-N propan-2-yl 4-[6-[6-(2-hydroxyethylsulfonyl)-2-methylpyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(OC=2C(=NC(=CC=2)S(=O)(=O)CCO)C)=C1C QLLZZXJBHZBUTF-UHFFFAOYSA-N 0.000 description 1
• VLLDZFQVXIVCLZ-UHFFFAOYSA-N propan-2-yl 4-[6-[6-(2-methoxyethylsulfanyl)-2-methylpyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(SCCOC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C VLLDZFQVXIVCLZ-UHFFFAOYSA-N 0.000 description 1
• QDXHFGRNGGKXSM-UHFFFAOYSA-N propan-2-yl 4-[6-[6-(2-methoxyethylsulfonyl)-2-methylpyridin-3-yl]oxy-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(S(=O)(=O)CCOC)=CC=C1OC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C QDXHFGRNGGKXSM-UHFFFAOYSA-N 0.000 description 1
• FGVGCWYIRFIJGJ-UHFFFAOYSA-N propan-2-yl 4-[6-[[2-methyl-6-(propan-2-ylamino)pyridin-3-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(NC(C)C)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)C)=NC=N1 FGVGCWYIRFIJGJ-UHFFFAOYSA-N 0.000 description 1
• ZMKTXMDBICQJDS-UHFFFAOYSA-N propan-2-yl 4-[6-[[2-methyl-6-(propylamino)pyridin-3-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(NCCC)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)C)=NC=N1 ZMKTXMDBICQJDS-UHFFFAOYSA-N 0.000 description 1
• BHGQKSLCMQRTOO-UHFFFAOYSA-N propan-2-yl 4-[6-[[4-(3,4-difluorophenyl)-1,3-thiazol-2-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2SC=C(N=2)C=2C=C(F)C(F)=CC=2)=NC=N1 BHGQKSLCMQRTOO-UHFFFAOYSA-N 0.000 description 1
• ZJARUQPGVWWHEV-UHFFFAOYSA-N propan-2-yl 4-[6-[[4-(benzenesulfonyl)thiophen-3-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2C(=CSC=2)S(=O)(=O)C=2C=CC=CC=2)=NC=N1 ZJARUQPGVWWHEV-UHFFFAOYSA-N 0.000 description 1
• AJXXWARSTYGSGI-UHFFFAOYSA-N propan-2-yl 4-[6-[[5-(1-methylpyrrolidin-2-yl)pyridin-2-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2N=CC(=CC=2)C2N(CCC2)C)=NC=N1 AJXXWARSTYGSGI-UHFFFAOYSA-N 0.000 description 1
• RDPCWCWIQMFMHE-UHFFFAOYSA-N propan-2-yl 4-[6-[[5-(trifluoromethyl)pyridin-2-yl]amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(NC=2N=CC(=CC=2)C(F)(F)F)=NC=N1 RDPCWCWIQMFMHE-UHFFFAOYSA-N 0.000 description 1
• JNOSANWQSCUMSZ-UHFFFAOYSA-N propan-2-yl 4-[6-[[6-(2-fluoroethyl)-2-methylpyridin-3-yl]amino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC(NC=2C(=NC(CCF)=CC=2)C)=C1C JNOSANWQSCUMSZ-UHFFFAOYSA-N 0.000 description 1
• WEFRNQBFKWOJDG-UHFFFAOYSA-N propan-2-yl 4-[6-[[6-(2-methoxyethoxy)-2-methylpyridin-3-yl]amino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(OCCOC)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C WEFRNQBFKWOJDG-UHFFFAOYSA-N 0.000 description 1
• OFCDUFVHTJERRH-UHFFFAOYSA-N propan-2-yl 4-[6-[[6-(2-methoxyethoxy)-4-methylpyridin-3-yl]amino]-5-methylpyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=NC(OCCOC)=CC(C)=C1NC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)C)=C1C OFCDUFVHTJERRH-UHFFFAOYSA-N 0.000 description 1
• AXFRSAXWXRXOFO-UHFFFAOYSA-N propan-2-yl 4-[6-[methyl-(2-methyl-4,5,6,7-tetrahydroindazol-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC(N(C)C=2N(N=C3CCCCC3=2)C)=NC=N1 AXFRSAXWXRXOFO-UHFFFAOYSA-N 0.000 description 1
• WDULIYFUCXVXKN-UHFFFAOYSA-N propan-2-yl 4-[8-(2,5-difluoro-4-methylsulfonylphenyl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C(C=3C(=CC(=C(F)C=3)S(C)(=O)=O)F)N=CC=C12 WDULIYFUCXVXKN-UHFFFAOYSA-N 0.000 description 1
• LPKPJFTTXSRUKD-UHFFFAOYSA-N propan-2-yl 4-[8-(2,5-difluoro-4-methylsulfonylphenyl)quinolin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC=NC2=C(C=3C(=CC(=C(F)C=3)S(C)(=O)=O)F)C=CC=C12 LPKPJFTTXSRUKD-UHFFFAOYSA-N 0.000 description 1
• PPBAZUDTGBYTBR-UHFFFAOYSA-N propan-2-yl 4-[8-(2,5-difluoro-4-sulfamoylphenyl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C(C=3C(=CC(=C(F)C=3)S(N)(=O)=O)F)N=CC=C12 PPBAZUDTGBYTBR-UHFFFAOYSA-N 0.000 description 1
• KEKYQUWQTHJLHP-UHFFFAOYSA-N propan-2-yl 4-[8-(2,5-difluoro-4-sulfamoylphenyl)quinolin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC=NC2=C(C=3C(=CC(=C(F)C=3)S(N)(=O)=O)F)C=CC=C12 KEKYQUWQTHJLHP-UHFFFAOYSA-N 0.000 description 1
• GOCSITBVDHDJHT-UHFFFAOYSA-N propan-2-yl 4-[8-(2-fluoro-4-sulfamoylphenyl)quinolin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC=NC2=C(C=3C(=CC(=CC=3)S(N)(=O)=O)F)C=CC=C12 GOCSITBVDHDJHT-UHFFFAOYSA-N 0.000 description 1
• KWVKNZLQBIVWTK-UHFFFAOYSA-N propan-2-yl 4-[8-(4-bromo-2-fluorophenyl)quinolin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC=NC2=C(C=3C(=CC(Br)=CC=3)F)C=CC=C12 KWVKNZLQBIVWTK-UHFFFAOYSA-N 0.000 description 1
• VEBDAVVHENSIOX-UHFFFAOYSA-N propan-2-yl 4-[8-(4-cyano-2-fluorophenyl)quinolin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC=NC2=C(C=3C(=CC(=CC=3)C#N)F)C=CC=C12 VEBDAVVHENSIOX-UHFFFAOYSA-N 0.000 description 1
• ZGDOJZSTYITLTM-UHFFFAOYSA-N propan-2-yl 4-[8-(4-fluoro-6-methoxypyridin-3-yl)pyrido[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=NC(OC)=CC(F)=C1C(C1=NC=N2)=NC=CC1=C2OC1CCN(C(=O)OC(C)C)CC1 ZGDOJZSTYITLTM-UHFFFAOYSA-N 0.000 description 1
• PQRDVQVGBVXQQY-UHFFFAOYSA-N propan-2-yl 4-[8-(4-fluoro-6-methoxypyridin-3-yl)quinolin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=NC(OC)=CC(F)=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C(=O)OC(C)C)CC1 PQRDVQVGBVXQQY-UHFFFAOYSA-N 0.000 description 1
• JFZFXQYQJDIFKQ-UHFFFAOYSA-N propan-2-yl 4-[8-(4-methylsulfonylphenyl)quinolin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC=NC2=C(C=3C=CC(=CC=3)S(C)(=O)=O)C=CC=C12 JFZFXQYQJDIFKQ-UHFFFAOYSA-N 0.000 description 1
• XBLHPXVPGXPRLO-UHFFFAOYSA-N propan-2-yl 4-[8-(4-propan-2-yloxyphenyl)quinolin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC=NC2=C(C=3C=CC(OC(C)C)=CC=3)C=CC=C12 XBLHPXVPGXPRLO-UHFFFAOYSA-N 0.000 description 1
• GBCCAAPXQUAFJY-UHFFFAOYSA-N propan-2-yl 4-[8-(6-methoxy-2-methylpyridin-3-yl)quinolin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(OC)=CC=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C(=O)OC(C)C)CC1 GBCCAAPXQUAFJY-UHFFFAOYSA-N 0.000 description 1
• WTFHPOOIFOLZQJ-UHFFFAOYSA-N propan-2-yl 4-[8-[2-fluoro-4-(propanoylsulfamoyl)phenyl]quinolin-4-yl]oxypiperidine-1-carboxylate Chemical compound FC1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C(C1=NC=C2)=CC=CC1=C2OC1CCN(C(=O)OC(C)C)CC1 WTFHPOOIFOLZQJ-UHFFFAOYSA-N 0.000 description 1
• NRVWBMCLVMFGAR-UHFFFAOYSA-N propan-2-yl 4-[9-(2,5-difluoro-4-sulfamoylphenyl)purin-6-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1N=CN2C1=CC(F)=C(S(N)(=O)=O)C=C1F NRVWBMCLVMFGAR-UHFFFAOYSA-N 0.000 description 1
• UKNFCUURCPKXPX-UHFFFAOYSA-N propan-2-yl 4-[9-(2-fluoro-4-sulfamoylphenyl)purin-6-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1N=CN2C1=CC=C(S(N)(=O)=O)C=C1F UKNFCUURCPKXPX-UHFFFAOYSA-N 0.000 description 1
• QUJYLFXDSLGUMV-UHFFFAOYSA-N propan-2-yl 4-[9-(4-cyano-2-fluorophenyl)purin-6-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1N=CN2C1=CC=C(C#N)C=C1F QUJYLFXDSLGUMV-UHFFFAOYSA-N 0.000 description 1
• HUDHXIUFUNEPFV-UHFFFAOYSA-N propan-2-yl 4-[[3-(4-methylsulfonylphenyl)-[1,2]oxazolo[4,5-d]pyrimidin-7-yl]oxy]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=NC=NC2=C1ON=C2C1=CC=C(S(C)(=O)=O)C=C1 HUDHXIUFUNEPFV-UHFFFAOYSA-N 0.000 description 1
• ZQUJBJQJFJEIHQ-UHFFFAOYSA-N propan-2-yl 4-[[8-(2-fluoro-4-methylsulfonylphenyl)-1,7-naphthyridin-4-yl]oxy]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1OC1=CC=NC2=C(C=3C(=CC(=CC=3)S(C)(=O)=O)F)N=CC=C12 ZQUJBJQJFJEIHQ-UHFFFAOYSA-N 0.000 description 1
• GNKXMOLBKSPBAL-UHFFFAOYSA-N propan-2-yl 4-[[[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]-propan-2-ylamino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1CN(C(C)C)C1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1F GNKXMOLBKSPBAL-UHFFFAOYSA-N 0.000 description 1
• DDUULDQMJHHKLP-UHFFFAOYSA-N propan-2-yl 4-[[[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1CN(C)C1=CC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC=N1 DDUULDQMJHHKLP-UHFFFAOYSA-N 0.000 description 1
• ACHYHTWFOZFNOJ-UHFFFAOYSA-N propan-2-yl 4-[[[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1CNC1=CC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC=N1 ACHYHTWFOZFNOJ-UHFFFAOYSA-N 0.000 description 1
• AUSHIJSUMCQIIA-UHFFFAOYSA-N propan-2-yl 4-[[[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]-propan-2-ylamino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1CN(C(C)C)C1=NC=NC(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C1C AUSHIJSUMCQIIA-UHFFFAOYSA-N 0.000 description 1
• NGPZOGZYLWHNQG-UHFFFAOYSA-N propan-2-yl 4-[[[6-(4-cyano-2,5-difluoroanilino)pyrimidin-4-yl]-ethylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=CC(=C(F)C=2)C#N)F)=NC=NC=1N(CC)CC1CCN(C(=O)OC(C)C)CC1 NGPZOGZYLWHNQG-UHFFFAOYSA-N 0.000 description 1
• RBMQOWFMSLUYHK-UHFFFAOYSA-N propan-2-yl 4-[[[6-(4-cyano-2-fluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1CN(C)C1=CC(NC=2C(=CC(=CC=2)C#N)F)=NC=N1 RBMQOWFMSLUYHK-UHFFFAOYSA-N 0.000 description 1
• BSYQXNOZYPAGLR-UHFFFAOYSA-N propan-2-yl 4-[[cyclopropylmethyl-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)C)CCC1CN(C=1C(=C(OC=2C(=CC(=CC=2)S(C)(=O)=O)F)N=CN=1)C)CC1CC1 BSYQXNOZYPAGLR-UHFFFAOYSA-N 0.000 description 1
• AUGNGWPXCWDUTA-UHFFFAOYSA-N propan-2-yl 4-[[ethyl-[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC=NC=1N(CC)CC1CCN(C(=O)OC(C)C)CC1 AUGNGWPXCWDUTA-UHFFFAOYSA-N 0.000 description 1
• 238000011321 prophylaxis Methods 0.000 description 1
• QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
• 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
• 125000006308 propyl amino group Chemical group 0.000 description 1
• UBEVLTHYAFYOEU-UHFFFAOYSA-N propyl cyclohexanecarboxylate Chemical compound CCCOC(=O)C1CCCCC1 UBEVLTHYAFYOEU-UHFFFAOYSA-N 0.000 description 1
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 235000013772 propylene glycol Nutrition 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 1
• 125000003373 pyrazinyl group Chemical group 0.000 description 1
• 125000002098 pyridazinyl group Chemical group 0.000 description 1
• VFGHOEGFPHLMIK-UHFFFAOYSA-N pyridine-2-carbonitrile Chemical compound N#CC1=C=CC=C[N]1 VFGHOEGFPHLMIK-UHFFFAOYSA-N 0.000 description 1
• 125000004076 pyridyl group Chemical group 0.000 description 1
• 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
• 125000000714 pyrimidinyl group Chemical group 0.000 description 1
• JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
• GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 1
• 238000000163 radioactive labelling Methods 0.000 description 1
• 238000011552 rat model Methods 0.000 description 1
• 229940044601 receptor agonist Drugs 0.000 description 1
• 239000000018 receptor agonist Substances 0.000 description 1
• 229960002354 repaglinide Drugs 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 238000011808 rodent model Methods 0.000 description 1
• 229960004586 rosiglitazone Drugs 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 230000036186 satiety Effects 0.000 description 1
• 235000019627 satiety Nutrition 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 235000015424 sodium Nutrition 0.000 description 1
• 235000010413 sodium alginate Nutrition 0.000 description 1
• 239000000661 sodium alginate Substances 0.000 description 1
• 229940005550 sodium alginate Drugs 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 239000007901 soft capsule Substances 0.000 description 1
• 239000012453 solvate Substances 0.000 description 1
• 238000001694 spray drying Methods 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 125000001174 sulfone group Chemical group 0.000 description 1
• YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
• 125000003375 sulfoxide group Chemical group 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical class S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 239000007939 sustained release tablet Substances 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000007916 tablet composition Substances 0.000 description 1
• RGAGQFGWAAKYGB-UHFFFAOYSA-N tert-butyl 3-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxypyrrolidine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O RGAGQFGWAAKYGB-UHFFFAOYSA-N 0.000 description 1
• WESIASPLBWOSTO-UHFFFAOYSA-N tert-butyl 4-[(2-pyridin-4-yl-1,3-thiazol-4-yl)methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CC1=CSC(C=2C=CN=CC=2)=N1 WESIASPLBWOSTO-UHFFFAOYSA-N 0.000 description 1
• DHIBFGHZLMBADV-UHFFFAOYSA-N tert-butyl 4-[(4-pyridin-4-yl-1,3-thiazol-2-yl)methoxy]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OCC1=NC(C=2C=CN=CC=2)=CS1 DHIBFGHZLMBADV-UHFFFAOYSA-N 0.000 description 1
• FDRHMAIJPIXWBZ-UHFFFAOYSA-N tert-butyl 4-[(5-pyridin-4-yl-1,2-oxazol-3-yl)methoxy]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OCC1=NOC(C=2C=CN=CC=2)=C1 FDRHMAIJPIXWBZ-UHFFFAOYSA-N 0.000 description 1
• OKPNANBGMBXLNA-UHFFFAOYSA-N tert-butyl 4-[(5-pyridin-4-yl-1,2-oxazol-3-yl)methyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CC1=NOC(C=2C=CN=CC=2)=C1 OKPNANBGMBXLNA-UHFFFAOYSA-N 0.000 description 1
• LZCNLEZPKDPKSO-UHFFFAOYSA-N tert-butyl 4-[1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=NC=NC2=C1C=NN2C1=CC=C(S(C)(=O)=O)C=C1 LZCNLEZPKDPKSO-UHFFFAOYSA-N 0.000 description 1
• BHOGBIUUVFUONZ-UHFFFAOYSA-N tert-butyl 4-[2-(5-pyridin-4-yl-1,2-oxazol-3-yl)ethyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CCC1=NOC(C=2C=CN=CC=2)=C1 BHOGBIUUVFUONZ-UHFFFAOYSA-N 0.000 description 1
• FKIHXQMQMOEAMV-UHFFFAOYSA-N tert-butyl 4-[2-[6-(4-methylsulfonylanilino)-5-nitropyrimidin-4-yl]oxyethyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CCOC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O FKIHXQMQMOEAMV-UHFFFAOYSA-N 0.000 description 1
• JEHGKJLXZUARCY-UHFFFAOYSA-N tert-butyl 4-[3,6-dimethyl-1-(4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C12=NC(C)=NC(OC3CCN(CC3)C(=O)OC(C)(C)C)=C2C(C)=NN1C1=CC=C(S(C)(=O)=O)C=C1 JEHGKJLXZUARCY-UHFFFAOYSA-N 0.000 description 1
• RNXQXVJILIUHTG-UHFFFAOYSA-N tert-butyl 4-[3-(4-methylsulfonylphenyl)triazolo[4,5-d]pyrimidin-7-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=NC=NC2=C1N=NN2C1=CC=C(S(C)(=O)=O)C=C1 RNXQXVJILIUHTG-UHFFFAOYSA-N 0.000 description 1
• SAMVLAMRISVWGR-UHFFFAOYSA-N tert-butyl 4-[5-acetyl-6-[(6-methylsulfonylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound N1=CN=C(OC2CCN(CC2)C(=O)OC(C)(C)C)C(C(=O)C)=C1NC1=CC=C(S(C)(=O)=O)N=C1 SAMVLAMRISVWGR-UHFFFAOYSA-N 0.000 description 1
• KEKFIYXWIZJMKJ-UHFFFAOYSA-N tert-butyl 4-[5-cyano-6-(3-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=NC=NC(NC=2C=C(F)C(=CC=2)S(C)(=O)=O)=C1C#N KEKFIYXWIZJMKJ-UHFFFAOYSA-N 0.000 description 1
• QVKBITMZDPTZKG-UHFFFAOYSA-N tert-butyl 4-[5-cyano-6-(4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=NC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=C1C#N QVKBITMZDPTZKG-UHFFFAOYSA-N 0.000 description 1
• IHTJOXCTNVRHKN-UHFFFAOYSA-N tert-butyl 4-[5-cyano-6-[(6-methylsulfanylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=NC(SC)=CC=C1NC1=NC=NC(OC2CCN(CC2)C(=O)OC(C)(C)C)=C1C#N IHTJOXCTNVRHKN-UHFFFAOYSA-N 0.000 description 1
• DXMWOHKWJKAKKF-UHFFFAOYSA-N tert-butyl 4-[6-(2,4,5-trifluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=CC(NC=2C(=CC(F)=C(F)C=2)F)=NC=N1 DXMWOHKWJKAKKF-UHFFFAOYSA-N 0.000 description 1
• VXORJLAWVPWALQ-UHFFFAOYSA-N tert-butyl 4-[6-(2,5-difluoro-4-methylsulfonylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=CC(NC=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=NC=N1 VXORJLAWVPWALQ-UHFFFAOYSA-N 0.000 description 1
• SLWJOYLTHZTIMI-UHFFFAOYSA-N tert-butyl 4-[6-(2,5-difluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=CC(NC=2C(=CC=C(F)C=2)F)=NC=N1 SLWJOYLTHZTIMI-UHFFFAOYSA-N 0.000 description 1
• ODYICEBBILZEES-UHFFFAOYSA-N tert-butyl 4-[6-(3-chloro-4-cyanoanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=CC(NC=2C=C(Cl)C(C#N)=CC=2)=NC=N1 ODYICEBBILZEES-UHFFFAOYSA-N 0.000 description 1
• MIIUYCQVBMKGHW-UHFFFAOYSA-N tert-butyl 4-[6-(3-fluoro-4-methylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(F)C(C)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 MIIUYCQVBMKGHW-UHFFFAOYSA-N 0.000 description 1
• WCSIWBZAFZMATF-UHFFFAOYSA-N tert-butyl 4-[6-(4-bromo-2,5-difluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=CC(NC=2C(=CC(Br)=C(F)C=2)F)=NC=N1 WCSIWBZAFZMATF-UHFFFAOYSA-N 0.000 description 1
• KPCJRGWCDVTICZ-UHFFFAOYSA-N tert-butyl 4-[6-(4-chloro-2-fluoroanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=CC(NC=2C(=CC(Cl)=CC=2)F)=NC=N1 KPCJRGWCDVTICZ-UHFFFAOYSA-N 0.000 description 1
• QVTJDDYVXSJKOP-UHFFFAOYSA-N tert-butyl 4-[6-(4-ethylsulfanylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=CC(SCC)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 QVTJDDYVXSJKOP-UHFFFAOYSA-N 0.000 description 1
• PHWQPKNWYHOPCW-UHFFFAOYSA-N tert-butyl 4-[6-(4-propan-2-ylsulfanylanilino)pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=CC(SC(C)C)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 PHWQPKNWYHOPCW-UHFFFAOYSA-N 0.000 description 1
• FIEUTLZUXFVECV-UHFFFAOYSA-N tert-butyl 4-[6-[(2-chloro-4-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=CC=NC(Cl)=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 FIEUTLZUXFVECV-UHFFFAOYSA-N 0.000 description 1
• QQDJBTGICVXVCN-UHFFFAOYSA-N tert-butyl 4-[6-[(2-methoxypyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound COC1=NC=CC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 QQDJBTGICVXVCN-UHFFFAOYSA-N 0.000 description 1
• UTTFZIMHPCSNCH-UHFFFAOYSA-N tert-butyl 4-[6-[(2-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC=CC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 UTTFZIMHPCSNCH-UHFFFAOYSA-N 0.000 description 1
• MTKAAQXJBGEGCA-UHFFFAOYSA-N tert-butyl 4-[6-[(4-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=CC=NC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 MTKAAQXJBGEGCA-UHFFFAOYSA-N 0.000 description 1
• MHCGMFYDBQLSBG-UHFFFAOYSA-N tert-butyl 4-[6-[(5-fluoro-4-methylpyridin-2-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(F)C(C)=CC(NC=2N=CN=C(OC3CCN(CC3)C(=O)OC(C)(C)C)C=2)=N1 MHCGMFYDBQLSBG-UHFFFAOYSA-N 0.000 description 1
• LUHHZPSVZXSYEU-UHFFFAOYSA-N tert-butyl 4-[6-[(5-fluoropyridin-2-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=CC(NC=2N=CC(F)=CC=2)=NC=N1 LUHHZPSVZXSYEU-UHFFFAOYSA-N 0.000 description 1
• GFQYDMFPQRMJTH-UHFFFAOYSA-N tert-butyl 4-[6-[(6-acetamido-4-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=NC(NC(=O)C)=CC(C)=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 GFQYDMFPQRMJTH-UHFFFAOYSA-N 0.000 description 1
• GGGPLIXPJOFOHA-UHFFFAOYSA-N tert-butyl 4-[6-[(6-chloro-5-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound N1=C(Cl)C(C)=CC(NC=2N=CN=C(OC3CCN(CC3)C(=O)OC(C)(C)C)C=2)=C1 GGGPLIXPJOFOHA-UHFFFAOYSA-N 0.000 description 1
• FEYLXVDOTUMFRX-UHFFFAOYSA-N tert-butyl 4-[6-[(6-fluoropyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=CC(NC=2C=NC(F)=CC=2)=NC=N1 FEYLXVDOTUMFRX-UHFFFAOYSA-N 0.000 description 1
• NWWQTKSOSNGVFO-UHFFFAOYSA-N tert-butyl 4-[6-[(6-methoxy-2-methylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound CC1=NC(OC)=CC=C1NC1=CC(OC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 NWWQTKSOSNGVFO-UHFFFAOYSA-N 0.000 description 1
• MRONFGQLGIAZRT-UHFFFAOYSA-N tert-butyl 4-[6-[(6-methylsulfonylpyridin-3-yl)amino]-5-nitropyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=NC=NC(NC=2C=NC(=CC=2)S(C)(=O)=O)=C1[N+]([O-])=O MRONFGQLGIAZRT-UHFFFAOYSA-N 0.000 description 1
• DUUPUBWFRFCDSF-UHFFFAOYSA-N tert-butyl 4-[6-[4-cyano-5-(ethylamino)-2-fluoroanilino]pyrimidin-4-yl]oxypiperidine-1-carboxylate Chemical compound C1=C(C#N)C(NCC)=CC(NC=2N=CN=C(OC3CCN(CC3)C(=O)OC(C)(C)C)C=2)=C1F DUUPUBWFRFCDSF-UHFFFAOYSA-N 0.000 description 1
• OCYNFFJJVQTMHY-UHFFFAOYSA-N tert-butyl 4-[9-(2-fluoro-4-methylsulfonylphenyl)purin-6-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=NC=NC2=C1N=CN2C1=CC=C(S(C)(=O)=O)C=C1F OCYNFFJJVQTMHY-UHFFFAOYSA-N 0.000 description 1
• BTYRTNRWQFWQNI-UHFFFAOYSA-N tert-butyl 4-[9-(4-methylsulfonylphenyl)purin-6-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=NC=NC2=C1N=CN2C1=CC=C(S(C)(=O)=O)C=C1 BTYRTNRWQFWQNI-UHFFFAOYSA-N 0.000 description 1
• LLNCYVQDERPCTB-UHFFFAOYSA-N tert-butyl 4-[9-(6-methylsulfonylpyridin-3-yl)purin-6-yl]oxypiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OC1=NC=NC2=C1N=CN2C1=CC=C(S(C)(=O)=O)N=C1 LLNCYVQDERPCTB-UHFFFAOYSA-N 0.000 description 1
• AWEXVOQVKODMQO-UHFFFAOYSA-N tert-butyl 4-[[3-(4-methylsulfonylphenyl)-[1,2]oxazolo[4,5-d]pyrimidin-7-yl]sulfanyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1SC1=NC=NC2=C1ON=C2C1=CC=C(S(C)(=O)=O)C=C1 AWEXVOQVKODMQO-UHFFFAOYSA-N 0.000 description 1
• DKWHSYDHMNJQSL-UHFFFAOYSA-N tert-butyl 4-[[5-[2-(2h-tetrazol-5-yl)pyridin-4-yl]-1,2,4-oxadiazol-3-yl]methoxy]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1OCC1=NOC(C=2C=C(N=CC=2)C2=NNN=N2)=N1 DKWHSYDHMNJQSL-UHFFFAOYSA-N 0.000 description 1
• WEZMGRMNJHETGX-UHFFFAOYSA-N tert-butyl 4-[[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]-methylamino]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC=NC=1N(C)C1CCN(C(=O)OC(C)(C)C)CC1 WEZMGRMNJHETGX-UHFFFAOYSA-N 0.000 description 1
• BEHIWMRJLUNCOY-UHFFFAOYSA-N tert-butyl 4-[[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]amino]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1NC1=CC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC=N1 BEHIWMRJLUNCOY-UHFFFAOYSA-N 0.000 description 1
• FBGQLNUXCINDQY-UHFFFAOYSA-N tert-butyl 4-[[[6-(2,3-difluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=C(F)C=CC=2)F)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 FBGQLNUXCINDQY-UHFFFAOYSA-N 0.000 description 1
• DVDLRDUZLXASQT-UHFFFAOYSA-N tert-butyl 4-[[[6-(2,5-difluoro-4-methylsulfonylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=CC(=C(F)C=2)S(C)(=O)=O)F)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 DVDLRDUZLXASQT-UHFFFAOYSA-N 0.000 description 1
• IQOOREDSVLRICW-UHFFFAOYSA-N tert-butyl 4-[[[6-(2,5-difluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=CC=C(F)C=2)F)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 IQOOREDSVLRICW-UHFFFAOYSA-N 0.000 description 1
• YELNVXLAXOUOBY-UHFFFAOYSA-N tert-butyl 4-[[[6-(2,5-difluorophenoxy)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(OC=2C(=CC=C(F)C=2)F)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 YELNVXLAXOUOBY-UHFFFAOYSA-N 0.000 description 1
• DSIGVEIKDAIQSE-UHFFFAOYSA-N tert-butyl 4-[[[6-(2,6-difluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=CC=CC=2F)F)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 DSIGVEIKDAIQSE-UHFFFAOYSA-N 0.000 description 1
• LGPMZKRZFRTNRM-UHFFFAOYSA-N tert-butyl 4-[[[6-(2-fluoro-4-methylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=CC(C)=CC=2)F)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 LGPMZKRZFRTNRM-UHFFFAOYSA-N 0.000 description 1
• ZPMVWRVSMSTFOR-UHFFFAOYSA-N tert-butyl 4-[[[6-(2-fluoro-4-methylsulfonylanilino)-5-methylpyrimidin-4-yl]-propan-2-ylamino]methyl]piperidine-1-carboxylate Chemical compound N=1C=NC(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=C(C)C=1N(C(C)C)CC1CCN(C(=O)OC(C)(C)C)CC1 ZPMVWRVSMSTFOR-UHFFFAOYSA-N 0.000 description 1
• QUFUTDMNYRSZNI-UHFFFAOYSA-N tert-butyl 4-[[[6-(2-fluoro-4-methylsulfonylanilino)pyrimidin-4-yl]-propan-2-ylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC=NC=1N(C(C)C)CC1CCN(C(=O)OC(C)(C)C)CC1 QUFUTDMNYRSZNI-UHFFFAOYSA-N 0.000 description 1
• UKIRMSQPZWPANJ-UHFFFAOYSA-N tert-butyl 4-[[[6-(2-fluoro-n-methyl-4-methylsulfonylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(N(C)C=2C(=CC(=CC=2)S(C)(=O)=O)F)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 UKIRMSQPZWPANJ-UHFFFAOYSA-N 0.000 description 1
• XXKRRJZMIHHGQT-UHFFFAOYSA-N tert-butyl 4-[[[6-(2-fluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=CC=CC=2)F)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 XXKRRJZMIHHGQT-UHFFFAOYSA-N 0.000 description 1
• QWTPEUOVBPWBQQ-UHFFFAOYSA-N tert-butyl 4-[[[6-(3-chloro-2-fluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=C(Cl)C=CC=2)F)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 QWTPEUOVBPWBQQ-UHFFFAOYSA-N 0.000 description 1
• OOPLUMYXIXSERK-UHFFFAOYSA-N tert-butyl 4-[[[6-(4-amino-2,5-difluorophenoxy)pyrimidin-4-yl]-ethylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(OC=2C(=CC(N)=C(F)C=2)F)=NC=NC=1N(CC)CC1CCN(C(=O)OC(C)(C)C)CC1 OOPLUMYXIXSERK-UHFFFAOYSA-N 0.000 description 1
• QIDFGUUYDATDJR-UHFFFAOYSA-N tert-butyl 4-[[[6-(4-bromo-2,5-difluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=CC(Br)=C(F)C=2)F)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 QIDFGUUYDATDJR-UHFFFAOYSA-N 0.000 description 1
• RDXHOFZPIHBZEU-UHFFFAOYSA-N tert-butyl 4-[[[6-(4-butanoylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C1=CC(C(=O)CCC)=CC=C1NC1=CC(N(C)CC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 RDXHOFZPIHBZEU-UHFFFAOYSA-N 0.000 description 1
• UIUBRIAKSKVFOA-UHFFFAOYSA-N tert-butyl 4-[[[6-(4-cyano-2-fluoroanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=CC(=CC=2)C#N)F)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 UIUBRIAKSKVFOA-UHFFFAOYSA-N 0.000 description 1
• PSIQZTCDQVYQKP-UHFFFAOYSA-N tert-butyl 4-[[[6-(4-ethylsulfanylanilino)pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C1=CC(SCC)=CC=C1NC1=CC(N(C)CC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 PSIQZTCDQVYQKP-UHFFFAOYSA-N 0.000 description 1
• LXYZFYSSVCARHV-UHFFFAOYSA-N tert-butyl 4-[[[6-[(3-bromo-5-methylpyridin-2-yl)amino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=CC(C)=CN=2)Br)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 LXYZFYSSVCARHV-UHFFFAOYSA-N 0.000 description 1
• SRJBDZPZKDQQKQ-UHFFFAOYSA-N tert-butyl 4-[[[6-[(5-fluoropyridin-2-yl)amino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2N=CC(F)=CC=2)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 SRJBDZPZKDQQKQ-UHFFFAOYSA-N 0.000 description 1
• AMXXVTHPKQUEGH-UHFFFAOYSA-N tert-butyl 4-[[[6-[(6-acetamidopyridin-3-yl)amino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C=NC(NC(C)=O)=CC=2)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 AMXXVTHPKQUEGH-UHFFFAOYSA-N 0.000 description 1
• UZUTWHDSGJTVJQ-UHFFFAOYSA-N tert-butyl 4-[[[6-[(6-methoxypyridin-3-yl)amino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C1=NC(OC)=CC=C1NC1=CC(N(C)CC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 UZUTWHDSGJTVJQ-UHFFFAOYSA-N 0.000 description 1
• SVWPFEQWTXAQQC-UHFFFAOYSA-N tert-butyl 4-[[[6-[2-(2-chlorophenoxy)ethylamino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NCCOC=2C(=CC=CC=2)Cl)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 SVWPFEQWTXAQQC-UHFFFAOYSA-N 0.000 description 1
• UJKVOHRGOJHTPX-UHFFFAOYSA-N tert-butyl 4-[[[6-[2-fluoro-4-(propan-2-ylsulfamoyl)anilino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound FC1=CC(S(=O)(=O)NC(C)C)=CC=C1NC1=CC(N(C)CC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 UJKVOHRGOJHTPX-UHFFFAOYSA-N 0.000 description 1
• ACENZFHHGLELEH-UHFFFAOYSA-N tert-butyl 4-[[[6-[4-(dimethylsulfamoyl)anilino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C1=CC(S(=O)(=O)N(C)C)=CC=C1NC1=CC(N(C)CC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 ACENZFHHGLELEH-UHFFFAOYSA-N 0.000 description 1
• GHMQFBXQDXQOKK-UHFFFAOYSA-N tert-butyl 4-[[[6-[4-(ethylsulfamoyl)-2-fluoroanilino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound FC1=CC(S(=O)(=O)NCC)=CC=C1NC1=CC(N(C)CC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 GHMQFBXQDXQOKK-UHFFFAOYSA-N 0.000 description 1
• AEDIOEKYCAAVFV-UHFFFAOYSA-N tert-butyl 4-[[[6-[4-(ethylsulfamoyl)anilino]pyrimidin-4-yl]-methylamino]methyl]piperidine-1-carboxylate Chemical compound C1=CC(S(=O)(=O)NCC)=CC=C1NC1=CC(N(C)CC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 AEDIOEKYCAAVFV-UHFFFAOYSA-N 0.000 description 1
• XBMAXMJVSLTTIB-UHFFFAOYSA-N tert-butyl 4-[[cyclopropyl-[6-(2-fluoro-4-methylsulfonylphenoxy)-5-methylpyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound N1=CN=C(N(CC2CCN(CC2)C(=O)OC(C)(C)C)C2CC2)C(C)=C1OC1=CC=C(S(C)(=O)=O)C=C1F XBMAXMJVSLTTIB-UHFFFAOYSA-N 0.000 description 1
• GKLRFGDHBQMBQS-UHFFFAOYSA-N tert-butyl 4-[[ethyl-[3-(4-methylsulfonylphenyl)-[1,2]oxazolo[4,5-d]pyrimidin-7-yl]amino]methyl]piperidine-1-carboxylate Chemical compound N=1C=NC=2C(C=3C=CC(=CC=3)S(C)(=O)=O)=NOC=2C=1N(CC)CC1CCN(C(=O)OC(C)(C)C)CC1 GKLRFGDHBQMBQS-UHFFFAOYSA-N 0.000 description 1
• HJVPPPPOUXXWKN-UHFFFAOYSA-N tert-butyl 4-[[ethyl-[6-(2,4,5-trifluoroanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C(=CC(F)=C(F)C=2)F)=NC=NC=1N(CC)CC1CCN(C(=O)OC(C)(C)C)CC1 HJVPPPPOUXXWKN-UHFFFAOYSA-N 0.000 description 1
• KXFQWSZPMPHTHY-UHFFFAOYSA-N tert-butyl 4-[[methyl-[6-(2-pyridin-4-ylethylamino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NCCC=2C=CN=CC=2)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 KXFQWSZPMPHTHY-UHFFFAOYSA-N 0.000 description 1
• VWTIPKYMROXKLJ-UHFFFAOYSA-N tert-butyl 4-[[methyl-[6-(4-methylsulfonylanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C=CC(=CC=2)S(C)(=O)=O)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 VWTIPKYMROXKLJ-UHFFFAOYSA-N 0.000 description 1
• ZMEQMUGHODIJRJ-UHFFFAOYSA-N tert-butyl 4-[[methyl-[6-(4-morpholin-4-ylsulfonylanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C=CC(=CC=2)S(=O)(=O)N2CCOCC2)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 ZMEQMUGHODIJRJ-UHFFFAOYSA-N 0.000 description 1
• LGZVHSYRARGANA-UHFFFAOYSA-N tert-butyl 4-[[methyl-[6-(4-propan-2-ylsulfanylanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound C1=CC(SC(C)C)=CC=C1NC1=CC(N(C)CC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 LGZVHSYRARGANA-UHFFFAOYSA-N 0.000 description 1
• MRZSQTDHZCASIQ-UHFFFAOYSA-N tert-butyl 4-[[methyl-[6-(4-sulfamoylanilino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C=CC(=CC=2)S(N)(=O)=O)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 MRZSQTDHZCASIQ-UHFFFAOYSA-N 0.000 description 1
• RJFVCLXPHFRRTN-UHFFFAOYSA-N tert-butyl 4-[[methyl-[6-(pyridin-3-ylmethylamino)pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NCC=2C=NC=CC=2)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 RJFVCLXPHFRRTN-UHFFFAOYSA-N 0.000 description 1
• VNZUITKKJSLRPL-UHFFFAOYSA-N tert-butyl 4-[[methyl-[6-[4-(2-methylsulfonylethyl)anilino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C=CC(CCS(C)(=O)=O)=CC=2)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 VNZUITKKJSLRPL-UHFFFAOYSA-N 0.000 description 1
• WQRRGUDMOZLDRA-UHFFFAOYSA-N tert-butyl 4-[[methyl-[6-[4-(methylsulfamoyl)anilino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound C1=CC(S(=O)(=O)NC)=CC=C1NC1=CC(N(C)CC2CCN(CC2)C(=O)OC(C)(C)C)=NC=N1 WQRRGUDMOZLDRA-UHFFFAOYSA-N 0.000 description 1
• RRWFPIOXQUMZBY-UHFFFAOYSA-N tert-butyl 4-[[methyl-[6-[4-[(2-oxo-1,3-oxazolidin-4-yl)methyl]anilino]pyrimidin-4-yl]amino]methyl]piperidine-1-carboxylate Chemical compound C=1C(NC=2C=CC(CC3NC(=O)OC3)=CC=2)=NC=NC=1N(C)CC1CCN(C(=O)OC(C)(C)C)CC1 RRWFPIOXQUMZBY-UHFFFAOYSA-N 0.000 description 1
• CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 1
• LPQZERIRKRYGGM-UHFFFAOYSA-N tert-butyl pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCC1 LPQZERIRKRYGGM-UHFFFAOYSA-N 0.000 description 1
• 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 125000001391 thioamide group Chemical group 0.000 description 1
• 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 1
• 125000000464 thioxo group Chemical group S=* 0.000 description 1
• 239000004408 titanium dioxide Substances 0.000 description 1
• 230000002110 toxicologic effect Effects 0.000 description 1
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 150000003626 triacylglycerols Chemical class 0.000 description 1
• 125000004306 triazinyl group Chemical group 0.000 description 1
• 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 description 1
• 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 1
• HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
• 229940038773 trisodium citrate Drugs 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 1
• 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 208000019553 vascular disease Diseases 0.000 description 1
• 239000013598 vector Substances 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 229960001729 voglibose Drugs 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
• 239000001993 wax Substances 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 229940075420 xanthine Drugs 0.000 description 1